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SUt1HARV 
The aims of this research were to est ab 1 i sh the drug use pat-
terns of an elderly population in the so1..1thern suburbs of the 
C.3pe peni nsu 1 a and to determine the e :< tent of know ledge with 
respect to their medicines . In addition the relationship between 
dr1J9 •Jse patterns and medication knowledge and the socio-
e c onomic status of the elderly , the health care services 
utilised by them and the amount of information conveyed on medi-
cine container labels was assessed. 
Two hundred and s i :<ty non-inst i tut i ona 1 i sed caucas i an e 1 der 1 y 
over the age of 65 years and living in old age residences were 
interviewed, The interviews were str•Jctured with 4 major com-
ponents : 
1, a questionnaire designed to collect participant particulars , 
2. an interview schedule to collect information on drug use pat-
terns and to assess participant knowledge of medicines used 
<Knowledge score) 
3. a container label assessment schedule (Label score) 
4 , a cognitive function test to identify and e :-(c 1 ude severe 1 y 
cognitively impaired elderly from the study population. 
Analysis of the data showed the majority of the participants 
were English-speaking women of social class 1 or 2, Approximate-
ly one fifth of all participants were male . The State-run health 
care services were .utilised by 38% of the participants whilst 
73% retained their own general practitioner. A total of 843 med-
icines were used with an average of 3 , 2 medicines per capita. 
Ninety-five percent of all participants took prescribed medi-
viii 
cines , with diuretics , non-narcotic analgesics/antipyretics , and 
tranquillisers the "7 ._, 
smaller percentage 
most fr eq•.J ent 1 y pres er i bed classes . A 
41 . 5% of participants used self-
prescribed medicines , of which non-narcotic .:inalgesics , 
homeopathic and herbal medicines . and vitamins were taken most 
frequently . When assessed against container label directions ap-
p ro :-( im .:itely one third of participants were non-compliant with 
their dosa,;ie regimens, The ma j or i t ·y1 of a 11 medicines had been 
used on a continuous basis for 1 to 10 years. 
Average knowledge score was 58% , The ma.Jori ty of participants 
had very little knowledge about interactions , side effects , and 
m.3:-( i mum p erro i ss i b le dose for their medicines , J 1Jst over one 
fifth of all participants co•Jld correctly state both the name 
and the strength of their medicine. Average knowledge score was 
found to decline with increasing age , but no relationships were 
found to e x ist with the other patient characteristics . Similar-
ly , no relationship was found to exist between knowledge score 
and label score . Participants utilising the public health care 
services tended to have a lower knowledge score than those 
receiving treatment from the private sector . Twenty-six percent 
of all labels did not have specific usage directions. The pri-
vate sector suppliers were most frequently culpable of omitting 
instr•.Jctions. Label legiblity also proved to be a problem for 
the elderly participants. 
The drug •Jse patterns identified in this study are similar to 
those of the American and British elderly and should be of value 
in compiling a health care plan for the South African elderly , 
.3 l tho ugh further research in vo 1 vi ng other race .3nd cu 1 tura l 
groups is needed. 
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 f ;;:1dherr:,inc:f,) to 
the dosage schedule as shown on the container la
bel 
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 they are being 
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n 8nd also in-
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Interact Interfere with the medi cine in such a wa
v that: 
a. it may be de-8ctiv8ted and thus rendered the
r8oeutic8lly in-
•::.•f f(':!,::.t:i.'v'(':!, 
b. its side effects may be potentiated to 8n int
oler8ble level 
of the disease beina treated. 
Knowledge Score Th,:,i .0.1mo unt of kno 1.,Jlf·id.-;.1r~i thi:,i p.=:1,-·t:i
.;::::i.p~.int h .::.i·=:;, r:,,:<-· 
pressed ass percent of the amount of knowledge
 he (she) should 
have to enable him (her) to use his (her) medici
ne 1n such a way 
that 1t will not be detri me ntal to his (her) hea
lth. 
Medicine A tablet or c8psule prepar8tion consume
d for the pur-
oose of mai nt8ining the present state of health 
or well-being or 
of restoring good health or well-being. 
Particip.ant Characteristics Th•?:! p;:.1,-·t :i. ;::u l .==.1r''::; of t
h•?:! p.=:.·1,~i:: :i. ;:: :i. p~.1rit 
;{'../ ]. 
d r :i. n 1<. :i. r1 q h .=.1 b i t <;; • 1 (·1 • ..; ;:,i l D f •::1 d 1 ..1 ,.: ;::1 t :i. ,::i n . ·=:; ci 1.: :i. ;_:_1 l <;; t ·':l t u ,,; 
. mo n t i"1 1 '/ i n ···· 
utilised. medicines supolier 8nd medic8l 8id 
benefits. 
Prescribed Medicine (m·'.i med:i. ,.::i. n<;,i th .:;:;t i <:, us,:7id on 
th,::-i b,,.1<; :i. s of 
the di8gnasis and instr u ction of a medi c8l do
ctor. 
Self-prescribed Medicine Anv medici ne that 1s used 
on the basis 
of the patient's own diagnosis ana without t
he instruction of a 
lrt(·~d i ,.:.:::i l do,:.'.tor. 
tvoes of tertiary education such as universi
ty and college (for 
examole teachers' and nurses ' tr8ining colleg
es) educ8tion, How-
ever. it does not include training at commer
cial colleges . 
}::'v' 1 l 
CHAPTER 1 
1,1 INTRODUCTION 
It has been noted (Heiring PdeV , 1989) that the health care ser-
vices provided for the South African elderly are inadequate . By 
the year 2020 South Africa will have a population of appro:-:i-
mately four million people aged 65 and over, many of whom will 
be needing supportive care (Glajchen, 1989) It is essential 
that any services to be provided to the elderly be carefully 
planned and based on known requirements so that there can be 
ma x imum utilisation of manpower . 
Old age is accompanied by numerous social as well as physiologi-
cal and pathological changes. Often, the social changes may have 
a negative impact upon the health status of the elderly person 
and vice versa. This makes health care management of the elderly 
particularly difficult and time consuming . 
0 f part i cu 1 ar cone ern is the drug management of the e 1 der 1 y 
patient . The elderly receive more prescriptions than younger 
patients (Cartwright et al . 1988). They tend to use their medi-
cines for longer periods of time, receiving more repeat pres-
criptions than other age groups (Murdoch 1980) and have been 
found to have a high incidence d f adverse drug reactions ( W i 1-
1 i amson et al 1980, Hartys 1982 , Casteldon et al 1988) . Drug re-
lated adverse events, irrespective of the reasons for them , can 
be e x pensive . In the study done by Cooke et al (1985) , length of 
inpatient stay due to adverse drug reactions ranged from 3 to 18 
days in the 65 years and older age group. 
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It is the recommendation of both the Royal College of Physicians 
(London , 1984) and the World Health Organisation (1980) that 
more emphasis be placed on the education of not only the health 
care providers , but also on the education of the elderly patient 
in the correct use of medicines . 
Several studies have shown that patients do consider medication 
inform.3tion to be important and that patient satisfaction and 
compliance improve with more detailed counselling (Gardner et al 
1988 , Culber~son et al 1988 , Hulka et al 1976) . The pharmacist, 
as the person who normally dispenses the patient ' s medication , 
can play a major part in the education of the elderly patient. 
In Sot.Jth Africa, very little is known about the elderly out-
patient and his use of medicines. Before any comprehensive plan 
to educate the elderly in the safe use of medicines can be drawn 
up , more information on their drug use patterns needs to be col-
lected. In addition, the knowledge that the elderly already have 
with respect to their medicines must be determined and any 
socio-economic factors influencing this knowledge and drug use 
must be taken into consideration. It is with these aspects in 
mind that this study has been undertaken. 
2 
1,2 LITERATURE REVIEW 
1 ... 2. 1 THE ELDERLY POPULATION 
The elderly sector of the population is growing rapidly, not 
only in E1-1rope and the United States of America, but also in 
South Africa. Glajchen (1989) draws attention to the prediction 
that by the year 2020, the total number of 65 year olds in South 
Africa will be only slightly less than that of the total white 
population in 1985. The number of aged in South Africa will in-
crease from Just under one and a third million in 1985 to over 4 
million by 2020 (President's Cduncil report PGI/1988) . This 
three-fold increase in the elderly population within 35 years 
will place heavy demands on th~ health care services and on the 
c om mu n ity as a whole. 
Old age is accompanied by social and financial changes as well 
as declining health. Most people retire from full-time employ-
ment within 5 to 10 years after reaching the age of 60 years. 
This results in a shift in the status of the retiree within the 
community and frequent 1 y an accompanying change in f i nanc i a 1 
circumstances. A further shift in social standing may occur with 
the loss of a spouse. Both of these major changes are stressful 
and Berardo (1988) points out that bereavement at least, has 
been shown to have a pronounced effect on both health and life 
satisfaction. 
Women tend to live longer than men and in the over 85 years age 
group, women may outnumber men b-y as much as 4: 1 (Cartwright et 
al 1988). Many of these old women may be living alone and may 
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need community help and support <Berardo 1988), Glajchen (1989) 
points out that the South African National Council for the Aged 
estimates that approximately 7% of the 65 to 74 years age group , 
for both sexes, needs some help with personal care and daily ac-
tivities and that this figure increases to 39% in the over 85 
year age ,;iroup. 
The elderly are a • ..mique sector of the population not only in 
terms of their position within the community, but also in terms 
of their health care needs. Old age itself is not a disease, but 
the agi-Y"ig process with the accompanying pathological and 
physiological changes complicates health care management of the 
elderly patient. This is particularly true when the patient 
needs medication 
1,2,2 DRUG USE IN THE ELDERLY 
Drug use by the elderly is characterised by the following major 
f .3ctors : 
1.2.2.1 ALTERED PHARHACOKINETICS AND PHARHACODYNAHICS 
The abi 1 i ty to metabolise and e:-,crete drugs, the distribution 
volumes of drugs 
alter as part of 
1982, Platt 1986, 
and the end organ sensitivity to drugs all 
the natural aging process (Greenblatt et al 
Beers et al 1989). For the average 80 year 
old, renal function may be reduced to as little as half of that 
of a 30 year old. This must be taken into consideration in 
treating the elderly as many drugs are e:<creted via the kidneys, 
and appropriate adjustments to their medication regimens must be 
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made (Lonergan 1988) In addition, drug metabolism by the liver 
may be reduced by diminished hepatic blood flow, impaired 
hepatic microsomal enzyme activity, and a reduction in size of 
the liver. Drug distribution is affected by a change in the lean 
muscle to fat ratio in the older body. Lean body mass declines 
while the adipose-tissue mass increases. There may also be an 
age-related decline in plasma albumin which may be of relevanc~ 
when highly protein bound drugs are used . 
Apart from these changes in pharmacoki net ics, pharmacodynami c 
alterations have also been noted. Usually, the elderly patient 
exhibits an increased sensitivity to drugs, typical examples in-
cl 1Jd i ng the narcotic analgesics and oral anti coagu 1 ants, a 1-
though a reduction in sensitivity has been noted for some drugs 
such as the beta-blockers and beta-agonists <Beers et al 1989), 
The influence of diet and nutrition on pharmacokinetic parame-
ters should also be borne in mind. The elderly are likely as a 
consequence of disease, drug use and social isolation to develop 
nutritional deficiencies and factors such as self-prescribed 
nutritional supplements and general nutrition are important con-
siderations in drug management ·of the elderly. <Lamy 1982, 
Anderson 1988, Stewart 1989) 
1,2,2,2 HIGH PER CAPITA USE OF MEDICINES 
Despite comparable paediatric and geriatric popu 1 at ions in the 
United Kingdom, 12Y. and 15Y. respectively, 32Y. of prescriptions 
are for the elderly, and 1 or.. only for the paediatric group 
<Report, Pharmaceutical Journal of the Royal Pharmaceutical 
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Society ,:::,f Great Britain 1987). In their book "Elderly people , 
their medicines, and their doctors" (1988), Cartwright and Smith 
e :-(ami ne prescribing trends in Eng 1 and. They find that between 
1959 and 1979 , the annual number of prescription items dispensed 
per person increased by one third . Over the ne:-(t nine years, 
there was no further significant increase overall, but more 
detailed analysis of the data showed that from 1977 , when sepa-
rate records of drug use by the elderly were started , the pres-
cribing rate for the elderly had increased by 27% compared with 
a fall of 6% among the non-elderly. An increase in medicine use 
by the elderly was also noted by Hale et al (1987) in their 
study in the state of Florida, USA where during the period from 
1980 to 1985, the average number of medicines per participant 
increased from 3.2 to 3.7. 
1 . 2.2 . 3 POLYPHARHACY 
The elderly may suffer from a multiplicity of pathologies each 
presenting with its own set of symptoms. It has been reported 
that the ambulatory elderly may experience from 4 to 7 disease 
states and that they may complain of an average of 3.7 symptoms 
per person (Stewart 1988) . The temptation to prescribe a new 
medicine to treat each set o-f symptoms is very great and 
polypharmacy is a widespread ocurrence in the elderly (Alexander 
et al 1985, Cartwright et al 1988). Polypharmacy is not only a 
doctor generated prob 1 em, but m·ay be compounded by the con-
comitant of use of self-prescribed medicines by the elderly 
(Lamy 1982, Hale et al. 1987, Cartwright et al 1988). Of note is 
the fact that the doctor is often unaware that his patient may 
be using self-prescribed medicines and even medicines prescribed 
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by other doctors consulted ,~oncurrently (Kiernan et .31, 1981 , 
Price et .31. 1986). Further compounding the problem is the fac:t 
that many self-prescribed medicines purchased over the counter 
may be polycomponent preparations. 
Whilst polypharmacy 
prescr i bi n,;i .• it has 
is not necessarily a sign of inappropriate 
been shown 
cidence of adverse drug _reactions 
to be linked to a higher in-
<Colt et al 1989 , ). In South 
Africa The Fifth Interim Report of the Commission of Inquiry 
into Health Services (Browne Commission, 1987) identified the 
excessive use of medicines as being potentially unsafe, ineffi-
cient and unnecessarily expensive. 
1.2.2.4 LONG-TERM USE WITH FREQUENT REPEAT PRESCRIBING 
Rest home or frail care centres are becoming a major component 
of the health care system for the elderly. In an American study, 
55% of residents in 55 rest homes were found to be taking at 
least one psychoactive medicine <Avorn et al, 1989). For half of 
those residents with high anti-psychotic drug use there was, for 
at least one year, no physician participation in decisions 
regarding the patients' mental health. In addition, assessment 
of staff competence revealed a low level of comprehension of the 
purpose and side effects of commonly used psychoactive agents. 
It has been shown that regular review by consultant pharmacists 
of the medicines used by patients in a long-term care facility 
can reduce the overall use of drugs by as much as 33.8% (Cooper 
et al 1978). 
Murdoch ( 1980) showed in his study of the prescribing patterns 
of urban general practice that long-term repeat prescribing may 
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account for 58.7% of all prescriptions for the over 65 age group 
and for Just under 50% of all prescribing. Several studies have 
shown that often the patient receives his or her repeat pres-
cription without seeing the doctor concerned. (Law et al 1976, 
Kiernan et al . 1981, Cartwright et al 1988), Research by 
C.3rtwright et al. (1988) revealed that the longer patients had 
been taking their medicine, the less likely they were to see the 
doctor when obtaining a repeat of their prescription . This was 
particularly true if the medicine concerned was a hypnotic, 
sedative or an:-:io lyt ic. Regular professional review of the 
elderly's medication profiles is important. 
1,2 , 2.5 HIGH INCIDENCE OF ADVERSE DRUG REACTIONS 
Drug induced illness is a significant problem in patients of all 
age groups. Between 2.9% and 9.4% of hospital admissions in the 
USA have been attributed to drug induced illness (Hiller 1974, 
Caranosis et al. 1974, Colt et al, 1989). In South Africa, a 
prospective study by Cooke et a·-i (1985) of 300 hospital admis-
sions revealed that 4.6% of these were considered to be related 
to adverse drug reactions, A 1 though adverse drug events within 
the community are more difficult to assess because their identi-
fication depends on spontaneous reporting, the incidence is 
reported to vary from 5% to 30% <Klein et al. 1984, Hutchinson 
et al. 1986), 
It is well established that adverse drug reactions occur most 
freq1Jently in the over 65 years age group (Greenblatt et al, 
1982, Hutchinson et al. 1986, Castelden et al. 1988), Williamson 
and Chopin (1980) found that-: · of patients admitted to the 
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Geriatric Hedicine Departments in England, Wales and Scotland, 
15,3% of prescribed drug takers exhibited an adverse drug reac-
tion. As much as 36% of patients 65 years and older in a com-
munity general practice were deemed to be suffering from symp-
toms that were drug induced (H.3rtys 1982), Similarly, 
spontaneo1Js reports, both in England and in South Africa show 
that there is higher incidence · of adverse drug reactions in the 
elderly than in other age groups ( Report of UCT : Ciba-Geigy Hed-
icines Safety Centre 1987, Castelden et al. 1988). Castelden et 
a 1 . further point out that the drug-induced mort a 1 i ty rate is 
higher in elderly patients than it is in younger patients. 
Drug induced illness is however, considered to be a preventable 
disease, and attention has been drawn to this fact by the World 
Health Organisation (1980) and the Royal College of Physicians 
(London, 1984). Both organisations emphasise that more rational 
prescribing and better informed use of medicines by both doctor 
and patient will help to reduce the incidence of dr•Jg induced 
disease in the elderly. 
1.2.2.6 POOR COHPLIANCE 
In its broadest terms, compliance can be described as the 
patient's adherence to a prescribed treatment regimen. Non-
compliance has been recognised as a major problem and has been 
extensively researched, with figures for the elderly as high as 
50% or more quoted in the literature (Wandless et al, 1979, 
Gryfe and Gryfe 1984, Morrow et al, 1988), Hulka et al. (1976) 
divided non-compliance into the following sub-categories: 
Omission - a drug prescribed but not taken 
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Commission - a drug taken but not prescribed 
Misconception - the schedule was misunderstood 
Non-compliance - the schedule was rejected. 
Although it is often difficult to establish what the causes of 
poor compliance are, five major factors have been identified 
(Hulka et al. 1976, WHO 1981, Lamy 1982) : 
1. Physical disablity pre venting the patient from using the med-
ici nes c orrect 1 y . Severe arthritis or hand tremor may prevent 
the removal of the medicine from its container. Poor vision may 
impair reading the label instructions and swallowing dif-
ficulties may make it difficult to take large tablets. 
2. The more drugs per patient, the greater the errors of omis-
sion and commission 
3. The greater the comple:-:ity of the dosage schedtJle, the 
greater the errors of commission and misconception. 
4. If the patient does not know or understand the function of 
all his drugs, errors of commission and misconception increase. 
5. An inverse relationship exists between doctor-patient commu-
nication and compliance - where communication is good, there is 
a low level of all types of medication errors. Typically, non-
compliance of the commission type, where the patient is taking a 
drug that has not been prescribed by the physician consulted, is 
frequently missed <Price et al 1986). It may be missed for 2 
reasons : 
1. the doctor does not question the patient in this respect 
2. even when asked, the patient cannot accurately recal 1 what 
the medicines are. 
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It has been estimated that between 4% and 35% of non-compliant 
elders may endanger their health by not taking their medication 
correctly (Stewart and Cluff 1972). The older patient is fre-
q•.Jently stabilised long-term, on medication having a narrow 
therapeutic index . Any increase or decrease in the dose may have 
a destabilising and detrimental effect (Grymonpre 1988). The 
most commonly reported form of non-compliance is under-adherance 
to the dosage schedule which may result in sub-optimal treatment 
with subsequent high costs in terms of morbidity and monetary 
e :-( pend i tu re ( K i er nan 1 9 81 ) . 
Non-compliance of the "commission" kind may also result in 
treatment failure. Even herbal or "natural" remedies can be 
responsible for otherwise unexplained changes in normally well 
managed patients . For example, a case was reported to the Com-
mittee on the Safety of Medicines (United Kingdom) where 
"devil's claw" herbal remedy was thought to have destabilised an 
elderly, well controlled parkinsonian patient <The Pharmaceuti-
cal Journal of the Royal Pharmaceutical Society of Great Britain 
1989) . 
1.2.3 STRATEGIES JO IMPROVE DRUG USE IN THE ELDERLY 
1.2.3,1 EDUCATION OF HEALTH CARE PROVIDERS IN CARE NEEDS OF THE 
ELDERLY 
Despite the fact that care of the elderly was recognised as a 
special problem as early as 1957, there has been a slow develop-
ment of geriatric medical services in South Africa <Glajchen 
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1988) , Only · in recent years has any structured pl an been for-
mulated for the training of medical practitioners in the field 
of geriatric medicine <De V Heiring, 1988), In the USA and Cana-
da , the first examinations for certification of geriatric medi-
cine were held only in April 1988. In their report (1984) the 
Royal College of Physicians <London) emphasise the importance of 
.:1dequate · training of doctcft'·_s ·, nurses , social workers and 
pharmacists if any impact is to be made on the high prevalence 
of adverse drug reactions in the elderly. 
1 . 2.3.2 COMMUNICATION WITH AND EDUCATION OF THE PATIENT 
Successful health care management requires a team approach with 
the co-operation of both the patient and his family. The most 
obvious indication of a patient's co-operation is the e x tent of 
his compliance. The doctor can aim to improve the patient's com-
pliance by ensuring that he can cope with the packaging and for-
mulation of the medicine , by confining the number of medicines 
to a minimum , by choosing simple dosage schedules, and most of 
all by communicating with the patient . Gardner et al. (1988) 
showed that patients do consider that detailed information 
regarding the safe use of their medication is important and that 
the more information communicated to them, the more satisfied 
they are in their relationship with their doctor and the better 
their compliance. 
Communication can take the form of verbal or written i nforma-
tion . Although the improvement may not be as great as for those 
with normal cognitive function, counselling of elderly patients 
with deficient cognitive funct·t ·on can significantly improve 
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their compliance <MacDonald et al .1977). Woroniecki et al . 
(1982) and MacDonald et al, (1977) showed that 15 minutes of 
verbal counselling had a significant effect on patient's recall 
of drug information, even after eight to 12 weeks. Dodds (1986) 
found that the provision of written information alone had a sig-
nifi ,.:ant and positive effect on patient compliance with 
antibiotic therapy. Other researchers <Regner et al. 1987, Cul-
bertson et al. 1988) indicate that printed information together 
with verbal counselling is more effective and even preferred by 
patients. Memory aids, such as tear-off calenders and tablet 
identification cards together with verbal counselling have been 
found to significantly improve drug compliance in the elderly 
<Wandless and Da~ie, 1977) 
1.2.3.3 COMMUNICATION OF THE NECESSARY INFORMATION 
In the USA a National Council on Patient Education and Informa-
tion <NCPIE) has been formed. In their report on "Priorities and 
Approaches for improving Prescription Medicine use by the Older 
Americans" (1987) the NCPIE consider improved communication 
within the entire healthcare network to be of prime importance. 
They have tried to improve communication of health care profes-
sionals by attempting to create a demand for more information. A 
country-wide media campaign encouraging the pub 1 i c to request 
more information about their medicines has been launched. To 
provide this type of service requires time and e:<pertise. The 
pharmacist is the professional who is best placed and most ac-
cessible to do this. In Britain and America, the role of the 
pharmacist in patient education is being emphasised (WHO 1980, 
L.3my 1982, Gryfe and Gryfe 1984, Royal College of Physicians 
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1984, George 1987, Horrow et al, 
et al, (1988) also outline rules 
1988) In their review, Harrow 
for the design of medication 
instruction and make recommendations on how these should be im-
plemented. 
1 , 2,3.4 IHPORTANT INFORMATION FOR THE DRUG-TAKING PATIENT 
In order for medication instructions to be effective, they must 
be complete. Morrow et al. (1988) list 13 items of information 
they considered to be important: 
1 , the patient's name 
2 , the physician's name and telephone number 
3. the medication's name 
4. the medication's purpose 
5, a brief description of how the medication works 
6 . warnings about foods and drugs to avoid when taking the 
medication 
7, the form in which the medication is taken 
8. the dose to take 
9. how often to take the dose and at what times of day 
10 , how long to take the medication and whether a refill is re-
quired or optional 
11,date of issue, shelf life of drug, and an explicit warning to 
destroy any remaining medicine after this date 
12.most likely side effects 
13 . emergency telephone number 
Gryfe and Gryfe (1984) and George (1987) each have a similar but 
shorter list, both omitting points 1, 2, 5, 10, 11 and 13, They 
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consider it important that the patient be fully informed on how 
to store his medication and to dispose of any that may be left 
over and George also recommends that the patient be advised on 
how to tell if the medicine is working or not . The NCPIE have 
made it the resposiblity of the patient to be informed about his 
medicines and have prepared .3 "Medication Memo" for distribution 
to the public . The uncomplicated memo poses 5 major questions : 
1 , What is the name of the drug and what is it supposed to do? 
2.How and when do I take it - and for how long? 
3.What foods , drinks , and other medicines or activities should I 
avoid while taking this drug? 
4.Are there any side effects and what do I do if they occur? 
5.Is there any written information available about the drug? 
In addition to covering those points most essential to ensure 
the safe use of medicines , the memo also makes provision in 
question 5 , for the patient who wants more detailed information. 
1.2.3.5 COMMUNICATION BY THE SOUTH AFRICAN HEALTH CARE PROVIDER 
There has been very little research into this subject. In South 
Africa communication between doctor and patient may be poor be-
cause of language and cultural differences and consequently com-
pliance may suffer. Gillis et al. (1987) found this to be the 
case and make a plea that more time be spent with patients ex-
plaining their treatment regimen prior to discharge from hospi-
tal. 
A small study by Regensberg and Tanchel (1988) revealed that in 
South Africa pharmacists are particulary poor providers of in-
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formation to patients. Of the 164 patients in their study group 
who had received information about their medicines, only 10 in-
dicated that they had received it from the pharmacist. In addi-
tion 18% of all the patients interviewed claimed that "No-one" 
had given them any information about their medicines. 
Duncan Reekie and Scott (1988) advocate that the pharmacist be-
come more involved in self-medication by patients . They point 
01Jt that 73.3% of all proprietary medicine sales during 1980 
took place outside a pharmacy, and that the pharmacist is gross-
1 y u n d e l" - u t i l i s e d a s a p r O v ·t d e r o f i n format i on for non-
prescription medicines. In his reply to their suggestions, Folb 
< 1988) points out that in South Africa an adequate system for 
the provision of patient-directed drug information is lacking 
but is, however, a realisable goal. 
In summary, the geriatric population poses particular problems 
of altered pharmacokinetics and · dynamics, polypharmacy and poor 
compliance. The projected increase in size of the elderly popu-
lation of South Africa underlines the urgency for more research 
into their heal th care management needs. Limited research in 
South Africa has shown that the incidence of adverse drug reac-
tions in the over 65 year olds is higher than for any other age 
group and that communication between heal th care professionals 
and patients is poor, but there is a paucity of information 
available on the drug use patterns of the South African elderly. 
In the light of this the present study was undertaken with the 
following aims in mind. 
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fU..!i 1 
To determine the drug use pattern of a study sample of the South 
Afric .3n elderly for both prescribed and self-prescribed medi-
cine. 
8..1 H g_ 
To determine the knowledge score of this study sample with 
respect to the medicines they are using. 
8IH I 
To determine the participant characteristics and ascertain if 
there is any significant relationship between these and the drug 
use patterns and the knowledge scores of the participants. 
AIH i 
To detef'"mine the amount of · :i:nformation conveyed to the 
participants via container labelling and ascertain if there is 
any significant relationship between this and the drug use pat-





Data collection w.3s facilitated by the administration of a 
structured interview to participants randomly selected from old 
age residences in the southern peninsular area of Cape Town. 
The interview was divided into 4 main sections : 
1.A closed question questionnaire designed to gather information 
about the participant's socio-economic status and the type of 
health care received by him. 
2 . An interview schedu 1 e with both open and c 1 osed questions, 
designed to gather information with respect to the drug use pat-
terns of the stiJdy population and the level of knowledge that 
the parti c ipants have with respect to the medicines that they 
are using , 
3,A container label assessment sheet to assess the amount of es-
sential information conveyed to the participant via the con-
tainer. 
4.A cognitive function and a short term memory test to identify 
and eliminate those participants with impaired cognitive func-
tion. 
The answers obtained were marked · and coded in order to facili-
t a t e s t a· t i s t i c a 1 an a 1 y s i s . ···;,he answers pertaining to the 
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participants' knowledge of their medicines were marked according 
to a set of Drug Profiles (See Appendix I> drawn up by the re-
searcher. Statistical analysis and sorting were undertaken using 
the SAS~ system of satistical analysis. The data were tested for 
any significant relationships between participant character-
istics, type of health care, drug use patterns, level of knowl-
edge and label information. 
~ QUESTIONNAIRE 
The questionnaire (see Appendi:·{ A) was designed to gather in-
formation on ~rticipant 9haracteristics . With the e:<ception of 
questions 1, 10, 11, 15, 17 and 20, it was designed with closed 
questions but was administered and filled in by the interviewer. 
Questions 1 to 13 are concerned with participant particulars and 
cover the following points : age, gender, marital status, co-
habitants, drinking and smoking habits, level of education, so-
cial class and retirement status, income and dependency on state 
social pensions . Questions 14 to 20 involve the following 
aspects relating to heal th care utilised by the participant : 
state or private sector, frequency of visits, main supplier of 
medicines and private medical aid. 
2.2~ ADHINISTRATION 9F QUESTIONNAIRE 
Answers were ticked off by the interviewer in the appropriate 
answer blocks on the questionnaire. Answers were coded <See Ap-
pendix: Coding sheet 1) into coding blocks down the right-hand 
side of - the page. One que~·t "'r ·onnaire sheet was used per 
participant. 
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2.~~ DETAILS OF QUESTIONNAIRE DESIG~ 
Question~ What is your date of birth? 
Coded : 65 - 100 
Age groups 1 - 8 
This was the first of the si:-, • open questions included in the 
questionnaire. Each paticipant' s age was calculated from his 
date of birth to the 31 December 1988 , when all interviews were 
complete. Participants were placed into 5-year age group cate-
gories . 
Q_uestion 2. What seH are you? 
Coded : male= 1, female= 2 
This question was included to determine if there were any se H-
related differences in knowledge score and drug use patterns . 
Question 3. What is your present marital status? 
Coded : 1 - 4 
This question was divided into 4 categories - Never married, 
divorced, widow or widower, and · married. If a participant had 
previously lost his spouse and then remarried, he was marked as 
married only and not under both widow or widower and married 
categories. The objective of this question was to determine 
whether marital status has any influence on knowledge score and 
drug use patterns. 
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Question i_._ Do you live alone? 
Coded : Ves = 1, No= 0. 
It was considered necessary to include this question as married 
people do not always live together and unmarried people may live 
with others. This question also served . as a leader for Question 
5. The objective of this question was to ascertain whether the 
participant's interaction with and sometimes reliance on a sec-
ond party influences his knowledge score or drug use pattern. 
~_i_iestion 2.!_ Who is living with you? 
Coded : 1 - 3, 0 
This question was divided into 4 categories - Spouse, Friend , 
Other family and Not Applicable. Participants who answered "yes" 
to Question 4 were immediately marked "Not Applicable" for this 
question. 
The hypothesis underlying this question was that people living 
with their spouse, particulary in a long term marriage, may be 
more dependent on the spouse and thus may have a lower knowledge 
score than those living with a friend or family member. 
Q1_1est ion ~a. Do yo,_i smoke tobacco at a 11? 
b. If you smoke, how many pipe/cigars/cigarettes do you smoke in 
24 hours? 
Coded : a. Ves = 1, No= 0 
b. 1 - 3,0 
Part (a) of this question was included as a leader question, 
with the participant being required to answer "yes" or "no" . 
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Part (b) was divided into 3 categories based upon the work of 
Van der Burgh (1979) plus a further category of "Not Appic.3ble" , 
If the participant anwered "No" to part (a), then part (b) was 
immediately marked "Not applicable " .3nd the interviewer pro-
c eeded to Question 7. 
This question was included because of the influence of smoking 
on drug metabolism and on disease and therefore potentially on 
dr1_1g use , 
Question L..!_a , -Do you drink any alcoholic beverages at all? 
b, On average , how often do you have a drink? 
Coded : a . Yes= 1 , No= 0 
b. 1 - 5, 0 
Once again part (a) was designed as leader to part (b) with the 
participant being required to answer "yes" or "no" . 
Part (b) was divided into 5 categories based on the work of Van 
Der Burgh ( 1979) with an e:-( tra category of "Not app 1 i cab 1 e. 
11 If 
the participant answered "No" to part (a) of this question, then 
part ( b) was i mmed i atey marked "Not app 1 i cab 1 e" and the inter-
vi ewer proceeded to Question 8. 
Determination of the drinking patterns of the elderly was not 
one of the aims of this study . This question was included to 
provide a rough guide to the extent of alcohol consumption. Some 
indication of the extent of alcohol consumption in the elderly 
was considered re 1 evant bee ause a 1 co ho 1 can interact with a 
large number of medicines, both prescribed and purchased over 
the counter. 
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Question ~ To what level did you complete your ed1Jcation? 
Coded : 1 - 6 
The si x subdivisions used were based upon those employed by the 
Department of Education. The purpose of this question was to as-
cert .3 in if the participant' s know 1 edge score and medicine •Jse 
were significantly influenced by his level of education. 
Question 9._ Are you fully retired? 
Coded : Yes= 1 , No= 0. 
This question was included in the questionnaire to try to 
determine whether participants who were still gainfully employed 
had a significantly different pattern of medicine use when com-
par ed with those who were not. 
question 1.Q..!.. Before retirement what was a) your occupation 
ti,:in 
Coded : 1 - 5 
01 - 20 
b)your husband's occupa-
This question was assessed according to the guide prepared by 
Schlemmer and Stopforth (1979), Questions 10 to 13 were intended 
to serve only as a rough indication of the social class and in-
come of the participants. 
Question~ What is a) your occupation now 
Coded : 1 - 5 
01 - 20 
b) your husband's occupation now? 
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This question was omitted if the answer to Question 9 was ''Yes" . 
Question 1? What is your approximate income per MONTH? 
Coded : 1 - 8 
1 - 5 
The answers were divided up into 8 categories. The minimum in-
come indicated was that at which a white pensioner may apply for 
a soci .31 pension from the State. In those instances where the 
participant refused to answer this question, it was marked as a 
non-answer. 
Q..1:ieston 13:.. Do yo•J receive a State Old Age Pension? 
Coded: Yes= 1, No= 0 
This question was included so that some indication of spending 
power could be obtained from those participants who refused to 
answer Question 12, 
Question li_:..a• Do you have a regular GP? 
b. When last did you consult him/her? 
Coded : a . Yes= 1, No= 0 
b. 1 - 3, 0 
One of the objectives of this research was to determine if the 
type of health care received by the elderly, had an influence on 
their knowledge scores and drug use patterns. This question con-
sidered not only whether the participant was receiving health 
care from a private doctor, but also enabled assessment of the 
relationship between the time of · the last visit and information 
recall. 
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Q.b!_~tion 15._ What is his/her name? 
Coded : 000 - 999 
The answers given here were coded according to a list which was 
drawn up as new names were given. This question was included to 
ascertain whether the patients of any one doctor had higher or 
lower than average Knowledge Scores. 
Question 1~...1..a. Do you ever go to any of the day clinics or state 
hospitals for treatment or check-ups? 
b. When did you last visit one of these? 
Coded : a. Yes= 1, No= 0 
b. 1 - 3, 0 
Apart from the fact that it considered health care received from 
the public sector, this question was identical to Question 14. 
Question~ Which one do you go to more often? 
Coded : 000 -999 
As for Question 15. 
Question 18. Where do you usually get your medicines? 
Coded : 1 - 4 
001 - 999 
Four categories of medicine supplier were allowed for here : pri-
v.3te pharmacy, doctor, st ate c 1 in i c, 
11 e 1 sewhere 11 • Patients do 
not necessarily receive their medicines at the place of consul-
tation and the degree of counselling may vary according to the 
s1Jpplier . This question was included firstly to determine the 
major source of supply of the elderly's medicines, and secondly 
to ascertain whether the participant's knowledge score is in-
fluenced by the supplier of the medicines . 
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Question~ Do you belong to a medical aid? 
Coded : Yes= 1, No= 0 
The objective of this question was to see whether the fact that 
the participant was receiving assistance ~ith his medical costs 
had an influence on his medicine use. 
Question 20. What is the name of yo•Jr medical aid? 
Coded : 000 - 999 
The names given here were coded according to a list that was 
drawn up as new names were submitted. This question was included 
with a view to determining whether there was a correlation be-
tween the pattern of medicine use and the medical aid. 
~ THE INTERVIEW SCHEDULE 
The interview schedule (See Appendi:-~ C) was designed to gather 
information about the drug ~ patterns of the study group and 
to ascertain the ~eve],_ 9_f knowledge that the participants have 
with respect to their medicines. 
The questions in the schedule are either open ended or closed. 
Q•Jestions on drug use are closed with a selection of answers 
provided. Questions 4, 6, 10 to 18, 23 and 24 are concerned only 
with participant knowledge. The remainder are "combination" 
questions yielding information on both participant knowledge and 
drug use patterns. Question 25 is an exception, asking about the 
participants' satisfaction with ·the amount of information pro-
vided by health care professionals. 
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Some of the questions are marked "applicable" or "not ap-
plicable". Questions 11 to 16 have been marked this way as in-
formation on drug, food and alcohol interactions may not be 
.3vailable or the interactions not significant . Question 3 is 
marked "not applicable" if the medicine concerned is m.3rketed in 
only one strength. 
?,3.1 ADMINISTRATION Q£ JNT~RVIEW SCHEDULE 
After the interview schedule was compiled, it was tested on a 
trial group of 5 participants in an attempt to find any serious 
points of misunderstanding in the wording of the questions. Only 
minor alterations were found to be necessary. 
The interview schedule questions were print~d onto cards. During 
the interviews, the questions were read off the cards by the in-
terviewer who then entered the answers on separate answer sheets 
< see Append i :-( D) . After completion of the interviews, the ans-
wers given were "marked" against a set of drug profiles and the 
knowledge score and drug use pattern details coded according to 
a coding sheet <See Appendix E), 
The participants were required to answer all the schedule ques-
tions only if they had used medicines in tablet or capsule form 
within the 2 weeks prior to the interview. Medicines which the 
participants used regularly, but which they had not used within 
_the preceding 2 week period or were e:-:cluded as they were not 
tablets or capsules were marked as "Additional Medicines". 
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2.3 . 2 DETAILS Q£ INTERVIEW SCHEDUL~ DESIGN 
~~3.2.i PATTERNS OF DRUG ws~ 
As indicated in the 1 i terat1Jre review drug cons1Jmpt ion by the 
elderly is characterised by a high per capita use of medicines , 
a n d a tendenc y to long term use . Although not necessaril y dif-
ferent from the rest of the adult population , use of self-
prescribed medicines and poor compliance are complicating fac-
tors in the management of the drug regimens of the elderly . 
The questions of the interview schedule were designed to inves-
tigate the following : 
1. The range and popularity of medicines used by the elderly and 
which of these are prescribed or self-prescribed. 
2. The per capita use for all medicines, prescribed medicines 
and self-prescribed medicines. 
3 . The extent to which the elderly change their dosage regimens . 
4 . The length of time for which the elderly use their medicines. 
2.3.2.2 KNOWLEDGE OF MEDICINES USED 
The National Council on Patient Information <USA) <See Appendix) 
recommends that in order to use medicines safely, patients must 
know several facts about every drug taken. The Council lists 
these as follows : 
1. The name of the drug and what it is supposed to do 
2 . How, when and how long to take it 
3. Food, drinks and other medications to avoid 
4. Side effects and what to do if they occur 
5 . What written information is available on the medicine con-
cerned 
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These recommendations are used as the basis for the knowledge 
score in this study. Host of the criteria listed by the National 
Council on Patient Information can be subdivided into more than 
1 point as shown below . Each subdivision has been allocated a 
score . Points 1 .3 through to 3c were given a score of 2 whilst 
points 4a, 4b and 5a were given a score of 1. The 1 atter 3 
points were given a lower score because it was considered that a 
lack of knowledge of these would have a less significant effect 
on the outcome of treatment. Furthermore, as can be seen in the 
interview schedule, many of the points la to 3c can be sub-
divided further. For eHample : "Dr•Jg Name" m•Jst take into consid-
eration not only the name but also the strength used. 
KNOWLEDGE SCORE : ALLOCATION OF POINTS 
1.a. name I I I I I It 1 I 1 t t I I I I I I 1 1 I I I I 
b. What the drug is supposed to do ... 
2.a. Quantity of medicine taken at each dose .. 
b. Hanner in which medicine should be taken. 
c. Dosage interval .... , , , , , . , . , . , , , .... , , , .. , 
Score 
,., 
I I I.;:_ 
I I I 2 




d. Duration for which medicine should be taken ..... 2 
3.a . Specific foods to avoid ... I I I 2 
b. Alcohol to be avoided .... I I I 12 
c. Other medicines (52· and below) to avoid. 
,., 
• ,<.. 
4.a. What side effects can be expected ....... . .1 
b. What to do if a side effect is experienced ...... 1 
5.a. What written information may be avilable ...... , ,1 
Total Knowledge Score possible , , , , , ................ 21 
(• - Schedule 2 as defined in the Medicines Control Act, No. 101 
of 1965) 
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If all the questions of the interview schedule are answered, the 
ma :d mum possible knowledge score is 21 . If the questions con-
cerning avoidance of alcohol, other medicines and particular 
foods become ''not applicable " , then the ma x imum knowledge score 
possible is 15 . Each participant's final knowledge score · is e :·( -
pressed as a percentage of the ma x imum possible for that drug. 
Within the past 2 weeks have you used any medi-
cines prescribed to you by a doctor? (Yes or No) 
Coded : yes= 1, no= 0 
Being a closed answer question the participant was required to 
.3nswer "Yes" or "No". This is - a drug use pattern question . It 
serves as a marker indicating those participants who used pres-
cribed medication . 
Q1Jestion 2 . - Can you name them for me? 
Knowledge Score Question la. 
Coded : 2, 1 or 0 
As the interviewer had no access to patient records and there-
fore had no prior indication of what answers to expect, this was 
designed as an open ended question. In order for the participant 
to score 2 points he had to clearly, and without reference to 
the tablet container label, give the name of the medicine that 
he was using. The participant was required to give either the 
trade name or the generic name in order to score, No e:·(tra 
points were scored if both trade and generic names were known. 
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In those cases where the medicine is available in 2 or more 
strengths , the participant was awarded only 1 point for stating 
the name and received his slcond point only if he answered ques-
tion 3 correctly . 
The participant scored O if he cou 1 d not re member the name 
without referring to the container or if the name he mentioned 
was incorrect when compared with that on the container . 
Question h - Can you tel 1 me what strength of Drug 1 (2 etc) 
you are using? 
Knowledge Score Question 1a. 
Coded : 1 .or 0 
Applicable= 1, not applicable= 0 
This was also designed as an open ended question for the same 
reason given for Question 2. This question was marked "not ap-
p 1 i cab 1 e" if the drug is marketed in on 1 y one strength. One 
point was scored for stating the medicine strength correctly. A 
score of O was allocated if the answer was incorrect or if it 
was not required. 
In those cases where an answer was not required , then the "not 
applicable" marker indicated that the total knowledge score ex-
cluded the points allowed for this question . 
Q1Jestion ~ - Can you tell me what you are using Drug 1 (2 etc) 
for? 
Knowledge Score Question 1b. 
Coded : 2 or 0 
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This was designed as an open ended question, as it was impos-
sible to anticipate all possible answers for the medicines like-
ly to be used by the elderly. 
The accuracy of the participant's reply was assessed against the 
indic .3tions stated in the drug profile for the medicine under 
consideration. Detailed e:-(planations were not required with 
short answers of 2 to 3 words considered sufficient. In order to 
score the full 2 points, the participant had to specify the site 
of action of the drug or name the disease which was being 
treated , for e:,(amp le : b.~ar.t-pa in tablets or ~ng in~- t .3b lets. 
Incorrect answers or "I dont know" scored O. 
Question~ - How often do you take a dose of this medicine? 
Knowledge Score Question 2c. 
Coded : Prn use= 1, Not prn use= 0 
Frequency category - 01 to 10 
Knowledge score - 2, 1 or 0 
This i$ a drug use pattern and a knowledge score question. For 
ease of coding, it was made a closed question with the answers 
divided into 2 categories. 'Th~ first category established 
whether the medicine was used on a regular or irregular basis 
(not prn use or prn use respectively). The second category was 
divided into 10 sub-categories of dosing intervals as follows: 
7 times & more per day (01) 6 times a day (02) 
4 times a day (03) 
twice daily (05) 
4 to 6 times a week (07) 
once a week (09) 
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3 times a day (04) 
once daily (06) 
2 to 3 times a week (08) 
less than once a week (10) 
When marking the knowledge score, the accuracy of the 
participant's answer was assessed against the instructions on 
the container label. This applied even if the dose on the label 
was outside the normal dose range specified in the drug profile 
as it was assumed throughout this study that the participant's 
doctor had made the correct diagnosis and had prescribed the 
correct medicines at the correct doses for that individ•.Jal. In 
those instances where the label instructions were not available 
or non-specific (eg. Take as directed) then the participant 
scored if his dosage schedule fell within the normal dose range 
indicated in the drug profiles. 
One point was allocated for correctly stating whether the medi-
cine was used only as needed or was used on a regular basis. In 
those cases where the participant needed to use the drug only as 
required, then it was e:-: pected that he be able to specify the 
ma:dmum dose permitted in 24 hours. This point was covered in 
Question 6 of the schedule. A second point was awarded for cor-
rectly stating the dosage interval. The participant scored O for 
an incorrect answer or if it was apparant that he had no knowl-
edge of the dosage interval. 
Qi.Jest ion ~ Can you tell me what is the ma:dmum number of 
doses that you may take in 24 hours? 
Knowledge Score 2c 
Coded : 1 or 0 
Again this was made an open ended question as it was impossible 
to anticipate all possible answers. As indicated at Question 5, 
this question was only applied to those participants who were 
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•Jsing their medicines on a "only as required" basis. Accurate 
responses were e:-~pected and even answers that gave a quantity 
less than that normally recommended as a maximum were marked in-
correct, This was done as under dosing may lead to treatment 
failure, Incorrect answers and "I dont know II were a 11 ocated a 
score of 0, 
Q_1Jestion 7 . . - How much do you take each time? 
Knowledge Score 2a. 
Coded : 2 or 0 
Dose increased= 3, Decreased= 2, Unchanged= 1, 
Not indicated on label= 0 
This was made a combination drug use pattern and knowledge 
score question, It is an open ended question for the same rea-
sons given for Questions 4 and 6. In marking the knowledge 
score, the instructions on the label were given precedence over 
those in the drug profiles as the dose is frequently tailored to 
the person' s needs. If the participant' s answer differed in any 
way from the 1 abe 1 or the drug prof i 1 e instructions, then a 
score of O was allocated. Correct answers received a full score 
of 2 points. 
In assessing comp 1 i ance, the answer given here was considered 
together with the answer for Question 5, Any changes were marked 
as one of the f o 11 owing : increased, decreased, unchanged or not 
indicated. 
34 
Question !;L_ - How do you t .3 ke it? 
Knowledge Score 2b 
Coded : 2, 1 or 0 
Hanner categories Food/liquid - 10 to 33 
Tablet/capsule - 1 to 5 
Again this was made a closed question for ease of coding and 
marking. The possible answers were divided into 3 main categori-
es. The first Food took into cons i de ration whet her the 
participant took the medicine on a fu 11 stomach or an empty 
stoma ch or either . The second category Liquid assessed 
whether he took the medicine with water or any other type of 
drink or neither. The third category considered whether the 
participant took the tablet or capsule whole, sucked it, chewed 
it, crushed it or dissolved it before swallowing it. 
Once again the container label instructions were given priority, 
but if there were no instructions on the manner of use, then the 
answer was compared with the drug profile. The participant was 
allocated a score of 1 for answering both food and liquid cate-
gories correctly and one point for answering th• t~bl•tlc~p~ul• 
category correctly. The maximum scored was 2 with incorrect ans-
wers scoring O. 
Question~ - How long have you been using this medicine? 
Knowledge Score 2d 
Coded: 1 or 0 
Time Interval category - 1 to 10 
This is a combination knowledge and drug use pattern question. 
It was made a closed question for ease of coding. The answers 
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were divided into 10 time interval categories which were coded 
from 1 to 10. 
1 to 5 days ( 1) 1 to 5 years (6) 
6 to 14 days (2) 6 to 10 years (7) 
14 days to 1 month (3) 11 to 15 years (8) 
1 to 6 months (4) 16 to 20 years (9) 
7 to 11 months (5) more than 20 years(10) 
The time interval indicated by the participant was compared with 
that specified by the container label or the drug profile. If it 
fell within that recommended for that dose and indication, then 
the participant scored 1 . No points were scored if the duration 
of use stated by the participant was greater than that recom-
mended. In those instances where there was no clear indication 
in the drug profiles, then the participant was given the benefit 
of the doubt and awarded a full score of 1 for his answer. 
~~tion 10. - Do you know, what is the recommended length of 
time for which you should carry on using this medicine? 
Knowledge Score 2d 
Coded : 1 or 0 
This knowledge score question was designed as an open ended 
question as it was impossible to anticipate all possible ans-
wers. Once again, the answer was compared with the label in-
structions or with the drug profile. The participant was re-
quired to be specific as use of medicine for periods longer than 
recommended may lead to habituation or toxic effects. Use for a 
shorter period of time may lead to treatment failure. 
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In those instances where the d•.Jration of use was not clearly 
stated in the drug profile, participants who indicated that the 
duration was dependent on regular review of their case by their 
doctor were awarded a full score . 
~stion 11 . a.Have you been cautioned about other medicines 
that you should be careful about taking while you are using this 
medicine? < Yes or No. > 
b . Can you name them for me? 
Knowledge Score 3c 
Coded : 1 or 0 
Part (a) was a closed q•.Jestion with a "yes" or "no" answer re-
quired . This answer was not directly included in the participant 
knowledge score, If answered "yes" then the interviewer pro-
ceeded to part (b) . An answer to part (b) was not required if 
the participant .3nswered "no". The interviewer then proceeded to 
Q•.Jestion 13 of the schedule . However if an answer to part (b) 
was applicable, then the participant was automatically allocated 
a score of 0. 
In order to score, the participant was required to clearly indi-
cate which medicines he should avoid whilst being treated with 
the drug under review. The participant was not expected to name 
all possible interacting drugs, but he was expected to give some 
indication at least of the type of medicine (eg. Cold and 'flu 
medicines). 
If the medicine under review wa~ Schedule 3 and above, then the 
participant was expected to know which Schedule 2 medicines and 
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below he should avoid. The converse also applied. If the medi-
cine under review was Schedule 2 and below, then the participant 
was required to indicate that he knew that it may interact with 
certain prescribed medicines. Those medicines classified as 
Schedule 2 and below may be purchased without a prescription. It 
is in the interests of the purchaser to be informed as to poten-
tial interactions involving these medicines. Although the com-
munity pharmacist is responsible for the sale of Schedule 2 med-
icines, he does not have access to full patient profile records 
and may not be aware of all the medicines administered to the 
person buying the medicine. 
If the participant answered "yes" to part (a) of this question 
and then gave the name or type of at least one medicine that 
could interact with the medicine under review, then he scored 1. 
If he answered "yes" to part (a) but could not give a sat i sf ac-
tory response to part (b), then he scored 0. He scored O if he 
answered "no" or "I dont know" where an interaction was likely, 
Question 12, - Why should you be careful about these medicines? 
Knowledge Score 3c 
Coded : 1 or 0 
Applicable= 1, Not Applicable= 0 
Again this knowledge question was made open-ended because it was 
impossible to anticipate all ·answers. It was felt that the 
participant would make more of an effort to avoid medicines 
likely to interact with his medication if he knew why they would 
interact and what would happen to him if he took them concur-
rently. Detailed e:,,planations were not required with short, 
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simple answers such as "It will make my high blood press1.Jre 
worse" considered sufficient for the participant to score 1. 
Questions 11 and 12 were excluded from the knowledge score if no 
drug interactions were indicated in the drug prof i 1 es, These 
questions were marked " .:ipplicable" or "not applicable", If the 
questions were marked "Not applicable", then the score points 
.3llocated to them were not included in the final knowledge 
score. 
Q.!Jestion .L~-!.. - a, Have you been ca•Jtioned to be caref•Jl about 
eating any particular foods or non-alcoholic drinks or beverages 
while you are using this medicine? <Yes or No.) 
b. Wh .3t are they? 
Knowledge Score 3a 
Coded : 1 or 0 
Part (a) of this question was designed as a closed question. 
Once again, it played no part in the knowledge score but acted 
as a leader question. If the participant answered "yes", the in-
terviewer proceeded to part Cb) of the question; if "no" the in-
terviewer proceeded to Question 15. 
Part Cb) was open ended as it was impossible to have a closed 
question that covered all possible answers for all medicines. 
The participant was not re qui red to 1 i st al 1 foods that could 
interact with the medicine under review but was required to name 
at least one type of food that should be avoided. Once again the 
answers were compared with the recommendations laid out in the 
drug profiles and correct answers scored 1. 
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Question ~ - Why should yo•J be caref•Jl abo1Jt these foods? 
Knowledge Score 3a 
Coded : 1 or 0 
Applicable= 1 , Not Applicable= 0 
Again this was made an open-ended question for the same reason 
.3s cited in Question 13.b. It was felt that compliance here 
would be improved if the participant was fully aware of any 
drug-food interactions and the potential outcome if the agents 
were consumed concurrently. The participant was awarded a knowl-
edge score of 1 for answering the question correctly . 
Questions 13 and 14 were marked "not applicable" and their 
points e xcluded from the Knowledge score if there was no indica-
tion in the drug profiles of possible interacting foods. 
Question ~ - Have you been cautioned to be careful for any 
reason about consuming alcohol while you are taking this medi-
cine? <Yes or No.) 
Knowledge Score 3b 
Coded : 1 or 0 
If the participant answered "no" to this closed question, then 
an answer to Question 16 of the schedule was not required and 
the interviewer proceeded to Question 17. The answer was com-
pared with the specifications in the drug profile and correct 
answers were allocated a score of 1. 
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Quest ion 16 - Why sho•J 1 d you be care fu 1 about consuming a 1 coho 1 
with this medicine? 
Knowledge Score 3b 
Coded : 1 or 0 
Applicable= 1, Not Applicable= 2 
Participants were e:-~pected to know any important drug-alcohol 
interactions and their possible outcome. A detailed answer was 
not required. A simple explanation of 2 to 3 words <eg. It will 
affect my driving) was sufficient if in atcordance with the drug 
profiles. If the answer was correct then the participant scored 
1. 
Questions 15 and 16 were marked ''applicable" or "not applicable" 
for each medicine under consideration . The score points for 
these questions were excluded from the maximum knowledge score 
if there was no indication in the drug profiles of a possible 
interaction. 
Q.y_estiolJ. ~ - a. Do you know of any side effects or 1Jnwanted ef-
fects that may arise out of the use of this medicine? <Yes or 
No.) 
b.Can you tell me what these side effects may be? 
Knowledge Score 4a 
Coded : 1 or 0 
Part Ca) was a closed leader question which did not count toward 
the knowledge score , If the participant answered "no", then the 
i n t e r v i e··w e r p r o c e e de d s t r ;rt gh t t o Que s t i on 1 8 a n d the 
participant was allocated a score of O for the entire question. 
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P.3rt (b) was open ended as it was impossible to allow for all 
possible answers for all medicines. The p~rticipant was not re-
quired to list all possible side effects , but to indicate he was 
aware the drug could give rise to side effects and to name one 
or 2 of the more serious or common side effects . If his answer 
was correct when compared with the side effects listed under the 
drug prof i 1 e , then he scored 1. In those instances where the 
participant's description of a possible side effect was open to 
interpretation , the answer was assessed in consultation with a 
pharmacologist before being allocated a score. 
Questio1J. 18 . - What would you do if you e:,:perienced any of these 
side effects? 
Knowledge Score 4b 
Coded : 1 or 0 
Again this was made an open ended question as it was impossible 
to anticipate all possible answers. It was felt that as the mem-
bers of the pub 1 i c are not trained in pharmaco 1 ogy they must 
contact a health care professional who can assess the serious-
ness of the side effect in their particular case. For prescribed 
medicines, participants who indicated that they would stop or 
continue with the medicine without consulting their doctor or 
pharmacist scored O. Answers open to interpretation were as-
sessed in consultation with a pharmacologist and correct answers 
scored 1. 
Question 12. - Are there any other medicines prescribed to yo1J in 
the past 2 weeks that you cannot remember the names of? (Yes or 
No.) 
Coded : Yes= 1 , No= 0 
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This was made a c 1 osed , 1 eader question to Question 20, It was 
not included in the knowledge score. If the participant answered 
"no'' then the interviewer proceeded to Question 22. 
Question 20 - How many are there? 
Coded : 01 to 99 
This was an open ended question and played no role in the knowl-
edge score. It served as a leader for Question 21. It was also 
used as an indicator as to the number of medicines whose names 
were not remembered by the participant. 
9_1Jestion 21 . - Can you tel 1 me what each one is used for? 
This question being identical to Question 4, the interviewer 
proceeded ne:-:t to Question 5. For each new medicine, the 
participant was required to answer Questions 5 to 18 of the 
schedule. 
~1Jestion 22. - Within the past 2 weeks have you used any medi-
cines that were NOT prescribed to you by a doctor? (Yes or · No.) 
Coded : Yes= 1, No= 0 
This was a closed, drug use pattern question. It served as a 
marker indicating those participants who used se 1 f-prescr i bed 
medicines. If the answer was "yes'' then the interviewer returned 
to Question 2 and the participant was required to answer Ques-
tions 2 to 18 for each new self-prescribed medicine. If the 
participant answered "no'' the interviewer proceeded to 
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Question 
'1b!_estion 23 . - Do you ever "Read up" about your medicines to try 
to find out more information about them? 
Knowledge Score Sa 
Coded : Yes= 1 , No= 0 
This was a closed knowledge score question. Participants answer-
in ,J "yes" scored 1 and participants answering "no" scored O. 
Q.!::1estion 24_ - Where do you normally get this information? 
Coded : DO to 99 
This is not a knowledge score question. It was designed as an 
open ended question as the number of possible answers is consid-
er .:ib 1 e. The answers given were dr .:iwn up into a 1 i st with each 
new answer allocated a new code number. 
Q.uest ion 25. - Do you fee 1 that yo•J are sufficient 1 y inf or med 
about your medicines to enable you to use them safely? (Yes or 
No.) 
Coded : Yes= 1, No= 0 
This closed question was not a knowledge score question, but was 
included in the interview schedule to serve as a point of com-
parison between the public's perception of the amount of knowl-
edge they need to have in order to use their medicines safely 
and what the experts feel they should know. 
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2.4 LABEL SCORE 
(See Aopendix D - Interview Schedule Answer Sheets) 
Thi:-? on th1:,! ,.:: o n t ;_:_, i r, r,,1 r· t: h (·': . D °Cl 1 \/ :i.mm,-=::d i···· 
.:.:1t1:2lv ;::i• .. ,.-;:_1i 1-=.ibli:!! to th1:.:! p.:,.1t:i.,~int on ho 1,,1 to u <:;r2 h:i. ·:;; mi:-,icl:i.c.inf:, F"or 
this reason it was decided to include a soecial analys:i.s of the 
container labels in this rese;::irch work. n l thouqh it 1,1.:;.1·,; ) ... f:.'1,-·,nn···· -· -· ... ::., 
nised that label size is a limiting factor, it was felt that an 
11 :i. de .':J 1 11 1 .:;.1 b ~,: 1 !,; ho u 1 d ,:~ Cl n t ~.l :i. r, ,::. f1 r t ;,:1 :i. r1 e <;; ,,; •?.·:· n t :i . . =:1 1 p i '"' ,::. r:,: ,,; o f 1 n ···· 
form.:.:1ticin . In '.::,01..1th n+r·:i . .-:.:.:;:1 , the M,::,id:i . .-.~i.ni,,1'::; Contrcil (1.-:::i:: (1'-lo. :!.Dl, 
1. 9 r!:., 5 ) ·;; [:, ,::2 ,::. i + :i. ,::,i '°:· •,1 h ;:_1 t di:.·: t ;:_1 i 1 ,,; mu s t b i::: ·:;; h o 1.,1 n o n t h r~i l .=.1 b ,::: l Cl f d :i. ,,; ···· 
t :i. Dn·:;; .=J 10 ne ;:ir··r,,: in <,;IJ ff i -::: :i. ,:;:,-r1t tG C,)~ O 'v' :i. ,:iE• thf:? p .=.1 i:: i >'.':: T'i t 1,,/ :i. th >:0T'!DU qh 
infDrmation to use his medicine orooerlv , Thus the reauirements 
laid out in the Medicines CDntrol Act were reviewed and exoanded 
and a new set cif what was considered tD be the minimum label l ing 
reauirements for all medicines dr~wn uo. Each of these reauire-
ments was allocated a scDre with a maximum of 1.0 points fDr an 
ideal label. The points were alloc~ted as fallows: 
:!. .. ' .. l.._<:£·.9.:i. b_:i. 1 :i .. t.'l. 
Question l. Can you read me the name on the label? 
~::. ,::: D r (7: : :l. D ) .. · I] 
s.-.~or~?. : :I. or C) 
asked to read with his normal readina glasses , where necess8ry , 
first the name of the medicine ~nd then the instructfons ta the 
inteviewer. If the p~rticip~nt was able to read these , then the 
label wa s alloc8ted a scDre of one ooint for e8ch, but nD ooints 
were scored when the oarticipant found the 
., : .. 
. I..:;.)!'.:, i::' .I. :i.l:Li:0,:J:i.bi.t:! . 
Label legibility 1s essential if the information orovid e d is to 
b,::,) of .:;) n 'v' to 
,·:.,:::, 
being legible to the majority of the medicine using poo u lation. 
failing eyesight. It was considered necessary to determine what 
p 1~ o p o ·1-· t j_ o n o f t he ,-:;i l d (-:-) r 1 '/ c: -':.l n no t u '.-:,-,:.-i t h .-: .. i s Ei l ;;1 b i:? 1 1,; b '/ .-::: h •?.~ .-:.: k i n (J 
their ability to read them with their normal reading aids. 
···:i 
,: .... , .. nH:':_d_ :i. _.-:.:_ i r,fi_ N;,.1m,::,) of the ..............•..... .......... .............. . 
Question 3 . a . Trade/Generic and strenqth 
~: • .-:..~ D r· i:-:-: : l C) r 0 
Question 3.b.Descriptive name (eg. Heart Tabs ) 
T h F:: c,; p •?.·1 .-::: :i. f i ;:_: ;~1 t i o n ::,. f Dr t h o::,i m ,,,i d :i. c :i. n f) n .==.1 m f::: 1,1 r:,i r e ·=:; u b d i. ·..,· i. d E• d i r1 t o 
.:;)nd de'::;.-:.:r' :i. pt i ·-.;e nam(?. for e:-:.=:.1mo l F, "H.-::,;:_1rt T .:.1b 1 et,,; " , It i '..;; rr::i·-· 
(] I.J i 1~ (':! d b 'y' th i':) Mi::) d :i . .-:.: :i. n '2 c.; (: 0 n t 1~ 0 l n Ct ( NO ' 1 C) 1 ' 1 9 6 ~) ) th;,:; t th•:.·! 
pr(JC,(?.r n;,.1 m1:.~ al1,1;::iv·=,; app1:,i.==.1r· ·::,. on thri 1;;.ib,= .. )1 -':.1'5 i.t i 0;; .':) m•?.·);:.1n<:; of 
identification of the medicine. A descriotive name was also con-
s:i.dered to be i moortant as the elderly freq uently u se more than 
one m E·:· d i .-:.: :i. n e.. for m o 1~ ('::· th .=.=1 n on r,? i n d :i . .-.~ .=:.1 t i on .==.1 n d th r::: r' i::1 f o )"· (?. to 
reduce confusion , a descriotive name is essential. 
one point for the descriot i v e name. In those instances where the 
c, r o c F:: r n .:::1 m ~? d :i. d n n t :i. n d :i . .-:.: .=,.1 ti::: th 01 ·,:: i:: r f) n 'J th c f th i::·, m F: d :i . .-:.: :i. n ,~i , .=::1 n d 
point was awarded for tne proper name. 
~--'- Direct i on.s 
This was subdivided as follows : 
Question 4 . a . Quantit y to be taken at each dose , 
Question 4.b.Frequen cy of dosing. ,,,,,,,,,, , ,,, 
. Score 1 or 0 
, , Scor·e 1 or 0 
Questio n 4,c,Manner in which dose should be taken .. Score 1 or 0 
Question 4. d . Dur .3tion of use .... .... .. . .Score 1 or 0 
Although such detail is not specified , it is also req1Jired by 
the Medicines Control Act that some directions on how to use the 
medicine .:1re shown on the container label . It was considered 
that in order for the patient to have a safe working knowledge 
on how to take his medication , all directions should cover the 4 
points 1 i sted above. In those cases where one of these di rec-
ti ves was found to be omitted , it was allocated a score of 0 . 
Instr•Jctions such as "Take as directed" or "Take when required" 
were not considered to be acceptable and the label was allocated 
no points for these direct ions. In the case of tablets and cap-
sules the words "Take" or "Drink" were considered to be suffi-
cient to imply oral consumption. 
4 . Name o f the. e_a t i en t 
Question 5. Patient Name 
Score : 1 or 0 
This is also required by the Medicines Control Act . It was con-
sidered to be important as it helps to prevent confusion in a 
house or an institution where more than one member is receiving 
me di ca t i on . T ho s e cont a i ne r 1··ab el s w hi ch did not have the 
patients name on them were allocated a score of 0. However, med-
icines at or below schedule 2 , were e:{empt from this requirement 
as they may be purchased over the counter or even at super-
markets. 
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5. Name of the. dispenser 
Question 6 . Dispenser's Name 
Score : 1 or 0 
This is a requisite of the Medicines Control Act as it enables 
the user or any other person to refer to the dispenser should 
any problems arise with respect to the use of the medicine . In 
the case of medicines which could be purchased over the counter , 
the label was checked to see that the manufacti.Jrer' s name was 
given. Any label which did not indicate either the dispenser ' s 
or the manufacturer's name was allocated a score of O. 
All of the points scored by each label were added up and then 
each label was allocated a label score expressed as a percentage 
mark of the maximum label score of 10 . 
In addition to the label score requirements , the medicine label 
was also checked for three other points which were not included 
in the label score, namely whether any "au:·: i l i ary II labels were 
attached , how the label was presented , and the type of heal th 
care service that had been responsible for dispensing the medi-
cine . 
Auxiliary labels are frequently sources of extra information on 
how to use or store the medicine. However, not all dispensers 
consistently use these labels , but prefer to counsel the patient 
verbally . Since there is controversy surrounding the effective-
ness of these labels as contributors to the patient's overal 1 
knowledge of his medicine they were not included as a labelling 
requisite (Regner et al. 1987, Brown et al. 1988). 
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The presentation of the label was considered to be an important 
point to check as this could affect the legibility of the label. 
Thus each label was checked to see whether it was handwritten , 
typed on a standard typewriter or a matrix-dot printer, commer-
cially printed or a combination of both handwriting and printing 
as is frequently found on the labels from hospitals or clinics. 
This was then compared with the score for legiblity to ascertain 
whether any significant relationship could be found between the 
2 points. 
The "health care type" check was included to compare the label 
scores of different suppliers. They included the retail or com-
munity pharmacist , the dispensing doctor, the state services and 
as .3 separate category "other" suppliers of medicines such as 
supermarkets. 
~ COGNITIVE FUNCTION AND SHORT TERN HENORV 
Declining mental function, which may be encountered in the 
elderly , will affect the ability to comprehend medication in-
structions, and a poor short term memory will impair the abiltiy 
to recall and comply with these instructions. However, if there 
is no deficiency in either of these mental functions, the elder-
ly patient may, with the use of certain memory aids, be capable 
of assimilating and complying with full and detailed medicatio-n 
instr•Jctions (Tymchuck et al. 1986, Ciocon et al. 1988, Leirer 
et al. 1988). 
As this work concentrates mainly on the patient's knowledge with 
respect to his ·medication, and adherence to medication instruc-
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ti ons , cognitive function and short term memory were assessed 
utilising the Abbreviated Mental Test as drawn up by Hodkinson 
(1972) and modified for the South African population by the 
Geriatric Unit , Universtity of Cape Town (Appendix F), This test 
was chosen because it is very easy to administer and despite its 
brevity , the Abbreviated Mental Test, when compared with other 
longer and more complex cognitive function tests, has been shown 
to be sufficiently powerful for the p•.Jrposes of such research 
work , 
This test was modified by the Geriatric Unit on 3 points. The 
first was the requirement that the participant recall the dates 
of World War 2 and not World War 1 and the second , that the full 
name, including initials, of the State President and not that of 
the present Monarch be given as South Africa does not have a 
monarchy, The third alteration focussed on short term memory 
rec a 11 , At the st art of the test, the interviewer asked the 
participant to identify 3 common and easily recognised articles. 
These were then concealed from the participant, and at the end 
of the test he was asked if he could remember them. For each one 
correctly named, one point was allocated. 
Of the Abbreviated Hental Test scores, a score of below 7 was 
taken to be an indication of significantly impaired cognitive 
function. Those participants scoring below 7 were not included 
in the study. 
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2.6 SELECTION OF PARTICIPANTS 
Participants had to meet the f o 11 owing 4 inc 1 us ion cr_i te_r _i _a : 
a. 65 years or more in age 
b. not under daily drug supervision 
c. be fully responsible for own health care management . 
d. be fluent in English 
~ SELECTION OF STUDV SAMPLE 
The Department of Health and Welfare regularly inspect a number 
of homes , flats and service centres for the aged. A list of 
these institutions was obtained from the Department and a second 
list of only the flats was compiled. 
The distribution of the flats was plotted onto a map of the Cape 
Peninsula area and only those flats within a 20km radius of the 
interviewer's residence in Plumstead were chosen for the study 
sample. The manager of each residence was visited and a complete 
list of all residents over the age of 65 years was obtained. The 
names of residents known to be away on holiday were e:-:cluded 
from these 1 i sts . The surnames on the 1 i sts were sorted a 1-
phabet ica 11 y , In the event of both husband and wife qualifying 
for inclusion in the study sample, the name of the husband was 
placed first on the list . If 2 different members of a residence 
had the same surname , then they were listed alphabetically ac-
cording to their initials. The names were then numbered consecu-
tively. Using a random number table a third of the names were 
selected for inclusion in the study sample . If the names of both 
husband and wife we re selected, then only the spouse chosen 
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first was included in the sample and another participant was 
selected in place of the second spouse. This was done in an at-
tempt to eliminate bias because of previous e:-:pos•.Jre to the 
questions of the interview, especially to those of the cognitive 
function and short term memory tests. 
2,8 DATA COLLECTION AND ANALVSIS 
2 ... 8, 1 DATA C_OLLECTION 
Data collection commenced in June 1988 and was completed by De-
cember 1988 , Al 1 the interviews were conducted by one inter-
viewer (myself). 
After selection of the study sample for each residence, the in-
terviewer visited each residence and approached each se 1 ected 
participant individually . The interviewer confined her visiting 
times to after 9 . OOam to 12. 00 noon and then from 3. OOpm to 
6.00pm in the afternoon. These visiting hours were chosen as it 
was found that many of the retired elderly are not ready to 
receive visitors early in the morning and that they frequently 
rest after lunch. The afternoon visiting time was e:<tended as 
1 ate as 6. OOpm in order to try and inc 1 ude those participants 
who were still working a full 8 hour working day . No interview-
ing was done on the weekends. 
The interviewer went from flat to flat knocking on the doors of 
the selected participants. When the 
d o o r , t h" e i n t e r v i e w e r i n t r' o··dl.J c e d 
participant answered the 
herself as a qualified 
pharmacist. She then explained that she was, under the supervi-
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sion of the medical school at the University of Cape Town , con-
d•.Jcting research into the use of medicines by the elder.ly and 
asked the participant for his or her co-operation . The inter-
viewer emphasised the fact that the interview would be confiden-
tial and that participants' names would not appear in the final 
research report. 
Depending on the number of medicines used by the participant and 
the degree of co-operation of the participant, each interview 
lasted from qetween twenty minutes to one and a half hours. If 
the participant had di ff i cu 1 ty understanding any of the ques-
tions during the interview, then the interviewer expanded on the 
question until both parties were satisfied that the participant 
had fully understood what was being asked. Similarly, if the 
participant expressed curiosity as to the research work and why 
it was being conducted, the interviewer did her best to satis-
factorily answer questions. 
As it frequently required several days of visits to complete one 
residence, the 3 articles •.Jsed for the short term memory test 
were changed regularly. Examples of articles used for this test 
I 
are an onion, an orange, an apple, a banana, a pencil, a ruler, 
a bunch of keys, a bull-dog paper clip , a comb or a ballpoint 
pen. Some of the participants were found to be blind so it was 
essential that items that could be easily identified by feel or 
smell were chosen. The items were changed appro:<imately every 
third day in an attempt to prevent participants not yet visited 
from learning the names of the items in the test from those who 
had already completed the interview. 
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If a selected particioant was no~ found at home, then the 1n~er-
oointment was made far completion of the interview. Participants 
who were not willing to participate were not included. 
allocated an identification number from 1 to 265. The interview 
answers we r e codea ac c oraing ta a set of c odinq r ules draw n uo 
t C) ,:.'. c, n, iYi i:-:·! r1 .-::: ,::-:· rn i:-:-:· 'f"i ·1:: _ .... . f • .• ! I thi:-:-:• .·.::c).-::i1:.-1d 
then entered onto the co mputer data caoture sheets used by the 
for the schedule and the label analysis were entered seoarately 
fi--·om tho·,;;1:,! obt ;::1 :i. nr-,id from th,,:.i q 1 ..1E•·=:; t :i. or1na :i. re,i and .:.'.o,0n :i. "I:: :i. ' /0) f 1..1n,:::···· 
tion and short term memory tests. 
In th 0: m :i. dd 1 E• of ,..i 1..1 l v 19B9, th(':! ,.::odf!:!d sh1:.~et-::; 1,1<::11~1::, -::;rant to th,-:..i 
Medical Research Co u ncil Institute for Biostatistics for analy-
·::- :i. ·::; , P n ;.,:1 1 'y' ,,; :i. '.::- 1,,1 .=:.l ',,; u n d 1:.·:· rt ;,:1 k •"':! n us. :i. n ·J th(':! ~:, (1 '.:i 1·~ ,::: om p 1..1 t ,-:..i r p ~.1 ,::: k .=:.1 <.:J r;,1 • 
Detailed analysis of all possible data combinations was not at-
d .01 t .:::i ,::1 r·· o 1..1 c, -:;;. 1.,1 .-:.,• r' r:.·i o f -::; u f f :i . .:.: :i. ;:..:, n t '::,-:i. :.,:. E• t o .=.1 l 1 o 1,1 f Ci r th F, 1..1 ·,;;. r:.~ o f 
regarded as statistically significant. The following tests were 
I.J·~;.1;~,d : 
l , F· ,~:· .:::i r·· <=; o n ' ·::; C o r' r' 1':J 1 :::, t :i. o n C: o •:::• + f :i. ,::: :i. r:,i n t ,,; (I r.:- ;::1 r' ~.) l1l E• t 1~ ] . .-:.: +· ,:., -:::. ·!·· f O \"' 
correlation between 2 samoles of data. 
2. Student' s t Test . A parametric test for significance be-
tween 2 independent samples. 
3. Chi-square Test, A non-parametric test for association be-
tween 2 v ariables . 
4. Analysis of 1Jariance , An analysis of variation among more 




3,1 PATIENT CHARACTERISTICS 
These results are presented in Tables 3.1,1, to 3.1,12, Only the 
total number of participants (Total (n)) according to gender and 
.3ge group is given in each table whereas , the number of 
participants conforming to each characteristic is expressed as a 
percentage of each gender and age group. Although the subdivi-
sion of data according to age groups may in some instances ap-
pear e:-: cessive for the purposes of this study , these details 
h -3Ve been included in the hope that they may be of value to 
other researchers in the field of geriatrics. 
3 , .. 1..d .. ~GE 
Table 3.1.1. 
A total of 260 participants with their ages ranging from 65 
years to 93 years, mean age 77 years was interviewed. Age dis-
tribution was similar for both se:-:es, The age distribution of 
all participants is shown graphically in Figure 3.1.1 .. Whilst 
the smaller numbers in the over 85 year age groups are predic-
table on the basis of increased mortality, the relatively low 
number of participants in the below 70 years age group is pro~a-
bly explained by the manner of selection. The only participants 
were those living in old age residences which are entered 
voluntarily, People under 70 years are probably less likely to 
desire the greater social security provided by these residences, 
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PATIENT CHARACTERISTICS 
Table 3.1.1 : Age distribution 
PERCENT 
. ------------------------------------------ . . . 
GROUP : ALL : HALE : FEHALE : 
------------------------------------------
: TOTAL (n) 260 49 211 
65 - 69 years 10 .4 8.2 10.9 
70 - 74 years 23 .8 26.4 23 .2 
75 - 79 years 30 .4 28.6 30.8 
80 - 84 years 26.5 28.6 26.5 
85 - 90 years 8.1 8.2 8.1 
90 - 94 years o.e 0 0.8 
--------------------------------------------
Table 3.1.2 : Relationship between 1arital status and gender/age (years) 
PERCENT FOR GENDER ANO AGE GROUP (Years) 
GROUP : ALL : HALE : FEHALE : 65-69 : 70-74 : 75-79 : 80-84 : 85-89 : 90-94 : 
: ------------------------------------------------------------------------------------------------
: TOTAL (n) 260 49 211 27 62 79 69 21 2 
: Never 1arried 12.7 6.1 14.2 18.5 16.1 8.9 11.6 14.3 0 
: Divorced 7.3 4.1 8.1 14.8 9.7 7.6 2.9 4.8 0 
: Widow/er 57 .3 24.5 64.9 44.5 50 55.7 66.7 66.7 100 
: Harried 22.7 65 .3 12.8 22.2 24.2 27.8 18 .8 14,2 0 
Table 3.1.3 : Relationship between co-habitants and gender/age (years) 
PERCENT FOR GENDER AHO AGE GROUP <Years) 
. ------------------------------------------------------------------------------------------------ . . . 
GROUP : ALL : KALE : FEHALE : 65-69 : 70-74 : 75-79 : 80-84 : 85-89 : 90-94 : 
: ------------------------------------------------------------------------------------------------
: TOTAL (n) 260 49 211 27 62 79 69 21 2 
: Live Alone 75.8 34.7 85.3 6',,7 74.2 72.2 85.7 85.7 100 
Spouse 23 65.3 13.3 25.9 24.2 27.8 14,3 14 .3 0 
Friend 0.4 0 0.5 3.7 0 0 0 0 0 
























































































































































































































































































































































































































































3 . 1 .. • 2 SEX 
Appro x imately one fifth of the participants was male. This num-
ber is less than the proportion of men in the residences where 
up to one third of the residents was male. Random selection of 
the participants did not alter this ratio , but there was a high 
refusal rate amongst the men asked to participate in the study. 
3 .. J .. 3. M.A.R.IT.AL. 5.T.AT_US A.ND. CO-HABITANTS 
Tables 3 . 1 . 2. and 3.1.3. 
Of all participants 87.3% were single at the time of the inter-
view . Of these , the majority were living on their own. Only 4 
sin,;ile participants were living with another person - one was 
living with her divorced h•.Jsband , two were living with their 
sisters and one was living with .3 friend . As may be e :-:pected , 
the incidence of bereavement increased with increasing age (Fig -
ure 3.1 . 2) . Of the single participants, 74 . 1% were widows or 
widowers .• 9. 5% were divorced, and 16. 4% had never married. Ap-
pro x imately two thirds of all women were widows whilst only one 
quarter of males were widowers. 
3. 1_. 4 SMOKING HABITS 
Table 3 . 1.4. 
Eighty-four percent of paticipants were non-smokers and of those 
who smoked 67.5% smoked less than 20 cigarettes per day . Of note 
is the decline in the percentage of smokers with increasing age 
<Figure 3 . 1. 3.). As the numbers of participants in the 85-89 .;rnd 
90-94 year age groups are very small , the groups have been com-




Table 3.1 .4 : Relationship between s1oking habits and gender/age (years) 
GROUP PERCENT FOR GENDER AHO AGE GROUP (Years) 
--------------------------------------------------------------------------------------- : 
: CIGARETTES/DAV : ALL : HALE FEHALE : 65-69 70-74 : 75-79 : 80-84 : 85-94 : 
--------------------------------------------------------------------------------------- : 
: TOTAL (n) 258 48 210 27 62 77 69 23 
: Hon-s1oker 83 .8 77, 1 84.7 70 .4 77 .4 83.1 91.3 91.3 
: S1oker 16 .2 22 .9 15.3 29.6 22.6 16 .9 8.7 8.7 
S1oker (n) 43 11 32 8 14 13 6 2 
: 1 - 19 /day 67.5 63 .6 68.8 50 64.3 61. 5 100 100 
: 20 -29 /day 20 .9 36 .4 15.6 12.5 28.6 30.8 0 0 
: > 30 /day 11.6 0 15.6 37.5 7.1 7.7 0 0 
Table 3.1.5 : Relationship between drinking habits and gender/age (years) 
PERCENT FOR GENDER AHO AGE GROIJ> <Years) 
------------------------------------------------------------------------------------------------ : GROUP : ALL : HALE : FEltALE : 65-69 70-74 : 75-79 : 80-84 : 85-89 90-94 : 
------------------------------------------------------------------------------------------------ : 
: TOTAL (n) 259 49 210 27 62 79 68 21 2 
: Teetotallers 23.9 18.4 25.2 22.2 22.6 29 ,1 26.5 4.8 0 
Drinkers 76.1 81.6 74.8 77.8 77 .4 70.9 73.5 95.2 100 
: Drinkers <n) 197 40 157 21 48 56 so 20 2 
: 6 - 7 days/week 37.1 62.5 30.6 38.1 37.5 33.9 34 55 0 
: 4 - 5 days/week : 1. 5 2.5 1.3 ·4.8 0 0 4 0 0 
: 2 - 3 days/week : 9.1 2.5 10.8 14.3 10 .4 14 .3 4 0 0 
Once weekly 8.6 10 8.3 4.8 6.3 8.9 10 15 0 




Table 3.1 .6: Relationship between level of education and gender/age (years) 
PERCENT FOR GENDER ANO AGE GROUP <Years) 
. ------------------------------------------------------------------------------------------------ . . . 
: 
GROUP : ALL : HALE : FEHALE : 65-69 : 70-74 : 75-79 : 80-84 : 85-89 : 90-94 : 
------------------------------------------------------------------------------------------------
TOTAL (n) 260 49 211 27 62 
Std 2, 3, 4 0.4 0 0.5 0 1.6 
Std 5, 6, 7 18.8 22.4 18 22 .2 19.4 
Std 8, 9, 10 60.8 51.2 61.1 70.4 67.7 
Tertiary 20 18.4 20.4 7.4 11.3 
Table 3.1.7 . : Social class before and after retire1ent 
PERCENT 




















79 69 21 2 
0 0 0 0 
20 .3 11.6 33.4 0 
51. 9 66 .7 47 .6 0 









































































































































































3.1 . 5 DRINKING HABITS 
Table 3 . 1 . 5. 
Three quarters of female participants and 81 . 6% of males con-
sumed alcohol . Males drank more often with 62.5% embibing 6 to 7 
days per week compared with 30 . 6% of females. Forty -nine percent 
of females onl y drank once monthly or on special occassions. 
The proportion of drinkers versus non-drinkers does not vary 
g r eatly with age although the percentage was higher in the small 
sample of over 85 year olds , where more than 95% were drinkers 
and over half embibed 6 to 7 days per week . 
3 ,..1 ._6 LE_V~_'=. 9F EDUCATION 
Table 3.1 . 6. 
Si x t y -one percent of participants had passed Standards 8 , 9 or 
10 and a further 20% had received a tertiary education . All had 
attended school at least up to Standard 4 . Only one participant 
had stopped her formal education at this level , while the rest 
had completed at least Standard 5 before leaving school. A high 
percent of female participants reached Standard 10 . Once again, 
this may be a reflection of bias introduced in the selection of 
the study sample . The manner of selection of participants may 
have favoured the inclusion of a higher percent of well-educated 
individuals . 
3.1 . 7 RETIREMENJ AND SOCIAL CATEGORY 
Table 3.1 . 7 . 
The social class distribution before and after retirement is 
shown in Figure 3.1.4 .. Only 5% of the participants interviewed 
were still in some kind of gainful employment. Of this small 
number still working, 77% fell within the Cass Social categories 
65 
PATIENT CHARACTERISTICS 
Table 3.1.8, : Relationship between 1onthly inco1e/state pensioners and gender/age (years) 
INCOME PERCENT FOR GENDER AND AGE GROUP (Years) 
. ------------------------------------------------------------------------------------------------ . . . 
(per 1onth) : ALL : 11ALE : FEMALE : 65-69 : 70-74 : 75-79 : 80-84 : 85-89 : 90-94 : 
------------------------------------------------------------------------------------------------ : 
: TOTAL (n) 203 40 163 22 52 62 53 13 1 
: > R3000 5.9 20 2.5 9.1 5.8 4.8 7.5 0 0 
: R2500 - R2999 0 0 0 0 0 0 0 0 0 
: R2000 - R2499 1. 5 5 0.6 0 0 3.2 1. 9 0 0 
: R1200 - R1999 5.4 7.5 4.9 0 1. 9 8, 1 5.7 15.4 0 
: R1000 - R1199 13 .3 12 .5 13.5 0 5.8 11.3 24.5 30.7 0 
R600 - R999 23.6 20 24.5 22,7 23.1 30.6 18.9 15.4 0 
: R500 - R599 16 .3 17.5 16 27.3 19.2 9.7 19 15 .4 0 
< R499 34 17 .5 38 40 .9 44 .2 32.3 24.5 23.1 100 
------------------------------------------------------------------------------------------------ : 
: TOTAL (n) 257 : 49 : 208 27 62 79 : 67 : 20 2 : 
: State Pensioner : 31. 9 22.4 34.1 : 40.8 : 41. 9 : 26 .6 : 26.9 : 30 : 0 
Table 3.1 .9·. : Incidence of health service attendance according to gender and age 
HEALTH CARE PERCENT FOR GENDER ANO AGE GROUP <Years> 
. ------------------------------------------------------------------------------------------------------------- . . . 
TVPE : ALL : 11ALE : FEMALE : 65-69 : 70-74 : 75-79 : 80-84 : 85-89 : 90-94 : 
. ------------------------------------------------------------------------------------------------------------- . . . 
: TOTAL Per Group <nl 
: PRIVATE : GP-yes 
: GP-no 
259 48 209 27 62 79 67 
: 73.4 : 83.3 : 70.8 : 66.7 : 64.5 : 77.2 : 76.1 : 
: 26.6 : 16.7 : 29.2 : 33.3 : 35.5 : 22.8 : 23 .9 : 
20 2 
80 : 100 : 
20 : 0 : 
. ------------------------------------------------------------------------------------------------------------- . . . 
: TOTAL Per Group <nl 
: STATE : CLINIC-yes 
: CLINIC-no 
259 
: 38.2 : 
: 61.8 : 
48 211 27 62 
25 : 41.2 : 40 .8 : 40.3 : 





69 20 2 
29 : 45 : 0 : 
71 : 65 : 100 : 
1 and 2. This can be expected as 74.9% of the participants were 
placed in these 2 categories before retirement. 
The separate frequencies for sex and age are not considered here 
as the social standing of the women is dependent on that of the 
husbands, and assessment of social standing is dependent on the 
present or last position of employment which does not alter when 
the person is retired, 
3 .. 1. 8 MONTHLY IN.CO.HE 
Table 3.1.8. 
Since the majority of the participants interviewed were grouped 
into the Cass Prestige categories of 1 and 2, it might bee:-( -
pected that the•y would be receiving incomes that would be at 
least likely to place them in the category one below that which 
they were in at the time of retirement ie. between R2500 to 
R1200 per month. Of the 203 participants who answered this ques-
tion , 73,9% were receiving a monthly income of less than R999. 
Thirty-four percent were earning less than R499 per month which, 
at the time that this study was undertaken , was the level at 
which .3 white pensioner could apply for a social welfare pen-
sion. It is therefore not surprising that of the 257 who ans-
wered, 31.9% were already receiving a state social pension, 
3.1.f TYPE OF HEALTH SERVICE 
Table 3.1.9, and 3.1.10, 
Seventy three comma four percent of the participants have a Gen-
eral Practitioner whom they consult for their health care prob-
lems , Of these 21.7% had last ~isited their doctor more than 6 




Table 3.1.10. : Visits to health care service 
HEALTH CARE PERCENT FOR GENDER AND AGE GROUP (Years) 
. ------------------------------------------------------------------------------------------------------------- . . . 
TYPE : ALL : HALE : FEMALE : 65-69 : 70-74 : 75-79 : 80-8~ : 85-89 : 90-94 : 
-------------------------------------------------------------------------------------------------------------
: TOTAL Per Group (n) 189 40 149 18 ~o 61 52 16 2 
PRIVATE VISIT- (1 tonth 38.6 47 .5 36.2 38.9 25 47.5 36.5 43 .7 50 
VISIT- 2-6 1onths : 39 .7 40 39 .6 61.1 45 39 .4 36.5 18 .8 0 
: VISIT- > 6 aonths : 21. 7 12 .5 24 .2 0 30 13 .1 27 37.5 50 
------------------------------------------------------------------------------------------------------------- : 
: TOTAL Per Group (n) 99 12 87 11 25 34 20 9 0 
: STATE VISIT- (11onth 69 .7 75 69 45.5 72 73.5 75 66,7 0 
: VISIT- 2-6 1onths : 21.2 25 20.7 ~5.5 16 23.5 10 22.2 0 
VISIT- >6. 1onths : 9.1 0 10.3 9 12 3 15 11 , 1 0 
Table 3.1.11, : Medicine suppliers. 
PERCENT FOR GENDER AND AGE GROUP (Years) 
. ------------------------------------------------------------------------------------------------------------- . . . 
TYPE : ALL : HALE : FEMALE : 65-69 : 70-74 : 75-79 : 80-84 : 85-89 : 90-94 : 
: ------------------------------------------------------------------------------------------------------------- : 
: TOTAL Per Group (n) 259 48 211 27 62 78 69 21 2 
: MEDICINE : Pharaacy 64 .9 79 .2 61.6 59.3 56 .4 65 .4 72 .5 66 .7 100 
SUPPLIER : Doctor 4.6 8.3 3.8 3.7 8.1 5.1 2. 9 0 0 
Clinic 25 .1 12 .5 28 33 .3 24.2 24.4 21. 7 33 .3 0 
Elsewhere 5.4 0 6,6 3.7 11 .3 5.1 2,9 0 0 
Table 3.1.12 , : Relationship between participants receiving 1edical aid and gender/age (years) 
PERCENT FOR GENOER AMO AGE GROUP (Years) 
. ------------------------------------------------------------------------------------------------------------- . . . 
TYPE : ALL : HALE : FEl1ALE : 65-69 : 70-74 : 75-79 : 80-84 : 85-89 : 90-9~ : 
. ------------------------------------------------------------------------------------------------------------- . . . 
: TOTAL Per Group (n) 
: MEDICAL : Ves 
: AID : Mo 
\ 
260 49 211 
: 51 .2 : 59.2 : 49 .3 : 
: ~8.8 : ~0.8 : 50.7 : 
68 
27 62 79 69 21 2 
63 : ~3 .2 : 54.3 : 49 .3 : 47 .3 : 50 : 











































































































































































































































































Thirty-eight comma two percent of the participants use the ser-
vices of a state-run health care centre or clinic and only 9.1% 
had not visited the clinic within the last 6 months. The majori-
ty - 69,7% - had visited the clinic within the last month, com-
pared with only 38.6% who had visited their private practitioner 
in this period. This discrepancy may be a reflection of the 
necessity to collect repeat medicines on a monthly basis from 
state clinics or may indicate more regular follow up by clinics 
than private practitioners. 
A higher percent age of women < 41 , 2%) as against men ( 2 5%) use 
the state clinics but more men attend general practitioners and 
appe .3r to be more conscientious about visiting their doctors. 
Forty seven point five percent and 75% of males compared with 
36, 2% .3nd 69% of f eina 1 es attended their private pr act it i toner or 
clinic respectively in the previous month. As shown in Figure 
3.1.5 visits to private practioners appear to increase with ad-
vancing age. This trend was not apparant, however, with clinic 
attenders, There is some overlap of the 2 groups with some 
participants attending the state health care clinics as well as 
consulting their own private general practitioner. 
~...J_\..l.Q. SOURCE OF HEDI CI NE SUPPLY 
Table 3.1.11. 
As shown in Figure 3,1,6, only 25,1% of the participants 
received their medicines directly from the state clinic , The ma-
jority - 64.9% - obtained their medicines at a retail pharmacy 
with only 4.6% receiving their medicines directly from their 
doctor and 5.4% purchasing them elsewhere. 
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3.1.11 MEDICAL AID 
Table 3 . 1.12. 
It is interesting to note that while 25.1% of the participants 
receive their medicine from the state , only 51.2% of the total 
number of participants are members of a medical aid. It can be 
assumed that one quarter of the participants receive no finan-
cial assistance for their health care and the purchase of medi-
cines. 
A higher percent of males than females receive medical aid -
59.2% as against 49.3% . 
3,1,12 COGNITIVE FUNCTION AND SHORT JE~tl MEMORY 
Cognitive function was assessed in 238 participants and was con-
sidered normal in 235. Three candidates were excluded from the 
study because of poor cognitive function. As a result of insuf-
ficient time for completion of the interview, cognitive function 
scores were not obtained for a further 25 participants. These 
participants were included in the study group, as the inter-
viewer f el t that they showed· no · signs of s · i g n if i cant l y 
diminished mental ability. 
;L..L_,13 PATIENT SATISFA~.Ij_ON ~ITH INFORMATION 9N MEDICINES 
The majority of participants were satisfied that they were 
receiving enough information from their health care providers to 
allow them to use their medicines safely. Only 12.5% of the 257 
participants asked were dissatisfied. 
72 
3,2 DRUG USE PATTERNS 
The information presented in this section was compiled out of 
d .3ta from the interview schedule. Relationships between per-
capita use of medicines , the incidence of dosage regimen changes 
by the participants and the participants characteristics were 
e:-:ami ned. 
3.2.1 MEDICINES W.?_g:~ 
Tables 3.2.1 to 3.2.4. 
A total of 843 medicines was used by the st•.Jdy population. Of 
these 544 were prescribed and 149 self-prescribed medicines 
used within the preceed i ng two wee ks. The remaining 150 med i-
c i nes were additional medicines that were used on an infrequent 
basis by the participant, and which had not been used within the 
previous 2 weeks. 
Tables 3. 2 . 1. to 3. 2. 4. show the incidence of use of al 1 medi-
cines , prescribed, self-prescribed and additional medicines 
respectively. The medicine·s ··· are listed according to the 
pharmacological classification as indicated on the product pack-
age insert. There is some overlap between the tables as some of 
the medicines which may normally have been self-prescribed may 
have been prescribed by a doctor, and not all prescribed medi-
cines were used on a continua 1 basis and may have fa 11 en into 
the additional medicines group. 
Non-narcotic analgesics are the most fre9uently used of all med-
icines, and self-prescribed medicines. They are the second most 
frequent 1 y prescribed medicines after diuretics and are second 
73 
DRUG USE PATTERNS 
Table 3.2 . 1 All 11edicines used listed according to frequenc·r of use 
CLASSIFIC , : DRUG CLASSIFICATION : INSTANCES : PERCENT 
NUHBER 
: 02 08 00 
: 18 01 00 
: 11 05 00 
: 03 01 00 
: 02 06 00 
: 07 01 04 
: 34 00 00 
: 07 01 03 
22 01 00 
: 11 04 01 
: 02 02 00 
: 22 01 04 
: 05 02 00 
: 06 03 00 
: 07 01 00 
: 24 00 00 
: 07 01 02 
: 01 02 00 
: 02 06 01 
: 21 03 00 
: 21 02 00 
: 10 01 00 
: 05 08 00 
: 05 07 01 
: 33 00 00 
: 02 09 00 
11 04 00 
10 02 02 
10 02 01 
10 02 00 
: 02 06 05 
: 20 01 01 
18 05 00 
18 03 00 
13 04 01 
11 02 00 
: 08 03 00 
: 08 02 00 
: 07 05 00 
: Non-narcotic analgesics, antipyretics 
: Diuretics 
: Laxatives 
: Antirheuaatics (anti-infla .. atory agents) 
: Tranquillisers 
: Vasodilators -coronary (angina pectoris) 
: Other (h011eopathic, herbal, etc) 
: Other hypotensives 
: Hultivita1ins and 1ultivita1ins with 1inerals 
: Acid neutralisers 
: Sedatives, hypnotics 
: Other vita1ins 
: Adrenolytics (sy1pathicolytics) 
: Cardiac glycosides 
: Vasodilators, hypotensive 1edicines 
: Hineral substitutes, electrolytes 
: Rauwolfia :diuretic c011binations 
: Psychoanaleptics <antidepressants) 
: Phenothiazines and derivatives 
: Thyroid preparatons 
: Oral hypoglycae.ics 
: Antitussives and expectorants 
: Preps. for co11on cold, nasal decongestants, antihistaainics 
: Antihistaainics 
: Tonics 
: Special analgesic colbinations 
: Antacids 
: Hedicines acting on respiratory systea : other 
: Inhalants 
: Bronchodilators 
: Central nervous syste1 depressants : 1iscellaneous structures : 
: Broad and aediua spectrua antibiotics 
: Urinary tract antiseptics 
: Genito-urinary systea: ion-exchange preparations 
: Corticosteroids with or without anti-infective agents 
: Gastro-intestinal antispasaodics and anti-cholinergics 
: Erythropoietics (haeaatinics) 
: Anticoagulants 
: Serua cholesterol reducers 















































































Table 3.2.1/ Continued : 
DRUG USE PATTERNS 
Table 3.2.1 (Contd.) : All aedicines used listed according to frequency of use 
CLASSIFIC . : DRUG CLASSIFICATION : INSTANCES : PERCENT 
NUHBER OF USE : OF TOTAL : 
: 22 01 02 : Vita1ins for prenatal use 3 0.36 
21 08 01 : Oestrogens 3 0.36 
21 05 01 : Corticosteroids and analogues 3 0.36 
15 04 00 : Opthal1ic preparations : other 3 0.36 
11 06 00 : Lubricants and faecal softeners 3 0.36 
11 04 03 : Antacids : other 3 0.36 
06 02 00 : Cardiac depressants 3 0.36 
03 03 00 : Antigout preparations 3 0.36 
02 03 00 Barbiturates 3 0.36 
: 20 01 07 : Antifungal antibiotics 2 0.24 
17 01 00 : Peripherally acting 1uscle relaxants 2 0.24 
16 01 00 : Nasal decongestants 2 0.24 
14 01 00 : Wound disinfectants 2 0.24 
13 06 00 : Rubefacients 2 0.24 
11 04 02 : Antacids : acid neutralisers with antispas1odics 2 0.24 
08 01 00 : Coagulants, haeaostatics 2 0.24 
: 07 03 00 : Higraine preparations 2 0.24 
: 07 01 01 : Rauwolfia and coabinations 2 0.24 
: 05 07 02 : Anti-eaetics and anti-vertigo preparations 2 0.24 
31 00 00 : Enzyaatic preparations 1 0.12 
30 01 00 : Biologicals : antigens 1 0.12 
22 01 05 : Vita.ins : 8-c01plex with vitaain C 1 0.12 
22 01 01 : Vita.ins for paediatric use 1 0.12 
: 21 07 00 : Hale sex hor1ones 1 0.12 
20 02 00 : Anti1icrobials (che1otherapeutics) : other than antibiotics 1 0.12 
20 01 02 : Penicillins 1 0.12 
20 01 00 : Antibiotics and antibiotic co1binations 1 0.12 
16 04 00 : Naso- and bucco-pharyngeal antiseptics 1 0.12 
16 03 00 : ENT surface anaesthetics 1 0.12 
16 00 00 : Ear , nose and throat preparations 1 0.12 
15 03 00 : Co1bin. antibiotics and/or sulphonaaides and corticosteroids : 1 0.12 
11 10 00 : Heds. acting on gastro-intestinal tract : special coabin . 1 0.12 
11 09 00 : Antidiarrhoeals 1 0.12 
: 07 01 05 : Vasodilators - peripheral 1 0.12 
: 05 04 02 : ltedicines affecting autonoaic functions : general 1 0.12 
: 05 04 01 : Anti-parkinsonis1 preparations 1 0.12 
: 05 01 00 : Adrel\Oli1etics (sy1pathico1i1etics) 1 0.12 
: 05 00 00 : Hedicines affecting autonoaic functions 1 0.12 
: 02 06 03 : Oiphenyl1ethane and its derivatives 1 0.12 
: 02 06 02 : Rauvolfia alkaloids and coabinations 1 0.12 









































































































































































































































































































ORUG USE PATTERNS 
Table 3.2.2 Prescribed aedicines used listed according to frequency of use 
: CLASS IF IC. : DRUG CLASSIFICATION : INSTANCES : PERCENT 
NUHBER OF USE : OF TOTAL 
. ---------------------------------------------------------------------------------------------------------
: 18 01 00 : Diuretics 84 15 .H 
: 02 08 00 : Non-narcotic analgesics, antipyretics 43 7.90 
: 02 06 00 Tranquillisers 36 6.62 
: 07 01 04 : Vasodilators -coronary (angina pectoris) 33 6.07 
: 03 01 00 : Antirheu1atics (anti-inflaaaatory agents) 33 6.07 
: 07 01 03 : Other hypotensives 30 5.51 
: 05 02 00 : Adrenolytics (sy1pathicolytics) 26 4.78 
: 06 03 00 : Cardiac glycosides 24 4.41 
: 02 02 00 : Sedatives, hypnotics 24 4.41 
: 07 01 00 : Vasodilators, hypotensive aedicines 23 4.23 
: 24 00 00 : Hineral substitutes, electrolytes 19 3.49 
: 07 01 02 : Rau\lOlfia :diuretic co1binations 19 3.49 
: 01 02 00 : Psychoanaleptics (antidepressants) 15 2.76 
: 21 03 00 Thyroid preparatons 11 2.02 
: 02 06 01 : Phenothiazines and derivatives 11 2.02 
: 22 01 00 : Hultivitaains and 1ultivita1ins with 1inerals 9 1.65 
: 21 02 00 : Oral hypoglycae1ics 9 1.65 
: 11 05 00 : laxatives 7 1.29 
: 05 07 01 : Antihistaainics 7 1.29 
: 22 01 04 : Other vita1ins 5 0.92 
02 06 05 : Central nervous syste1 depressants : 1iscellaneous structures 5 0.92 
: 20 01 01 : Broard and 1ediua spectrua antibiotics 4 0.74 
: 18 05 00 : Urinary tract antiseptics 4 0.74 
: 08 03 00 : Erythropoetics (haeaatinics) 4 0.74 
: 07 05 00 : Seru1 cholesterol reducers 4 0.74 
: 21 08 01 : Oestrogens 3 0.55 
11 04 03 Antacids: other 3 0.55 
10 02 02 : Hedicines acting on respiratory syste1: other 3 0.55 
10 02 00 : Bronchodilators 3 0.55 
06 02 00 : Cardiac depressants 3 0.55 
: 02 03 00 : Barbiturates 3 0.55 
20 01 07 : Antifungal antibiotics 2 0.37 
11 04 00 : Antacids 2 0,37 
11 02 00 : Castro-intestinal antispasaodics and anti-cholinergics 2 0.37 
08 02 00 : Anticoagulants 2 0.37 
08 01 00 : Coagulants, haeaostatics 2 0.37 
07 01 01 : Rauwolfia and co1binations 2 0.37 
05 08 00 : Preps. for co11on cold, nasal decongestants, antihistaainics 2 0.37 
05 07 02 : Anti-e1etics and anti-vertigo preparations 2 0.37 
: 03 03 00 : Antigout preparations 2 0.37 
02 09 00 : Special analgesic coabinations 2 0.37 
Table 3.2.2/Continued: 
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DRUG USE PATTERNS 
hble 3. 2. 2 (Contd.} Prescribed 1edidnes 1Jsed listed ;:i,:cordinq to freq1Jen,:y of 1Jse 
CLASSIFIC . : 
tlUHBER 
22 01 05 
22 01 02 
21 07 00 
20 02 00 
20 01 02 
20 01 00 
17 01 00 
16 03 00 
11 04 01 
10 01 00 
07 03 00 
07 01 05 
05 04 02 
05 04 01 
05 01 00 
02 06 02 
01 03 00 
DRUG CLASSIFICATION 
Uita1ins : B-cot11plex with vita1in C 
1Jit;:i11ins for prenat;:il 1Jse 
Hale sex hor1ones 
Anti11icrobials khet11other;:ipe1Jti,:si : other than antibiotics 
Penici 11 ins 
Antibioti,:s ;:ind antibiotic co11binations 
Peripherally acting MIJscle relaxants 
ENT s1Jrf;:ice ;:inaesthetics 
Acid ne1Jtralisers 
Anti t1Jssi'.,ies and e:<pectorants 
Migraine pre~,arations 
IJasodilators - peripher;:il 
tied id nes affecting a1Jtono1i ,: functions : general 
Anti-parkinsonis1 prep;:irations 
Adreno1i1etics (sy111pathicot11it11eticsl 
Ra1Jwolfia ;:ilkaloids ;:ind co1bin;:itions 
Special antidepressant ,:01bi nations 
: INSTANCES : F'ERWH 
OF USE : OF TOTAL 
1 0.18 
1 0.18 
1 0 .18 
1 0 .18 
1 0.18 
1 0 .18 
1 0.18 
1 0 .18 
1 0.18 
1 0.18 




1 0 .18 
1 0 .18 
1 0 .18 
Table 3.2.3 Self-pres,:ribed 1edi,:ines used listed according to frequency of use 
CLASSIFIC. : DRUG CLASSIFICATION : INSTANCES : PERCENT 
NUMBER OF USE : OF TOTAL 
02 08 00 Non-n;:ircotic ;:in;:ilgesics, antipyretics 32 21 .48 
34 00 00 Other (ho1eopathic, herbal , etc} 21 14.09 
22 01 04 Other vita1ins 20 13.42 
22 01 00 Hultivita1ins and 1ultivita1ins with 1inerals 20 13 .42 
11 05 00 La:<atives 16 10.74 
11 04 01 Acid neutralisers 14 9.40 
05 08 00 Preps. for co11on ,:old, n;:isal decongestants, antihista1inics 5 3.36 
02 09 00 Special ;:inalgesic co1binations 5 3.36 
11 04 00 Antacids 3 2.01 
02 02 00 Sedatives , hypnotics 3 2.01 
24 00 00 Mineral s1Jbstit1Jtes, electrolytes 2 1.34 
22 01 02 Vi ta1ins for prenatal 1Jse ') 1.34 '-
30 01 00 Biologicals : antigens 1 0.67 
17 01 00 Peripherally acting 11usde relaxants 1 0.67 
16 04 00 Naso- and bucco-pharyngeal antiseptics 1 0.67 
10 01 00 Antitussives and expectorants 1 0.67 
05 07 01 Antihista1inics 1 0.67 
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DRUG USE PATTERNS 
Table 3.2.4 Addition;;il medidnes 1Jsed listed a,:,:ording to freQ•Jeni:y of 1Jse 
CLASSIFIC. : DRUG CLASSIFICATION 
NUHBER 
11 05 00 Lax.3tives 
02 08 00 !lon-nar,:oti,: analgesi,:s , anti~,yreti,:s 
11 04 01 Ai:id neutralisers 
34 00 00 Other (ho1eopathi,: , herbal , etd 
03 01 00 Anti rheuaati ,:s (anti -i nfla11atory agents ) 
33 00 00 Toni,:s 
10 01 00 Antitussives and e:-:pedorants 
10 02 01 Inhalants 
18 03 00 Genito-urinary syste11 : ion-ex,:hange preparations 
13 04 01 Corticosteroids with or without anti-infective agents 
21 05 01 Corti,:osteroids and analogues 
15 04 00 Opthal1i,: preparations : other 
11 06 00 Lubricants and fae,:al softeners 
02 06 00 Tranqui 11 isers 
18 Qi 00 Oiureti,:s 
16 01 00 Nasal de,:ongestants 
14 01 00 Wound disinfectants 
13 06 00 Rubefa,:ients 
11 04 02 Antadds : add neutralisers with antispas1odi ,:s 
11 02 00 Gastro-i n'testi nal anti spasaodi,:s and anti-chol i nergi,:s 
10 02 02 Hedidnes a,:ting on respiratory syste1 : other 
10 02 00 Bron,:hodi lators 
08 02 00 Anti,:oagulants 
07 01 04 Vasodilators -,:oronary (angina pe,:toris) 
05 08 00 Preps . for ,:011on ,:old , nasal decongestants , antihista1inir:s 
02 06 01 Phenothiazines and derivatives 
31 00 00 Enzy1ati,: preparations 
24 00 00 Hineral substitutes , electrolytes 
22 01 04 Other vita1ins 
22 01 01 Vita1ins for paediatri,: use 
16 00 00 Ear , nose and throat preparations 
15 03 00 Co1bin. antibioti,:s and/or s1Jlphona1ides and ,:orti,:osteroids 
11 10 00 Heds . acting on gastro-intestinal tract : special ,:01bin . 
11 09 00 Antidiarrhoeals 
07 03 00 Higraine preparations 
07 01 02 Ra1Jwolfia :diureti,: ,:01binations 
05 00 00 Hedidnes affe,:ting autono1i,: flJn,:tions 
03 03 00 Antigout preparations 
02 06 03 Diphenyl1ethane and its derivatives 
01 02 00 Psy,:hoanalepti,:s (antidepressants) 
81 
: INSTANCES : PERCENT 
OF USE : OF TOTAL 
















') 1.33 ,;. 
2 1.33 
2 1. 33 






















after laxatives in the additional medicines group. Diuretics are 
the second and la:<atives the third most commonly used of all 
medicines, Tranqu i 11 i sers are the third most often prescribed 
medicine. Of note in the self-prescribed group is the fact that 
"Other'' or hoemeopathic and herbal medicines are the second most 
often used with "Other vitamins" and "multivitamins and multi-
vit .3mins with minerals" falling into joint third place. In the 
.3dditional medicines group, acid neutralisers are third on the 
list. The instances of use of the ten most commonly used classes 
of drugs .3re shown in Figure 3. 2. 1.. Figures 3. 2. 2 and 3, 2. 2 
show the ten most commonly used classes of prescribed and self-
prescribed drugs respectively. 
3 .. 2 .. 2 PER CAPITA USE OF HEDICINES 
Tables 3.2.5. to 3.2.10. 
A total of 260 participants showed 843 instances of drug use, 
Some of the participants claimed to use no medicines at al 1 , 
whilest others were using up to 10 different medications. 
From Table 3. 2. 5. 5. 8% of al 1 participants claimed no medicine 
use at all. A minority of 20.4 % were not taking any prescribed 
medicine but over ha 1 f 58.5% were not taking any self-
prescribed medicines. The highest number of prescribed medicines 
1Jsed by any participant was 7 with 2. 3% of al 1 participants 
receiving that number. The average per capita use of all medi-
cines was 3.2, prescribed medicines 2.6 and 1.4 each for self-
prescribed and additional medicines (Figure 3.2.4). The distri-
b•Jtion of the per capita use of the different groups of medi-
cines is graphically illustrated in Figures 3.2.5. and 3.2.6. 
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Table 3.2.5 : Per capita use of each 
aedicine type 
: HEDS . : PERCENT PARTICIPANTS per TYPE 
: PER : --------------------------------- : 
: CAPITA : ALL : PRESCR : S-PRES : AD.HED : 
--------------------------------------------
<n> 260 260 260 260 
0 5.8 20 .4 58.5 60 
1 12.3 18.5 31. 5 30.4 
2 18 .8 21.1 6.9 5 
3 22.3 23 .5 1. 5 2.7 
4 18.5 9.2 1. 2 1. 5 
5 8.8 4.2 0.4 0 
6 7.3 0.8 0 0 
7 4.6 .2.3 0 0 
8 1.2 0 0 0.4 
9 0 0 0 0 
10 0.4 0 0 0 
--------------------------------------------
Table 3.2.6 : Average per capita use of aedicines accordi~ to gender and age (years) 
: HED , GENOER AGE 
. ------------------------------------------------------------------------------ . . . 






ALL 3.2 2.9 3.3 3.4 3.4 3.1 3.1 3.3 3.5 
PRESCR : 2.6 2.4 2.7 2.4 2.9 2.7 2.5 2.4 4 
S-PRES : 1. 4 1.1 1.4 1.8 1.6 1.3 1.2 1 1. 5 
A-HEDS 1.4 1. 7 1.4 2.1 1. 5 1.2 1.3 1. 7 0 
Table 3.2.7 : Average per capita use of all aedicines according to health care type, 
aedical aid and aedicine supplier 
: HED, HEALTH CARE HEDICAI. AID SUPf>I..IER 
. --------------------------------------------------------------------- . . . 
: TYPE : CLINIC : GP : H.AID : NO AID : PH'CV : DOCTOR : CLINIC : OTHER : 
------------------------------------------------------------------------------- : 
: ALL 3.7 3.1 3.2 3.3 3.3 2.8 3.6 2.1 
: PRESCR : 2.9 2.6 2.6 2.7 2.5 2.4 3 2 
: S-PRES : 1.2 1.4 1.4 1.3 1.4 1.1 1.1 1.9 










































































































































































































































































































































































































































































































































DRUG USE PATTERNS 
Table 3.2.8 : Average per capita use of 1edicines according to s1oking and drinking habits, 
co-habitants , retire1ent and state pensions. 
: HED . : SHOKING HABITS : DRINKING HABITS : CO - HABITANTS RETIREMENT & PENSION 
. ------------------------------------------------------------------------------------------------ . . . 
: TYPE : SHOKER : NON-SH : DRINKS : NON-DR : SPOUSE : FRIEND : FAHILY : ALONE : RETIRE : NOT RE : PENS'N : 
----------------------------------------------------------------------------------------------------------
: ALL 3.3 3.2 3.2 3.3 3.4 2 5.5 3.2 3.2 3.8 3.4 
: PRESCR : 2.5 2.7 2.6 2.7 2.7 0 3 2.6 2.6 2.5 2.8 
S-PRES 1. 5 1.3 1. 4 1.1 1.4 0 4 1.3 1.3 1. 9 1.4 
: A-HEDS 2.2 1.3 1.4 1. 5 1.6 2 1 1.4 1.4 1. 5 1.4 
Table 3.2.9 : Average per capita use of 1edicines according to social class and incoae group 
S~IAL CLASS INCOl1E GROUP : NED. 
: TYPE 
. ------------------------------------------------------------------------------------------------ . . . 





ALL 3.0 3.4 3.5 2.9 3.4 4.0 
PRESCR 2.4 2.9 2,9 2.5 2.7 3.0 
S-PRES : 1.3 1.3 1. 5 1.2 1.3 1.0 
A-HEDS 1.6 1.4 1.4 1.1 1.3 2.3 
Table 3.2.10 : Average per capita use of 1edicines according to 




1.0 1. 7 
: HED. HARITAL STATUS LEVEL Of EDUCATION 
. --------------------------------------------------------------------- . . . 
: TYPE : NEVER : DIVORC : WIDOV : HARR. : SD 2-4 : SO 5-7 : 508-10 : TERT. : 
: ------------------------------------------------------------------------------
: ALL 3.6 4.1 3 3.3 3 3.3 3.2 3.4 
: PRESCR : 3 2.8 2.5 2.7 3 2.6 2.6 2.6 
: S-PRES : 1. 5 1.4 1.3 1.3 0 1.2 1. 5 1.2 
: A-HEDS : 1.6 1.3 1.4 1. 5 0 1.4 1.4 1.6 
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3.6 3.5 3.1 
2.7 2.6 2.6 
1.4 1. 5 1.4 
1.6 1.3 1.2 
: 
Tables 3.2.6, to 3.2.10. give the average per capita medicine 
use against patient characteristics and type of heal th care, 
From Table 3, 2 , 6, it is apparent that there is a tendency for 
women to use more medicines than men - 3 . 3 versus 2.9 per capita 
respectively. There is a decline in the per capita use of 
self-pr_escribed medicines with increasing age. An,:1lysis using 
Pearson's correlation coefficient has shown this to be sig-
nificant <r = -0.244 , p = 0.0109), Of interest is the apparent 
absence of any increase in the total medicine or prescribed med-
icine use with increasing age. 
There is a higher per capita use of 3 . 7 medicines in the state 
as opposed to 3.1 in the private health care services . Analysis 
•.Jsing St•.Jdent ' s t-test showed that this difference was sig-
nificant <p = 0 . 0149) , There is no relationship between medicine 
supplier or medical aid and per capita use. 
Similarly, no significant relationship exists between per capita 
use of medicines and level of education , monthly income and 
marital status , nor are there any obvious trends to be found 
with respect to per capita use and the other patient character-
istics shown in Tables 3.2.8. to 3.2.10. 
~-!.2.3 MEDICINES ~sgo ON A~ LNF~EQUENT VERSUS ~ONTINUOUS ~ASIS 
Some of the medicines were used by the participants on a "pro re 
nata" or only "as required" basis , Table 3.2.11. lists in order 
of frequency of use , the 32 classes of drugs indicated by the 
participants as being used on this basis, Figure 3, 2, 7, shows 
the ten classes of drugs most frequently used on a "prn" basis. 
Three participants were using their anti depressant medication 
and one his anti-parkinsonian therapy on an infrequent basis. 
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Table 3.2.11 : Classes of dr1Jgs 1Jsed on an "onlv as req1Jired• basis 
CLASSIFIC . : 
t!IJl'IBER 
02 08 00 
11 05 00 
11 04 01 
03 01 00 
07 01 04 
02 06 00 
02 09 00 
05 08 00 
11 04 00 
02 02 00 
02 06 01 
01 02 00 
22 01 04 
22 01 00 
24 00 00 
02 03 00 
07 01 00 
11 04 03 
05 07 01 
22 01 02 
05 07 02 
11 02 00 
07 03 00 
20 01 01 
17 01 00 
18 01 00 
05 04 01 
18 05 00 
10 02 02 
10 01 00 
16 03 00 
16 04 00 
DRUG CLASSIFICATION 
Non-nar,:otic analgesics , antipyreti,:s 
La:r;itives 
Acid ne1Jtralisers 
Antirhe1J1atics (anti-infla11atory agents) 
Vasodilators -,:oronary <angina pectoris) 
Tr anq1J i 11 i sers 
Spe,:ial analgesi,: co1binations 
Preps . for co11on ,:old , nasal decongestants , antihista1ini,:s 
Antacids 
Sedatives . hypnoti,:s 
Phenothiazines and derivatives 
Psychoanalepti,:s (antidepressants> 
Other vitaains 
1'11Jltivita1ins and 11Jltivita1ins with 1inerals 
Iii neral s1Jbsti t1Jtes , e le,:trol ytes 
Barbi t1Jrates 
Vasodilators , hypotensive 1edidnes 
Antacids : other 
Antihista1inics 
Vita1ins for prenatal 1Jse 
Anti-e1etics and anti-vertigo preparations · 
Gastro-intestinal antispas1odics and anti-cholinergics 
Migraine preparations 
Broad and 1edi1J1 spectr1J1 antibiotics 
Peripherally acting 11Jsde relaxants 
Di1Jretics 
Anti-parkinsonis1 preparations 
Urinary tract antiseptics 
Medicines acting on respiratory syste1: other 
AntittJssives and expectorants 
ENT stJrface anaesthetics 
Naso- and btJcco-pharyngeal antiseptics 
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3 1. 9 
2 1. 3 
2 1.3 
') 1.3 .:.. 
') 1.3 .:.. 
































































































































































































































































































Table 3,2,12, lists those medicines 1Jsed on .3 continuous basis 
by the participants. There are 55 classes of medicines being 
used on this basis. Some medicines such as non-narcotic anal-
gesics, may be found on both lists. In 34 instances, the 
participants were using their non-narcotic analgesics on a con-
ti n1Jous basis, Tranqu i 11 i sers and sedative hypnotics a 1 so show 
high incidences of continuous use - 28 and 23 respectively, Con-
tinuous use of laxatives was noted in 8 instances, broad and me-
dium spectrum antibiotics in 3 instances, and prepartions for 
common colds, nasal decongestants . anti histaminics in 2 in-
stances. 
3, 2. 4 PATIENT "COHPL IAN.CE II WITH DOSAGE SCHEDULE 
As the interviewer did not have access to patient records, ad-
her .3nce to dosage sched1J 1 e was measured against the 1 abe 1 in-
structions. · In some instances, the label gave no indication of 
dosage schedule. The relationships between incidence of changes 
in dose and medicine type, gender and age, and health care ser-
vice and medicine supplier are shown in Tables 3, 2 .13. to 
3.2.15. 
Twenty-six point eight percent of all medicine container labels 
had no dosage instruct i ans, with a higher percent of 31 . 4 for 
prescription medicine labels. In · those cases where instructions 
were clearly stated, participants took less than the indicated 
dose in 35. 1 % of a 11 cases, whereas the dose was increased in 
2.2%. For 62.7% of all medicines with dose instructions dosages 
were correctly adhered to. The highest incidence of changes in 
dose was in the self-prescribed group of medicines - 64.4%, This 
may be e :-,pe cte d to a ce rta i h . ·e :-{tent as me die i ne doses are 
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Table 3. 2 .12 Classes of dr1Jgs 1Jsed on a contin1Jal basis by parti,:ipants 
CLAS5IFIC . : 
NUHe,ER 
18 01 00 
02 08 00 
07 01 03 
02 06 00 
22 01 00 
05 02 00 
06 03 00 
07 01 04 
02 02 00 
22 01 04 
07 01 00 
34 00 00 
03 01 00 
24 00 00 
07 01 02 
01 02 00 
21 03 00 
21 02 00 
11 05 00 
05 07 01 
1)2 06 01 
02 06 05 
07 05 00 
08 03 00 
18 05 00 
20 01 01 
10 02 00 
06 02 00 
21 08 01 
08 01 00 
03 03 00 
05 08 00 
22 01 02 
07 01 01 
11 04 01 
10 02 02 
20 01 07 
08 02 00 
DRUG CLASSIFICATION 
Oi1Jreti,:s 
Non-narcoti,: analgesi,:s , antipyreti,:s 
Other hypotensives 
Tranq1Jillisers 
H1Jltivita1ins and 11Jltivita1ins with 1inerals 
Adrenolytics (sympathicolytics) 
Cardiac glycosides 
Vasodilators -coronary (angina pectoris) 
Sedatives , hypnotics 
Other vita1ins 
'Jasodi la tors , hypotensi ve 1edicines 
Other (ho1eopathic , herbal , etd 
Antirhe1J1atics (anti-infla111atory agents) 






Anti hi sta1i ni,:s 
f'henothiazines and derivatives 
Central nervous syste1 depressants: 1iscellaneo1Js str1Ji:tures 
Seru1 cholesterol reducers 
Erythropoietics (hae1atinics) 
Urinary tract antiseptics 






Preps. for co1aon cold, nasal decongestants, antihista1inics 
Vih1ins for prenatal use 
Ra1Jwolfia and co1binations 
Acid neutralisers 
Hedicines acting on respiratory syste1 : other 
Anti fungal antibiotics 
Anticoa91Jlants 
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Table 3. 2 .12/Conti n1Jed: 
DRUG USE PATTERNS 
Table 3.2.12 . (Contd .) Classes of drtJgs tJsed on a ,:ontin11al basis by participants 
CLASSIFIC . DRUG CLASSIFICATION 
NIJHBER 
05 07 02 Anti-e1etics and anti-verti90 preparations 
05 04 02 Hedi,:ines affecting a1Jtono1i,: fiJndions : general 
10 01 00 Anti t11ssives and expectorants 
07 01 05 Vasodilators - peripheral 
02 03 00 e.arbi ttJrates 
20 01 00 Antibiotics and antibiotic co1binations 
11 02 00 Gastro-intestin..l antispas11odics and anti-cholinergics 
20 01 02 Penicillins 
02 06 02 Rauwol fia alkaloids and ,::01binations 
20 02 00 Anti11icrobials (,:he1otherapeuti ,:s) : other than antibiotics 
11 04 03 Antacids : other 
21 07 00 Hale sex hormones 
01 03 00 Special antidepressant ,:01bin..tions 
17 01 00 Peripherally acting 11Jsde rela:<ants 
05 01 00 Adreno1i1eti,:s (sy1pathico1i1etics) 
22 01 05 Vita1ins : e.-,:01plex with vita1in C 
30 01 00 Biologicals : antigens 
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Table 3.2. 13 : Co1pliance with dosage regiaens (percent) according to label 
instructions 
DOSAGE ALL LABELS : LABELS WITH INSTRUCTION : 
--------------------------------------------------------------------- : 
GROUP : ALL PRESC . : S-PRES ALL : PRESC. : S-PRES : 
---------------------------------------------------------------------
TOTAL <n> 688 542 H6 504 372 132 
Not indicated 26.8 31.4 9.6 0 0 0 
Unchanged 45 .9 49.6 32 .2 62.7 72.3 35 .6 
Decreased 25 .7 17 .5 56.2 35 .1 25.5 62 .1 
Increased 1.6 1. 5 2 2.2 2.2 2.3 
Table 3.2 .14 : Relationship between changes in dosage regi1en (percent) and 
participant gender and age 
DOSAGE GENDER AGES (Years) 
. --------------------------------------------------------------------------------------- . . . 
GROUP : HALE : FEHALE : 65-69 : 70-74 : 75-79 : 80-84 : 85-89 : 90-94 : 
: ---------------------------------------------------------------------------------------
: 
TOTAL (n) 73 431 59 121 160 118 
Unchanged 67.1 62 59 .3 60 .4 69.4 53.4 
Decreased 31. 5 35 .7 39 38.8 26.9 44 .9 
Increased 1.4 2.3 1. 7 0.8 3.7 1. 7 
Table 3.2 .15 : Relationship between changes to dosage regi1ens (percent) 
and health care type and 1edicine supplier . 
DOSAGE : H. CARE TYPE HEDICINE SUPPlIER 
. --------------------------------------------------------------------- . . . 
GROUP : STATE : G.P. : PH' CY : DOCTOR : CLINIC : ELSEWH : 
: --------------------------------------------------------------------- : 
TOTAL (n) 297 494 442 30 195 21 
: Not indicated 20 .2 30.8 32.6 36.7 13.8 9.5 
: Unchanged 58 .6 39 .9 40 .5 36.7 62.6 19.1 
: Decreased 20 .5 27.3 24.6 26 .6 23 .1 71.4 
: Increased 0.7 2 2.3 0 0.5 0 
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40 6 
77 .5 50 
20 50 
2.5 0 
frequently tailored to the individual so as to allow for minimal 
side effects , but ma:d mum efficacy . The doctor makes this ad-
j ustment when he writes a prescription for his patient , but for 
medicines purchased over the counter and used with out med i ca 1 
supervision , the dose must be adjusted by the individual using 
the drug . Of particular note is the fact that the dose was 
changed in 27 . 7% of prescription medicines. What proportion of 
these changes were effected with the prescriber ' s knowledge was 
not investigated. 
From Table 3.2.14. it can be seen that women are slightly more 
likely (38%) than men (32.9%) to change the dose . However, there 
does not appear to be a rel at i onsh i p between compliance with 
dosage regimens and age. 
The influence of type of health care received or the medicine 
supplier on compliance can be seen in Table 3 . 2 . 15 .. In addition 
to the greater tendency for the private sector supplier not to 
give dosage instructions on the container label , there is a 
higher incidence of non-compliance for those medicines received 
from the private sector - 29.3% as opposed to 21 . 2% in the pub-
lic sector. 
In Table 3.2.16. the change in dose is compared against the per 
capita use of medicines. The data are analysed for significant 
relationships using the Chi-s~uare test . As the number of 
participants was low in groups 1, 8 and 10, the per capita cate-
gories were grouped into "Low" (Groups 1, 2 and 3) .• 11 Hedi•.Jm 11 
<Groups 4 , 5 and 6) and "High" <Groups 7, 8 and 10). Using these 
groups , no significant relationship was found to exist between 
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fable 3, 2, 16 Rel.ationshio between dos.age ch<mges (per,;ent) .and n1J1ber of aedi,:ines t.aken 
DOSAGE MEDICINES PER CAPITA 
GROUP 2 3 4 5 6 7 8 10 
Tot.al (n) 26 74 150 167 99 80 70 20 2 
Not indic;;ited 26 .9 31.1 22.6 22,2 30.3 35 24 .3 40 0 
IJn,;h;;inged 34 .6 31.1 46 .7 49.1 53 .5 42 .5 45. 7 55 100 
De,:reased 38.5 33 .8 30 26. 9 16 .2 20 28.6 0 0 
Increased 0 4 0.7 1.8 0 2.5 1.4 5 0 
Table 3.2.17 : Classes of dr1Jgs where the dose indicated on the container label was exceeded 
CLASSIFIC. : DRUG CLASSIFICATION 
NUMBER 
18 01 00 Di1Jretics 
11 05 00 Laxatives 
03 01 00 Anti rheua.atics (.anti-infl.a11atory agents) 
07 01 04 V.asodilators -coronary (angina pectoris) 
22 01 00 Hultivitaains .and 1ultivita1ins with 1inerals 
11 04 01 Acid ne•Jtralisers 
07 01 02 Ra1Jwol fia : di•Jretic coabinations 
02 06 02 Rauwolfia alkaloids and coabinations 
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the tot a 1 number of med i ,::: i nes per capita and change in dose 
<Chi-square= 8.70 , p = 0.191) . However , there was .3 signific .3nt 
relationship between the number of prescribed medicines per 
c .3p it .3 and dose change (Chi-square = 28 . 3 ., p = 0 . 0001) and 
similarly between the dose change and the percapita use of self-
prescribed medicines (Chi-square= 10.8 , p = 0.013) , 
Table 3 . 2.17 . gives in rank order, the classes of medicines 
where the dose indicated on the container label was e:,(ceeded. 
This occurred in four instances with diuretics and in only one 
instance with each of the other agents. 
Table 3. 2. 18 . 1 ists those classes of drugs where the dose taken 
was 1 ess than that specified on the container 1 abe 1 . The 37 
classes are listed in descending order of frequency of change. 
The dose was most frequently reduced for the class ''Non-narcotic 
analgesics or antipyretics". 
3 . 2.5 ~URATION OF USE 
Tables 3.2.19. and 3.2.20. 
Table 3.2.19 . shows a tendency for the elderly to take their 
medicines on a long-term basis, where 44.2% of all medicines 
were used for 1 to 5 years and 15. 1% for 6 to 10 years. The 
figures for prescribed medicines were similar where 44.8% were 
used from 1 to 5 years and 15. 9% for 6 to 10 years, SiN comma 
si:·( percent of all medicines had been used for over 20 years. 
The figure was smaller 4. 5% - for prescribed medicines, but 
more than double - 14.7% - for self-prescribed medicines. 
In Table 3 . 2 . 20 . drug cl asses have been grouped according to 
duration of use as depicted in Table 3.2.19 .. The classes are 
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Table 3.2, 18 : Cl ;_isses of drugs for 11hich the ~,articipant dose 11as less than that indi,:ated on the 
,:ont;_ii ner label 
CLASSIFIC . : DRUG CLASSIFICATION : INSTANCES : PERCENT 
NUHf.ER OF IJSE : OF TOTAL 
02 08 00 Non-n;_ir,:oti,: anal,1esics , ;_intipyreti,:s 32 18 , 1 
34 00 00 Other (hoaeopathic, herbal , etd 14 7.9 
22 01 04 Other vita111ins 12 6.8 
11 05 00 Laxatives 12 6.8 
02 06 00 Tr;_inq1Jillisers 10 5.6 
03 01 00 Antirheuaatics (;_inti-infla11atorv agents ) 10 5.6 
02 09 00 Sc,e,: ial analgesic co1binations 7 4.0 
11 04 01 Acid neutralisers 7 4.0 
i8 01 00 Oi1Jreti,:s 7 4.0 
02 02 00 Sedatives , hypnotics 6 3.4 
07 01 04 Vasodilators -coronary (;_ingin;_i pectoris ) 5 2. 8 
24 00 00 Hiner al s1JbstitiJtes , electrolytes 5 2.8 
02 06 01 Phenothiazines ;_ind derivatives 4 2.3 
01 02 00 Psychoanaleptics (antidepressants) 4 ? ' ~,.., 
05 08 00 Preps . for ,:011on ,:old , n;_is;_il decongest;_ints , antihista1inics 4 2.3 
06 03 00 Cardiac glycosides 4 2.3 
11 04 00 Ant;_icids 4 2.3 
22 01 00 H1Jltivita1ins and 11Jltivita1ins 11ith 1inerals 3 1. 7 
05 07 01 Anti hi sta1ini,:s 3 1. 7 
07 01 02 Ra1J11ol fia : diuretic co1binations 3 1. 7 
1i 04 03 Antacids : other 2 1. 1 
07 01 03 Other hypertensives " 1. i ,:. 
05 02 00 Adrenolytics (sy1pathicolytics) 2 1.1 
07 01 00 Vasodilators , hypotensive 1edicines 2 1.1 
02 06 05 Central nervous syste1 depressants : 1iscell;_ineo1Js str1Jct1Jres 1 0.6 
02 03 00 Barbit1Jrates 1 0.6 
21 02 00 Oral hypoglycae1ics 1 0.6 
06 02 00 Cardiac depressants 1 0.6 
10 01 00 Antit1Jssives and expectorants 1 0.6 
21 03 00 Thyroid preparatons 1 0.6 
18 05 00 Urinary tract antiseptics 1 0.6 
22 01 02 Vita1ins for prenatal use 1 0.6 
10 02 02 Hedicines acting on respiratory syste1 : other 1 0.6 
20 01 01 Broad and 1ediu1 spectr1J1 antibiotics 1 0.6 
07 05 00 Ser1J1 cholesterol redu,:ers 1 0.6 
05 07 02 Anti-e1etics and anti-vertigo preparations 1 0.6 
16 03 00 ENT s1Jrface anaesthetics 1 0.6 
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Table 3.2.19 . : Percent of all 1edicines, prescribed and self-
prescribed 1edicines used for each ti1e interval 
TIHE INTERVAL HEOICIHE TYPE (%) 
. -------------------------------------------------------
•(Group) : ALL : PRES. : S.PRES 
. -------------------------------------------------------
: Total nu1ber of 1edicines(n) 683 540 143 
: 1 to 5 days (1)• 3.4 3.2 4.2 
: b to 14 days (2) 3.9 3.5 5.b 
14 days to 11onth (3) 2.5 2.2 3.5 
1 to b 1onths (4) 13.9 13.5 15.4 
7 to 111onths (5) 4.1 5 0.7 
1 to 5 years (6) 44.2 44.8 ,1. 9 
: b to 10 years (7) 15.1 15.9 11.9 
: 11 to 15 years (8) 4,5 5.2 2,1 
: 16 to 20 years (9) 1.8 2.2 
: aore than 20 years (10) b.b 4.5 H.7 
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fable 3.2.20 : Gro•Jping of dr•Jgs a,:,:ording to 1ost freoJJent dJJration of use 
CLASSIFIC . : 
t!IJHBER 
05 07 01 
05 07 02 
05 08 00 
10 01 00 
10 02 00 
16 03 00 
20 01 01 
20 01 02 
30 01 00 
05 08 00 
10 02 00 
20 01 00 
20 01 01 
20 01 07 
20 02 00 
21 07 00 
DRUG CLASSIFICATION 
Antihista1ini,:s 
Anti -e1eti,:s and anti -vertigo preparations 
Preps . for ,:011on ,:old , nasal de,:ongest;;ints , antihish1ini,:s 
Anti bJs s i ves and expedor ants 
Bron,:hodilators 
ENT surface anaesthetics 
e,road and 1ediu1 spectr•JI antibiotics 
Peni,:illins 
Biologicals: antigens 
Preps. for ,:011on ,:old , nasal decongestants, antihista1ini,:s 
Bron,:hodilators 
Antibiotics and antibiotic ,:01binations 
Broad and 1edi•.111 spedr•J1 antibiotics 
Anti fungal antibiotks 
Anti11icrobials khe1otherapeuti,:s) : other than antibiotics 
Male se:< hor1ones 
22 01 02 : Vi h1ins for prenatal •Jse 
05 01 00 
05 04 01 
05 07 01 
07 05 00 
08 01 00 
11 02 00 
18 05 00 
20 01 01 
20 01 07 




Seru1 cholesterol reducers 
Coag•Jhnts, haeaoshtics 
Gastro-intestinal antispas1odi,:s and anti-cholinergi,:s 
Urinary tract antiseptics 
Broad and 1edi1J1 spectru1 antibiotics 
Anti fungal antibiotics 
Multivita1ins and 1ultivita1ins with 1inerals 
11 04 03 : Antacids : other 
DURATION 
1 - 5 days 
6 - 14 days 
: 14 days-1 1onth 
1 - 6 1onths 
: 7 - 11 1onths 
Table 3.2.20/Contin•Jed: 
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T::ible 3.2.20 (Contd) : Gro•Jping of dr1Jgs ::iccording to 1ost freq•Jent d1Jr::ition of 1Jse 
CLASSIFIC . : 
NUMe,ER 
01 02 00 
02 02 00 
02 03 00 
02 06 00 
02 06 01 
02 06 02 
02 06 05 
02 08 00 
02 09 00 
03 01 00 
03 03 00 
05 02 QI) 
05 04 02 
05 07 01 
05 07 02 
06 03 00 
07 01 00 
07 01 02 
07 01 03 
07 01 04 
08 02 00 
08 03 00 
10 01 00 
10 02 00 
10 02 02 
11 02 00 
11 04 00 
11 04 01 
11 04 03 
11 05 00 
16 04 00 
17 01 00 
18 01 00 
21 02 00 
21 08 01 
22 01 02 
22 01 04 
22 01 05 
24 00 00 
34 00 00 
DRUG CLASSIFICATION 
Psyd,o::in::ileptics (::intide~,ress::ints) 
Sed::itives , hypnotics 
e,::irbi t1Jr::ites 
Tr::inq1Jillisers 
Phenothi::izines ::ind deriv::itives 
R::iuwol fi::i ::il k::iloids ::ind co1bin::itions 
Centr::il nervous syste1 depress::ints : 1iscell::ineo1Js structures 
Non-n::ircotic ::in::ilgesics , ::intipyretics 
Speci::il ::in::ilgesic co1bin::itions 
Anti-rheua::itics (::inti-infl::i11::itory ::igents) 
Antigout prep.ar::itions 
Adrenolytics (sy1p::ithicolytics) 
Hedicines ::iffecting ::i1Jtono1ic functions : gener::il 
Anti hi st::i111inics 
Anti -e1eti,:s ::ind ::inti -vertigo prep::ir::itions 
C::irdi ::i,: gl y,:osides 
V::isodil::itors , hypotensive medicines 
R::i1J11ol f i::i : di1Jretic ,:01bin::itions 
Other hypotensives 
V::isodil::itors -coron::iry (::ingin::i pectoris) 
Antico.agul::ints 
Erythropoietics (h::ie1::itinics) 
Antit1Jssives ::ind expector::ints 
Bronchodil::itors 
Hedicines acting on respiratory syste1 : other 
G;.istro-i ntesti nal ::inti sp::is1odics ::ind ::inti -cholinergi,:s 
Antacids 
Acid ne1Jtralisers 
Antacids : other 
Lr.:·<atives 
N::iso- ::ind bucco-ph::iryngeal antiseptics 




'Ji t::i1i ns for pren::it::il use 
Other vit::i1ins 
Vit::i1ins : e,-co1plex with vita1in C 
Hiner.al s1Jbstit1Jtes , electrolytes 
Other (hoaeopathic, herb::il , etc) 
DURATION 
1 - 5 ye::irs 
Table 3.2.20/Continued : 
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DRUG USE PATTERNS 
T;;ible 3.2 .20 (Contd): Gro1Jping of dr1Jgs ;;i,:,:ording to most frequent d1Jr<1tion of use 
CLASSIFIC . 
NUMBER 
01 03 00 
02 03 00 
03 03 00 
05 02 00 
05 08 00 
Ob 02 00 
07 01 01 
07 03 00 
10 02 02 
11 04 03 
20 01 01 
22 01 02 
07 01 01 
08 01 00 
08 02 00 
10 02 02 
21 08 01 
02 03 00 
02 09 00 
21 03 00 
21 08 01 
DRUG CLASSIFICATION 
Scedal antidepressant ,:01binations 
e,arbi tiJr;;ites 
Antigout_ preparations 
Adreno 1 yti ,:s ( sy11p;;ith i,:o 1 yt ics) 
Preps, for ,:0111on cold , nasal de,:ongestants , antihista1inics 
Cardi;;i,: depressants 
Rauwol fia and ,:01binations 
Migraine prepar;;itions 
Medicines acting on respiratory syste1 : other 
Ant;;icids : other 
Broad and 1ediu1 spectru11 antibiotics 
1Jit;;i1ins for prenatal use 
Rauwol fi;,i ;;ind ,:01binations 
: Coagulants , hs1e1ostatics 
: Antico<1g1Jl<1nts 
: Medicines actin,J on respir;;itory syste1 : other 
: Oestrogens 
Barbiturates 





6 - 10 years 
11 - 15 years 
: 16 - 20 years 
tore than 20 
years 
alloc.3ted to the time interval for which they were most fre-
q1Jently used . Some classes which were •Jsed an equal number of 
times for two or more time intervals are shown in both time in-
terval groups. For e:-{ample , "adrenolytics (sympathicolytics) 11 
appears under time interval groups 6 and 7 because it was marked 
9 times under group 6 (1 to 5 years) and 9 times under group 7 
(6 to 10 years). It should be noted that in many cases medicines 
were not used on a continual basis throughout the time period 
shown . For e:·{ ample, the class "Broad and medium spectrum 
antibiotics" is shown in the 6 to 10 years group , but as can be 
seen in Table 3.2.11. the medicines in this class may have been 
used on a "only as required" b .3sis. 
~ KNOWLEDGE SCORE 
The knowledge score is a measure of the number of correct ans-
wers given to the questions posed in the interview schedule . As 
the possible maximum score varies from 15 to 21 depending on the 
medicine , the knowledge score is e :·{pressed as a percentage of 
the maxi mum possible for the medicine under review. 
3.3.1 KNOWLEDGE SCORE VARIATION WITH HEDICINE TYPE 
Table 3.3 . 1 . 
It can be seen in Table 3.3.1, that from a total of 693 medi-
cines , the mean knowledge score was 54.7% with a ma:dmum of 
93.3% and a minimum of 9.5%. Although the figures appear to be 
slightly lower for prescribed medicines - 53.7%, 86.7% and 9.5% 
respectively, and higher for self-prescribed medicines - 58.5%, 
93.3% and 15.8% respectively this was not significant (Pearson 
correlation coefficient r = 0.012, p = 0.8778), 
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KNOWLEDGE SCORE 
Table 3.3.1 : Relationship between know 
score and 1edicine type 
: KNOW . HEOICINE TVPE 
. ------------------------ . . . 
: SCORE : ALL : PRESCR : S - PR : 
. --------------------------------- . . . 
: <n> 
: HEAN 
: HAX , 













Table 3.3.2 : Relationship between knowledge scores and participant 
gender and age (years) 
: KNOW . GENDER AGE 
. ------------------------------------------------------------------------------ . . . 
: SCORE : ALL : HALE : FEHALE : 65-69y : 70-74y : 75-79y : 80-84y : 85-89y : 90-94y : 
----------------------------------------------------------------------------------------
(n) 693 111 582 24 53 72 63 21 2 
: HEAN 54 .7 54 .4 54.8 59 .8 57.5 54 .7 53.0 52 .0 46 .7 
: HAX . 93 .3 84 .2 93 .3 72.0 76.7 78.0 71.0 71. 7 49 .8 
: HIN . 9.5 15.8 9.5 50.0 35.5 27 .7 33.3 28 .6 43 .5 
Table 3.3.3 : Relationship between knowledge scores and health care type, aedicine supplier and 
satisfaction with inforaation provided by the health care professionals . 
: KNOW. HEALTH CARE TVPE SUPPLIER : SATISFACTION 
. --------------------------------------------------------------------------------------- . . . 
: SCORE : CLINIC : GP : H.AIO : NO AID : PH'CV : DOCTOR : CLINIC : OTHER : VES NO 
------------------------------------------------------------------------------------------------- : 
(n) 94 171 352 341 154 10 60 11 582 108 
: HEAN 54 .4 55 .4 55.3 54.2 55.1 60 .8 53.3 59 .2 55 53.6 
: HAX. 78 78 93.3 86.7 78 73.3 72.3 76.7 86.7 93.3 



















































































































































































3 .. ... 3 .... 2. K_NO_W_LED_GE. SC.OR.E. V_A_RIA_TIO_N_ W_I _TH. P_AR_T_I_CIPAN.T. CHAR.AC.T.E.R.I .S_T_IC_S_ 
Tables 3 . 3.2. to 3.3.6. 
The re 1 at i onsh i p between mean, ma:-: i mum , -:ind mini mum know 1 edge 
scores and patient characteristics is shown in Tables 3.3 .2, to 
3, 3, ,5, , In s,::ime 9ro1Jps , the s .3mple size (n) is very smal 1 .3nd in 
c .3te,;ior i es such .3s "Leve 1 of education , Standards 2 to 4" and 
"S,::ici -31 class 5" I only the mean knowledge score is quoted .3s 
there is one participant in each group and no maximum or minimum 
score. 
Ex amination of these tables reveals very little variation among 
the knowledge scores for each participant characteristic. No 
sign if ic.3nt re 1 at ionshi p was f 01Jnd to e:d st between know 1 edge 
score .3nd : 
1. level of ed1Jcation ., monthly income, soci .31 class, marital 
status , co-habitants, and smoking or drinking habits, using 
Pearsons correlation coefficient 
2, gender and satisfaction with information supplied by health 
care professionals using Students t-test 
3. participant medicine supplier using the Analysis of variance. 
However , it can be seen from Table 3.3.2 and Figure 3.3.1, that 
mean knowledge score declines with increasing age. Further anal-
ysis using Pearsons correlation coefficient demonstrated a sig-
nificant but inverse relationship between participant age and 
knowled9e score (r = -0.260, p = 0.0001), This significant rela-
tionship between participant age and knowledge score was found 
to sti 11 e:dst when prescription medicines only were analysed 
<Pearsons correlation coefficient r = -0, 245, p = 0, 0004) , How-
ever, there was no significant relationship in the case of self-
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KNOWLEDGE SCORE 
Table 3.3.4 : Relationship between knowledge scores and stoking habits, drinking habits, 
co-habitants, retireaent and state pensions. 
: KNOW. : SHOKING HABITS : DRINKING HABITS : CO - HABITANTS RETIREMENT & PENSION 








(n) 38 195 176 58 56 0 2 177 224 11 
HEAN 55.3 55 55.1 55.1 56.1 - : 56.2 54.8 55 57.4 
HAX. 73 78 78 68.4 78 - : 61.4 76.7 78 66.2 
HIN. 35.5 27.7 27.7 33.3 40 .1 - : 51.1 27 .7 27.7 42 .9 
Table 3.3.5 : Relationship between knowledge scores against social class and incoae category 
NOTE : n = 1 for Social class 5: Hean Score= 65 .8 






SCORE 1 2 3 4 1 3 4 5 6 7 8 
----------------------------------------------------------------------------------------------------------<n) 101 76 44 12 12 3 9 
HEAN 55 55.7 54.3 54.2 54.2 52 55.3 
HAX. 78 76 .7 72 63.8 73 66.7 64.7 
HIM . 28.6 27.7 35.7 33.3 40.1 42.4 42.8 
Table 3.3.6 : Relationship between knowledge scores and participant 
aarital status and level of education. 
25 45 30 62 
55.5 56.4 57.6 56 
73.3 72.9 78 72.3 
27.7 33.3 41.2 33.3 
: KNOW • MARITAL STATUS LEVEL Of EDUCATION 
. --------------------------------------------------------------------- . . . 
: SCORE : NEVER : OIVORC : WIDOW : HARR. : SO 2-4 : SO 5-7: S08-10 : TERT. : 
: ------------------------------------------------------------------------------
(n) 31 17 132 S5 1 45 140 49 
: HEAN 58.1 57 .6 53.6 56 47.6 55.2 55.4 54.2 
: HAX. 73.3 71. 5 76.7 78 68.4 76.7 78 
: HIN. 35.5 43.7 27.7 40.1 37.6 27.7 33.3 
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: 
prescribed medicines only. (Pearson correlation coefficient r = 
-0 . 159, p = 0 . 0999). 
Al though not readily apparant from Table 3. 3. 3. , when tested 
using the analysis of variance , a significant relationship (p = 
0.0001) was found to exist between the knowledge scores and the 
health care type. 
3 . 3 .... 3 KN.OWLEDGE. SCORE VARI.AT ION W_ITH PAT_TER_NS Qf_ QR!Jg_ ~S~ 
Tables 3 . 3 .7. and 3.3.8. 
Table 3.3 . 7 shows the mean , maximum and minimum knowledge scores 
for participants versus their percapita use of medicines. It is 
apparant that there is no obvious relationship between the num-
ber of medicines used and knowledge score . This was confirmed by 
analysis using Pearsons correlation coefficient < r = -0.106 , p 
= 0.1) 
Similarly, there is no relationship between knowledge score and 
d•Jration of medicine use (Table 3.3.8). Pearsons correlation 
coefficient (r = 0.046, p = 0 . 22). To facilitate the use of this 
test, all time intervals were converted to days. 
3 . 3.4 KNOWLEDGE SCORE CHARACTERISTICS._ 
Tables 3.3.9. and 3.3.10 
In these tables the percentage of correct answers for each 
knowledge score question is shown. Table 3.3 . 9. shows the per-
centage of correct answers against participant gender and age, 
and Table 3.3 . 10 shows the percentage of correct answers against 
health care type and medicine supplier . 
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KNOWLEDGE SCORE 
Table 3.3.7 : Relationship between knowledge score and per capita use of 1edicines 
: KNOW. HEOICINES PERCAPITA 
. ------------------------------------------------------------------------------ . . . 
: SCORE 2 3 4 5 6 7 8 10 
---------------------------------------------------------------------------------------- : 
: (n) 26 45 58 48 23 19 12 3 1 
HEAN 54 . 9 56.2 55.3 56.3 55.1 53.2 48.6 58.9 44.7 
: HAX, 73,3 70.2 78.0 72.0 73.0 68.2 66.2 62.9 44.7 
: HIN. 33.3 28.6 27.7 31.6 35.5 37.6 42.6 55.8 44.7 
Table 3.3.8: Relationship between knowledge score and duration of 1edicine use 
DURATION Of USE (Groups) : KNOW. 
: SCORE 
. --------------------------------------------------------------------------------------- . . . 
2 3 5 6 7 8 9 10 
------------------------------------------------------------------------------------------------- : 
(n) 23 27 17 95 28 302 103 31 12 45 
: HEAN 54.9 54.7 49.9 54.6 55.4 54.3 55.7 59.6 56.4 55.3 
HAX. 93.3 76.5 63.2 82.4 80.0 86.7 80.0 86.7 86.7 76.5 
: HIN. 31.6 9.5 26.3 23.8 28.6 21.1 28.6 31.6 33.3 36.8 
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KNOWLEDGE SCORE 
Table 3.3.9 : Relationship between percent correct answers given for each knowledge score question and 
participant gender/age (years) 
---------------------------------------------------------------------------------------------------------------
KNOWLEDGE SCORE PERCENT FOR GENDER AND AGE GROUP <Vears) 
: ------------------------------------------------------------------------------------------------------------- . 
QUESTION : ALL : HALE : FEHAlE : 65-69 : 70-74 : 75-79 : 80-84 : 85-89 : 90-94 : 
: ------------------------------------------------------------------------------------------------------------- . : Na1e and Strength (Q2+Q3) 52 52.9 51.8 52 .4 59.3 51.8 49.1 36 66 .7 
: Na1e or Strength (Q2 or Q3) 22 .8 19.2 23 .5 25 .4 17 .9 23 .3 25 .7 22 33 .3 
: Reason for Use (Q4) 86 .7 77 . 5 88 .4 91.8 86 .1 88 .2 83.7 87 71 .4 
: Dose Frequency (Q5) 84 .9 86 .4 84 .7 87.7 86.3 83.3 84 .7 83 .3 85.7 
: Haxi1u1 Dose (Q6) 16.9 7.7 19 .2 29 .4 12.2 27 .6 9.7 11.1 0 
: Dose Quantity (Q7) 91.2 89 .1 91. 5 87.8 94.2 93 .1 87 .8 92 .6 71.4 
: Hanner of Use (Q8) ( i) 18 18 .35 17.9 13. 7 20 .5 21. 4 11 .8 22 .2 33.3 
: Hanner of Use (Q8) (ii) 79 .5 78 .9 79.6 84.9 76 .6 76 .1 85 .4 75 .9 66 .7 
: Duration Use-Previous (Q9) 88 .1 92.6 87 .2 91.9 91.2 88 .7 84 .1 83 .3 85.7 
: Duration Use-Expected (Q10) 36 .4 36 .7 36.3 41. 9 41. 7 32 .1 33 .7 38 .9 14.3 
: Hedicines to Avoid (Q11) 0.8 1.9 0.6 2.9 0 1 0.6 0 0 
: Reasons (Q12) 0.3 1 0.2 2.9 0 0 0 0 0 
: Foods to Avoid (Q13) 4 5.1 3.7 10.5 3.8 3.3 2 6.2 0 
: Reasons (Q14) 3.5 2.6 3.7 10.5 1. 9 3.4 2 6.2 0 
: Alcohol to be avoided (Q15) 7.7 6.9 7.8 22.7 7.1 6.8 5.4 2.8 0 
: Reasons (Q16) 2.4 1.4 2.6 6.8 3.6 2 0.9 0 0 
: Side Effects (Q17) 19 .8 25 .2 18.7 27 22.7 17.6 15.8 20 .4 28 .6 
: Corrective Action (Q18) 64.8 64.1 65 .2 100 65 .8 41 69.2 100 




Table 3.3 . 10 . : Percent correct answers for each Knowledge score question against 
health care type and 1edicine supplier 
------------------------------------------------------------------------------------
KNOWLEDGE SCORE : H.CARE TYPE (%) : HEDICINE SUPPLIER (%) 
: ---------------------------------------------------------------------------------- : 
QUESTION GP : STATE : PH'CV : Dr. : CLINIC : ELSEWH : 
---------------------------------------------------------------------------------- . 
: Na1e and Strength (Q1+Q2) S4.2 S0 .4 S3 72.4 42.S 80 .9 
: Na1e or Strength (Q1 or Q2l 22 .9 22 23.2 20.7 24 .1 4.8 
: Reason for Use (Q4) 86 .7 87.2 8S.8 93.3 87 .1 90.S 
: Dose Frequency (QS) 83 .1 68.6 83 .7 85.7 88 81 
: Haxi1u1 Dose (Q6) 14 .3 25.S 11 . 7 S7 .1 21.6 11.1 
: Dose Quantity (Q7) 90.7 92 91. S 89.7 90 .3 95 .2 
: Hanner of Use (Q8) (i) 16.8 19.3 16.6 16.7 20 .2 30 
: Hanner of Use (Q8) (ii) 80.8 79 80.9 80 77 .2 70 
: Duration Use-Previous (Q9) 87.6 43.1 88 86 .2 87 .6 9S 
: Duration Use-Expected (Q10) 34 .9 38 .3 37.1 37 36 .3 20 
: Hedicines to Avoid (Q11) 1.1 0 1.2 0 0 0 
: Reasons (Q12l 0.4 0 o.s 0 0 0 
: Foods to Avoid (Q13) 3.7 4 4.7 0 3.4 0 
: Reasons (QH) 3.7 3 3.9 0 3.4 0 
: Alcohol to be avoided (Q1S) 7 8.1 6.6 10 9.2 11 .1 
: Reasons (Q16) 2.S 1 Jt 2.2 10 2.1 0 
: Side Effects (Q17) 20 .6 17.9 19.3 26.7 19.7 20 
: Corrective Action (Q18) 70 .8 S8.6 67 .1 100 S4.8 0 
: Reading for Infor1ation(Q23) SS.4 52 .3 S6.S S6.3 S4 6S .2 
------------------------------------------------------------------------------------
.. ., 
On examination of the data presented in Table 3.3.9. and Figure 
3. 3. 2. the most outstanding feature is the low score rate for 
the questions concerned with poss i b 1 e interactions with ,:)ther 
medicines. foods and alcohol. Only O. 8, 4 and 7. 7% respectively 
of answers were correct to questions on what medicines to avoid , 
what foods to avoid and whether alcohol is contra-indicated. 
Simil .3rly , the reasons for avoidance were mostly not known -
0.3, 3 . 5 and 2.4% correct answers respectively. 
The score with respect to side effects was also low at 19.8% , 
although in 64.8% of cases the participants indicated correctly 
what would be the best course of action if side ~ffects were ex-
perienced. 
In contrast scores for reasons for use, dose frequency , dose 
quantity, and duration of use (previous) were all over 80% with 
manner of use indicated correctly in 79, 5% of cases. Name and 
strength of the medicine were correctly given in 52% of cases 
and just over half (56%) of the participants "read 1Jp 11 about 
their medicines to try and find out more information about them. 
The scores for male and female participants show little varia-
tion. 
The biggest differences lie with "Reason for use" and "Reading 
for information". A higher percent of females correctly indi-
cated the reason for use of their medicine - 88.4%, as against 
77.5% for males. In the case of further reading, the converse is 
true with a higher percentage of males than females scoring cor-
rectly - 63.5%, compared with 54.6% of females. This may help to 
explain why there was no significant relationship between over-




















































































































































































































































































































































































































A significant decline in knowledge score with increasing age was 
noted earlier . From the results presented in Table 3.3.9 , it ap-
pears a similar trend is followed in the questions concerning 
duration of use (previous), possible interactions with medi-
cines , foods and alcohol, possible side effects , and further 
reading for information. 
The data presented in Table 3.3.10. reveals few differences be-
tween the percent of correct answers given by private patients 
and by state care patients. The notable exceptions are : 
1 . dose frequency - correctly answered by 83 . 1% of participants 
who attend a general practitioner compared with 68.6% who attend 
a state clinic , 
2 . duration of use (previous) - 87.6% versus 43.1% and 
3. correct action with respect to side effects - 70. 7% vers•.Js 
58.6%. 
Table 3. 3. 10 also shows the percent correct answers for each 
knowledge question against the participant's main supplier of 
medicines. The group of participants supplied by their doctor is 
small and includes only 12 participants which limits the poten-
tial for meaningful comparison . The doctor group gave a higher 
percent of correct answers than either the private pharmacy or 
clinic groups for the questions on name and strength of the med-
icine , reasons for use, avoidance of alcohol and correct action 
with respect to side effects. However, they scored 0% for the 
questions on medicines and on foods to be avoided and the rea-
sons for avoiding them. 
Participants in the group purchasing their medicines "Elsewhere" 
gave the highest percent of correct answers for name and 
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strength of medicines , dose quantit y, manner of use , duration of 
use (previous) , avoidance of alcohol and further reading for in-
formation, They scored 0% however , for the questions concerning 
reasons for a v oiding alcohol , avoidance of medicines and foods 
and the reasons , and the correct action to be taken if side ef-
fects occur . 
In common with the two previous groups, the participants s1.Jp-
pl ied by the clinic gained zero score for the questions on other 
medicines to be avoided and the reasons for avoiding them. Of 
a 11 the supp 1 i er groups , the c 1 i ni c group scored lowest with 
respect to the name and strength of the medicine with 42.5% of 
answers being correct , In other respects , the score pattern for 
the clinic group is very similar to that for the group supplied 
by private pharmacies. 
The private pharmacy group did not score 0% for any of the ques-
tions , but sti 11 had a low percent of correct answers for the 
questions concerning avoidance of interacting medicines , foods, 
and alcohol . The pharmacy group scored lowest of all the groups 
on questions on reasons for use of the medicine, avoidance of 
alcohol , and possible side effects. 
~ LABEL SCORE 
3.4 . 1 LABEL SCOR£ CHARACTERISTICS 
The label score was composed of a set of 10 questions, with a 
maHim•Jm possible score of 10 points. Table 3.4.1 . lists these 
questions and shows the percentage of correct answers received 
for each question according to type of medicine and medicine 
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LABEL SCORE 
Table 3.4.1 : Percent correct answers for each label score question according to 
1edicine type and health care supplier 
------------------------------------------------------------------------------------r--------
LABEL SCORE HEOICINE TVPE m HEOICINE SUPPLIER (%) 
: -------------------------------------------------------------------------------------------
QUESTION ALL : PRESC . S-PRES : PH'CV : Or : CLINIC : ELSWH . 
: -------------------------------------------------------------------------------------------
: Legibility :Hedicine na1e(Q1) 75 .6 77.9 67.1 91.3 100 81.8 73 .8 
: Legibility :Oirections (Q2) 72 .7 77 .4 55 .7 91.3 100 81.8 63.9 
: Drug na1e (Q3 .a + b) 20.9 9.1 64.4 2.3 0 6.8 36 .1 
: Drug naae (Q3 .a orb) 68.8 80 28 .2 95 .8 100 93 .2 63 .9 
: Oirections :Quantity (Q4 .al 73.3 69 .5 87 .2 71.1 63.6 98 82 .2 
: Oirections :Frequency (Q4 .b) 69 .7 66 .9 79 .9 68.1 63 .6 93.9 76.7 
: Directions :Hanner (Q4 .c) 16 .9 11.8 35 .6 9.1 9.1 21.6 28 .7 
Oirections :Ouration (Q4 .d) 11 .1 5.7 30 .7 1.9 0 0 35 .6 
: Patient na1e 61 77.4 1.3 98.9 81.8 97 .3 3.5 
: Dispenser (aanuf .) na1e 86 .1 84 .7 91.3 99.2 90.9 99 .3 87 .1 
Total score (1ean) 63.8 56.9 60.6 63.1 60.9 68 61.5 
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supplier group. The mean label score expressed as a percentage , 
is also shown for each group. 
The differences among the mean label scores were small, regard-
less of medicine type or supplier. Prescribed medicines had the 
lowest score of 56.9%. The mean label score for all medicines 
was 63.8%. Of the supplier groups, the clinic group had the 
highest score of 68% and the doctor group the lowest of 60,9%. 
On e l·:ami nation of the percent correct answers for each label 
score question , it is apparant that little information on manner 
of use of the preparation and on duration of use are provided on 
the label. Information on manner is provided on 35,6% of self-
prescribed medicine labels, but only on 11.8% of prescribed med-
icine labels. For duration of use, the values are lower with in-
formation appearing on 30.7% of self-prescribed medicine labels , 
and 5. 7% of prescription medicine labels. Low scores for these 
points are also found for the labels of medicines supplied by 
private pharmacies (9 . 1% and 1. 9%) , doctors (9. 1% and 0%), and 
clinics (21 . 6% and 0%) , the only legally permitted suppliers of 
prescribed medicines. 
The labels on prescribed medicines are more likely to have only 
the proper name of the medicine , or its descriptive name or in-
dication - 80% - than to have both shown on its label - 9.1%. 
The converse is true with self-prescribed medicines, with 64 . 4% 
showing both name and indications, but 28.2% showing only one or 
the other . Labels of medicines supplied by private pharmacies, 
doctors or the clinics also have a low incidence of showing both 
name and indication on the label with the incidence ranging from 
0% to 6.8%. 
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The labels on self-prescribed medicines tend to be less legible 
than those on prescribed medicines. Participants could read the 
name and instructions in 67.1% and 55.7% of instances respec-
t i Ye 1 y . The c: om par a t i 'v e 'v a 1 u es for pres c: r i bed med i c: i n es we re 
77 . 9% .,rnd 77.4% respectively. The legibility scores for medi-
cines purchased "Elsewhere" were .3lso lower than those for me,ji-
cines obtained from the 3 other supply groups. 
3 .. 4 .. ' 2_ L.A.eEL S.C.0.RE. RELAT.IONSHIP TO KNOWLEDGE SCOR.E 
The relationship between knowledge score and label score was 
analysed using Pearsons correlation coefficients. No significant 
relationship was found to exist. 
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CHAPTER i. 
DISCUSSION OF RESULTS 
4.1 PATIENT CHARACTERISTICS 
It was not the aim of this work to establish the socio-economic 
ch .3r.3cteristics of the South African elderly . These data were 
collected primarily with the intention of establishing the 
identity of the study population and how this was related to 
drug use patterns and participant knowledge of the medicines 
used . 
A potential criticism is that the study population was limited 
to predominantly female , relatively well-educated upper to 
upper-middle class, Caucasians living in old-age residences , 
which represents a relatively small percentage of the South Af-
rican elderly . However , it was impossible for a single investi-
gator to include all racial , social and cultural groups and it 
is hoped that the knowledge gained will stimulate further com-
parative studies. An advantage of the population in this project 
is that it was fairly typical of a first-world geriatric group 
and therefore allowed for ready comparison with similar pub-
lished studies, particularly from the United Kingdom and the 
United States of America. 
Patient selection may have accounted for the fact that the ma-
Jori ty of participants were over 70 years and only one fifth 
were male. Although the relatively small male sample of 49 
participants enabled comparison of se:-~-related data, a larger 
sample is likely to have provided more meaningful information. 
120 
Th .3t 87% of participants were single, of whom almost all were 
1 iv i ng a 1 one emphasises the need for community support groups 
and the regular follow up of elderly patients. 
The finding that only 16.2% of participants were smokers is in-
teresting as this is considerably less than the figure of 44.6% 
quoted by Van der Burgh (1979) for the general white population. 
This discrepancy may be due to a number of differences between 
the two sample groups. Van der Burgh did not include the over 60 
year olds in his study whilst the sample group chosen for this 
study specifically e xcluded participants under 65 years . In ad-
dition , participants who spoke only Afrikaans were excluded from 
this study, and the population was heavily weighted with female 
participants , Women in Van der Burgh ' s study had a lower in-
cidence of smoking and there was a decline in the proportion of 
smokers in the 50 to 59 years age group. The findings in this 
study demonstrate that this decline in the number of smokers 
continues as age increases. The reasons for this are beyond the 
scope of this research but factors playing a role may include 
increased mortality due to smoking which would select out 
smokers, possible increased awareness of the health hazards of 
smoking with the greater frailty and incidence of illness asso-
ciated with aging, or simply that the elderly can no longer af-
ford the habit. The proportion of light smokers is also much 
higher in this study group than in Van der Burgh's work. There 
is no clear e xplanation for this . 
However , in line with Van der Burgh, appro:dmately one quarter 
of participants claimed to be teetotallers which may be an in-
dication that drinking habits do not change substantially with 
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.':.J l ,:::oho l iT is aoo~rent that women drink less th8n men with h~lf 
mon thly on special occms 1ons. The over 85 ye~r olds were an ex-
,::. e p -;:: :i. o n ,3 ·,; mo ,~ F! t h ;_:_i n 9 ~i ::-;. -'.'.\ r •::' d r :i. n k (·'1 r '::; 1,,1 :i. th h ~:1 l f e:! m b :i. b :i. n ·J /:, ·- "? 
d .:,1 y ·;; p (':: r 1,1 ,,:·i ,::,, k , A l t h Du q h t h :i. ':; C-.1 r o u D :i. s '::; m ;,.l 1 l ( '.? ::::: o ;,.l \~ t :i. 1::. :i. c, ~.l n t s ) 
and therefore the results m~y be misle~ding , the relatively high 
r~te of alcohol consumotion may po:i.nt toward incre~sed lDneli-
ness ~nd deoressiDn associmted with advmnced age. This warr~nts 
further investigation. 
It l ',; ·1 ., YJ(·?.1 .I • .i. t-:.no• .. 1n th;,:1t th(':! of disemse incre8ses with 
advance in age, ~nd the rise in general oractitioner attendance 
with greater age noted 1n this study 1s in keeoing with this. A 
tr:,ind.:.::1n.-::.(,~, but th ,0,ir'(',, 1 ·,; no obv :i. ouc:,. i':!>:p 1.,,:1n;,:1t :i. on \,/h\' th :i. '::; 1,,1;_,:1·::; ni::?t 
the case. With the high number of reqistered disoensing doctors 
i r1 <.:,out h ;::if r :i. ,:.:.::.1 , 1 r 1 ·;;; ·::;1 . .1 r'pl~ :i. s.;. :i. nr;_1 th ;::1t only ~i '.%: o -f p;.::1r't :i . .-:.: :i. p -c:1n·i::·:;; 
r,:'f!,·::.,::~ :i. \J(·?d ·i:h,:,: i r tn•:::d :i. ,:.:in,::,,-,::. from thi::, :i. r do,.7:·1::Dr'1;;. ThE· -f-".:~·1c.t th;::1t th,:7, 
interviewer introduced herself as a pharmacist may have bi~sed 
the oarticioants answers, althouqh it is also oossible that most 
practitioners attended by the limited study smmole did not dis-
pense their own prescriotions. 
4.2 DRUG USE PATTERNS 
.:1· .. .. .'.::: ..... 1. \I_M_J_LJ\F:_IT_I.E::::. To_ u.~~._t1_ i'.'.!_N.D. u1< E:L._D_EF:L..v 
Th1:!.· druc1 1..1·31'.·1 o.:::\-f::tr:.•rn·,:; of th:i.<:; <;;.'::impl1:.~ of '::,0 1..1th (t-fr':i.,:~ -',.ln r,,ild(71rlv 
America and Britain in the following asoects. 
4.2 . 1 . 1 MEDICINES USED 
Despite the use of different classification criteria, the first 
of these similarities can be seen in the drugs most frequently 
used by the elderly. In this study, the 3 most frequently used 
of all medicines wer·e : 1 , non-narcotic analgesics , 2. di•Jreti c s 
-3nd prescribed was ranking 
7 .., . For medicines , the 1 a:-~ at i ves . 
slightly different with diuretics first , non-narcotic anal-
gesics second and tranquillisers third. In their study of the 
elderly of England , Cartwright and Smith (1988) found that the 
r-3nking for prescribed medicines was almost identical to that 
described above . Diuretics were the most frequently prescribed , 
-3n-3lgesics were second and hypnotics , sedatives and anxiolytics 
third. Stewart (1988) found a slightly different ranking of 
prescribed -3nd self-prescribed medicines among elderly Americans 
with vitamins most commonly •Jsed , analgesics second and car-
diovascular medicines third. If, in the present study all 
vitamin containing preparations are grouped together , vitamins 
are the third most frequently used of all medicines and the most 
frequently self-prescribed. 
4.2.1.2 PER CAPITA USE OF MEDICINES 
The average per capita use of medicines also shows little varia-
tion from American and British studies . In this study, the aver-
age per capita use for -:111 medicines, prescribed and self-
prescribed medicines was 3. 2, 2 , 6 and 1.4 respectively . In 
elderly hospital outpatients, Davis (1987) found a higher figure 
of 4.57 per patient . Four point three medicines per capita were 
used by the USA elderly in the study undertaken by Kiernan et al 
< 1980) . In their recent update on the patterns of drug use in 
the elderly population of Dunedin , Florida, USA, Hale et al 
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(1987) note that there the average number of medicines (includ-
ing both prescribed and self-prescribed) per participant is 3.7. 
Cartwright and Smith ( 1988) discovered that on average , the 
British elderly were taking 1 . 90 prescribed medicines and 0.85 
self-prescribed medicines per capita . The different inclusion 
criteria for the drugs as •.Jsed by the researchers may help to 
e :-:p lain the sma 11 variations in the per capita usage rates. In 
this study all medicines used over a 2 week period were consid-
ered , whereas Kiernan and Hale considered only medicines that 
were used regularly over a period of years, and Cartwright and 
Smith considered only medicines that were used within a 24 hour 
period . It could not be ascertained from the present sti.Jdy 
whether per capita use of medicine by the elderly had increased 
over ti me , as was reported by Ha le et al . < 1987) and Cartwright 
.3nd Smith (1988) . 
Near 1 y s i :-: percent 5.8% - of the participants in this study 
claimed to use no medication at all. Similarly, Hale et al . 
found that 6.7% of their study population was using no medicine. 
Only half the participants in Cartwright and Smith ' s study were 
using self-prescribed medicines as was the case in this study. 
However , self-prescribed medicines may be under-reported as they 
are often used on an infrequent basis and may be forgotten about 
at the time of interview. 
Stewart (1988) noted that American women may use up to twice as 
many drugs as men. Whilst a similar trend was noticed in this 
study, the ratio was not so large with the average per capita 
use rate being 3.3 for women and 2.9 for males. 
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4.2.1.3 COMPLIANCE WITH DOSAGE INSTRUCTIONS 
.I. n t h ,-:_., 1. 1~ .:;:, ·=:; s; i::: s ':::. m F:: n t o f c, r e ·=::· ;:_: Y' :i. b .-,2 .-::I m E,· d i ;:.: :i. n ,:0 ·=:; , C ~-1 r t 1,,1 r :i. ·:;.1 h t .=.1 n d 
'.:,mith -Found th-':.1t one f:i.fth of th0• ·:'.Onta:i.n,7:ir l.:::1br,,il'.::- h~.1d non ···· 
·:::-e,>:0 .. :::i. f:i.,:.: :i.n·::;tr1.1 ,.:t :i.on;,; ·;;;u,:.:h .:,1·5 ''T.:::iki:-?.• .=.::i·::; dire,.:t,::,id''. Th,:-:-i pr' .oDorticin 
was mu ch higher 1n this study, ~ith nearly one third 
of all orescriotion med:i.c:i.ne labels having no dose instructions . 
When a ssessed against those labels with more exolicit instruc-
t1.on·,;_. ··:-,·? .. :>"/ :: •• / t / :"11 non-co moliant with 
the schedule for their orescribed medicines. A sim:i.lar incidence 
of non-compliance was found by Cartwright and S mith , where one 
ouarter of the British elderly interviewed were not tak:i.ng their 
medic i ne as prescribed. As in the oresent stud y, the ma jor i ty of 
changes were reductions 1n dose with only 1% of the oartic:i.oants 
Kiernen et al. revealed a h:i.qher non-compl:i.ance inc:i.dence of 36% 
p-':lrt i ,.: :i. D-':.1nt·=; \•/E•r ,:,-: =.11 '.:;o mor' f::: l :i. ki:.-1 l ·-/ to di::,i .. : 1~€-1 ;,_)':::- e:: th>:-,: i l~ mi::,id :i. ,.: i nr:,, 
doses (30%) than to increase them (6%), 
Th f.-1 f i n d :i. n ·J b '-/ 1.~ ;_,_1 n d l •7:i s; c;; i::i t =.1 1 . ( l 9 / 9 ) th .=:.1 t r:_-i 1 d 1:.-1 ,~ 1 '/ P, r i t :i. :,; h 1,1 om>"?: n 
are more inclined than men ta be non-camoliant was conf i rmed in 
less, this study d:i.d not find that there w0s 0 tendency for the 
elderly to beco me more non-compliant with increasing age . Hu lka 
be taken and the mare comolex the dosage regimen ., the ooorer the 
[:, ;:_1 t i f·i n t C. 0 111 C, l :i. ·''.l n ,::  i::1 , ·r h j_ '.::- \,/ -'::; ·;;; ;] :i. '::; D f Cl 1..l n d t D h P th('·) ,.: ·'.'.l '.::· ;:_.) •,/ :i. th 
resoect to prescribed med:i.cines and self-orescibed medicines 1n 
thi ·=s ·,stud ·/ 
oarticipant was using the greater the likelihood that he or she 
would deviate from the recommenced dose. 
4.2.1.4 DURATION OF USE 
Lon,;i term use of medicines is a common phenomenom amongst the 
elde r ly ( law et al. 1976, Murdoch 1980 . Kiernen 1981). In their 
study, Cartwright and Smith found that for prescribed medicines , 
43% had been used for 1 to 5 years, and 16% had been used for 6 
to 10 years. The figures are virtually identical from this study 
with 44 . 2% of all medicines being •.Jsed from 1 to 5 years and 
15 . 9% being used for 6 to 10 years. 
4.2.1.5 IMPLICATIONS OF DRUG USE PATTERN RESULTS 
Ninety-five percent of the participants were using some kind of 
medicine, and appro:<i mate 1 y five s i:-:ths of a 11 medicines were 
prescribed. This may be taken as an indication of the 
responsiblity and involvement of the health care professionals 
in the well-being of the elderly. 
In their year-long study into adverse drug reactions in the 
elderly , Williamson and Chopin (1980) identified certain drugs 
with increased risk of adverse react ions in the e 1 der 1 y user. 
The risk was greatest with hypotensives, antiparkinsonian drugs 
and psychotropics . However , the incidence of adverse drug reac-
tions was highest for diuretics, antidepressives, tranquillisers 
and psychomimetics, and digitalis. 
These are important points to bear in mind when considering the 
medicines used by the participants in this study. Of particular 
concern is the fact that psychotropics carry a high adverse drug 
reaction risk factor and yet when al 1 the classes of 
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psychotropics are grouped together, they are found to be the 
most commonly used of all medicines in this study. In addition 
in most cases, the participants indicated that they were using 
these drugs on a regular basis and had been doing so for at 
least 1 to 5 years or longer. As the participants in this study 
were independent active members of the community , their continu-
ing need for such prepartions warrants further investigation. 
Hore problematic is the high use of non-narcotic analgesics and 
anti rheumatics (anti-inflammatory agents). Castelden et al. 
(1988) identified gastro-intestinal bleeding as the most common-
ly reported adverse drug reaction in the elderly and found that 
non-steroidal analgesics were the agents most often responsible. 
As it is unreasonable to expect the elderly to go without these 
pain relieving drugs , careful follow up and monitoring is impor-
tant if they are being used on a regular and long-term basis. In 
many cases the participants indicated that these drugs had been 
used regularly for periods of 1 year or more. In addition, non-
narcotic analgesics are the most frequently used of self-
prescribed medicines indicating that often these preparations 
are used without regular professional supervision. Patient 
counselling on the correct use of these drugs and their poten-
tial side effects becomes essential in the light of these find-
ings. 
Of all self-prescribed medicines the second most commonly used 
was homeopathic or herbal preparations - 14%. Whilst at first, 
this may appear to be inconsequential, there has in recent years 
been an increase in reports of adverse drug events following the 
use of herbal remedies (Report The Pharmaceutical Journal of 
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the Royal Pharmaceutical Society of Great Britain 1989 ; Mac-
Gregor et al . 1989) These preparations are frequentl y promoted 
as being "natural" and therefore harmless , but in common with 
"synthetic" drugs inappropriate use of these preparations can 
have unfortunate consequences . It is important that medical 
professionals and the public at large are made aware of this . 
In not al 1 instances were the medicines taken on a regular 
basis. Non-compliance was found to occur in over one quarter of 
prescription medicines users· , where the tendency of the 
participants was to decrease rather than e:,:ceed the indicated 
dose . Of note, · there were no instances of an increase in dose 
with psychotropic preparations. This may be the true case but 
may also be an indication of the participants ' unwillingness to 
disclose that they are indulging in such an activity. When con-
sidering those classes of drugs where dose was increased, the 
potential for increased side effects in the elderly is substan-
tial . The excessive use of diuretics may lead to dehydration and 
electrolyte disturbances, abuse of anti-inflammatory agents may 
lead to increased potential for peptic ulceration , sodium and 
water retention and nephrotoxic effects, and the excessive in-
take of rauwolfia combinations may produce depression, hypoten-
sion and diuretic related adverse effects. 
In contrast , the reduction in dose of preparations such as anal-
gesics, 1 axat i ves , hypnotics, co 1 d and ' f 1 u and herb a 1 prepar-
t ions may be desirable or not counter-productive . However , •Jn-
dertreatment of conditions such as cardiac failure , depression , 
hypertension and diabetes is potentially serious and identifies 
an important component of non-compliance. The need to identify 
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and co•Jnsel the non- c ompliant elderly is highlighted by this 
failure to take the prescribed or recommended doses of agents 
such as diuretics, cardiac glycosides , antihy potensi·v es and 
hy po9 lycae mics. 
The ty pe of health care utilised b y the parti c ipant or the medi-
cine supplier may have an infl•Jence on compliance . In addition 
to the greater tendency for the private sector supplier not to 
9ive dosage instructions on the container label , there is .3 
higher incidence of non-compliance for those medicines received 
from the private sector -29.3% as opposed to 21.2% in the public 
sector . This may be an indication of the failure of the health 
care professionals to communicate not only with the patient but 
also with each other. It is not possible for the supplier of the 
medicine to re-inforce dosage instructions if they are not com-
municated to him by the originator of the prescription. 
Over 30 classes of drugs were indicated as being prescribed or 
used on a "prn" basis. In many cases this may be an acceptable 
practice , but of note is the fact that 3 participants were using 
their psychoanaleptic (antidepressant) preparations , and one 
participant his anti-parkinsonian drug on an intermittant basis. 
For optimal efficacy these drugs should be used on a continual 
basis , and failure to do so indicates a lack of understanding of 
the prepartion on the part of the prescriber or the patient. 
Also of concern were the 34 instances where the participants 
used their non-narcotic analgesics on a continuous basis, This 
practice predisposes to increased adverse effects , in particular 
.3na 1 ges i c nephropat hy with prolonged e~-,p osure. Tranqu i 11 i se rs 
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and sedative hypnotics , l a :-: at i ves , bro ad and medium spec tr um 
.3ntibiotics , and prepar .3tions for common colds , nasal 
decongestants, antihistaminics were also used on a continuous 
b .3sis . Such use of these medicines over e :-: tended periods is 
contra-indicated because of such problems as habituation , treat-
ment failure and emergence of resistant organisms in the case of 
antibiotic abuse. 
Further hazards in drug management of the elderly patient are 
introduced by the concomittant use of several preparations. Two 
fifths of the participants in this study were using 4 or more 
medicines (prescribed and self-prescribed) concurrently . Al-
though this may not necessarily be an indication of the inap-
propriate 1Jse of medicines , it does indicate the need for care-
ful review of the elderly patient's drug regimen before starting 
a new medicine. The higher per capita use of medicines for those 
elderly attending state health services may be an indicator of 
such a deficiency in the system. Patients attending state hospi-
tals do not always see the same doctor at each visit and fre-
quently the doctor must rely on the notes of other practitioners 
.as pressure from high work loads may not permit him to take a 
more detailed history before prescribing a new preparation. As 
discussed in the previous section , the higher per capita use of 
medicines may help to explain why a higher non-compliance rate 
was also found to exist in the state health care services. Care-
ful attention to these 2 points may help to reduce expenditure 
on medicines by the State through their more efficient use. 
In addition to there being an increased per capita consumption 
rate with health care type, an increase in use of medicines was 
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ncit1:2.-::I 1,,1 i tr-i , ..1om1::,n. 1,,ihv th :i. •,; '::,ho1..1 l d bE'! th;;;, .-2;;:;<:.;,7::, h.=:J<:; not b 1::, 1'::n in···· 
vestiJated in this st1..1dy, b1..1t may be an indication of the dif-
f,7:,r(0nt ;::1tt:i.tudr;;,s of thi:0 :;•"2>=:es to•,.;.::.,r··d'.::- he .=:.1lth st.:;.1t1..1:;. ~!om,:-:-in m.:::,v 
be mcire inclined tci admit that they are 1..1nwell and conseq1..1ently 
may demand more medicines. More diffic1..1lt to explain is the ap-
carant lack of infl1..1ence that age has on the per capita 1..1se cif 
medicines. One possible exolanation is that no increase in medi-
.-.:'. :i. n ;;2 u '.-5 i::: 1.,1 i t h ;;.1 ·Ji::: 1 ·,;; ob ·;;; e ,~ v "-~ d b E· ,2 ;;_1 u ·;;; f? t he f::- t u d 'y' p op u 1 ;;_1 t i o n 
·;;(01 r::, .-.:: t i?.d 1 ·::; c.cimc.o'.,,i,:: d of '' hr::-i ;:1]. t i"°t'y' '' 0, 1 di:21~ l '·/ .:::ind th,0:~rr,i f or1:,, th,:~, i r 
nE'!ed for 1111::,d :i . .-.:'. :i. na:,'!<:; ri:-2111;_:J 1 n:; 1..1n.-:h;::,n9(0,-:I .-:l,7:,·=:;p i tF! th,,":! :i. r' i n.-~:r'1:::•;;.1·=,; :i. n,:;i 
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\,' :i. t h :i. 1! .-2 )"' '::! .:.::i <,; I::·: d n 1..1 Ill bi::: )"' s; 0 f Ill (0 d :i . .-:: i n i::: <;; ( 1,,/ :i. ]. l :i. ;;.1 Ill 'c:; O n •"2 t ;;.1 l , 1 9 UC) , 
important in the l:i.qht of the finding that 72% of medicines were 
used fcir over 1 year and thus may be forgotten or discounted on 
c. o u n t ere d .. th('~ m 0:• d :i . .-:.: i r1 i::: i <.:, s:; .:;:i f e .=J n d u n :L i k E' l ·-; to b r:,, re•,; po n ·:,; i b 1 (·,) 
far any adverse effects :i.n the fut1..1re. Patients who are well in-
formed about their medicines should be better able to assist the 
doctors and other orofessionals in their health care management . 
4.3 KNOWLEDGE SCORE 
The knowledge that the elderlv have w:i.tr-i resoect ta their medi-
.-:.:in•"::.··,; h-=:.1 :; bE'!f!!n :i.n·,;r:::·;;;tj.,J -':.l-i::E•d bv oth(-:-)r' ·::; (l{i(~:·rn;_,_,n i::-1:: .:;.11. :l.9f:l :I.. 
p r·· i m .=:, r i 1 '/ o n t h (,-i n ,,.1 rn f:! ;;.1 n d p 1..11~ p o •,; (·? o + u '.-5 r:,i o -F t h i::~ m E·:· d :i. .-:.: :i. n ""= ·,=; 
:1.:3:1. 
1,1 h ,:-:-:· r •?. .::1 ·;:; th :i. <;; stud '/ h -':.l '.,; .::it t E· mp t f:: d .:;:, mor e ,: om D ,~ .-2 h .-2 r, ·;:; :i. o..; <=.~ =:.1 ·::; ·:;; 1?. <,; ·::; ···· 
me nt. Based an the literature, the knowledge tested in the pres-
ent study was that considered essential for the safe use of med-
icines. The average knowledqe score of 54.7% raises the question 
1,1 h\,-,thr;;i·i~ t h01 r::, J. dr::i Y' l '/ ;::,r··1:.,• .::.1dr1:: ou;,.1t1::.• l v inf ormf! .. id .:;.1bout t hr: :i. ,~ mr:,! d :i. ··-
cines. However, more than one explanation for this low score may 
be pr~o· .. 1 :L dE-:1 .-::i: 
:I. • Dci ,:~tor'<::. ;;.ind ph.=,.1rm.::.1.-::: :i. '.,; t'..;; ;,.,,~r::i ncit ,:oun'::;;,..i 11 :i. n(.:J th.-,,i :i. r' p.=.1t :i. E·int ·:c; 
2. The doctors and pharmacists themselves are insufficiently in-
form i:?. d ;,.1 b o 1..1 t th,:.~ m r::i d :i. ,::: :i. n •?. <; ;;.1 n d th u ·,=; are u n .:;:; b 1 0i t,::, ·] 1 · . .; ,,,, th i::: 
oatients more in-deoth counselling 
d (?. t .':) i l -::; ·::.; u •. ~ h ,:::i ·,;; i n t ,,:-i r -7.'i .-.~ t :i. o n <; .=:.1 n d '.::-:i. di:'.·: €-! f f •?. ,.~ t <:,. .':) ·;:; i ·i:: :i. ·::; t h ,,:~ 
resoonsiblity of the doctor to monitor such asoects of drug us e 
4. The criteria used for assessment of the oarticipant's knowl-
edge were over-strict 
5. The cognitive function test employed to eli minate cogn itively 
impaired oarticipants was inadequate and the inclusion of c aq ni-
tively deficient participants lowered the · knowledge score 
Thi:::· d0,t;;.1:i.l;; .. id .:::,n.:,.1lv<:.;i<,; of th;:,i kno 1.,1lr=.·dqi:.~ s,. ,.~cire .=:.ind it ·::; rEil;,.1 ···· 
tionshio with p~tient char~cteris tics , he~lth care tyoe ~nd med-
icine suoplier, helps to address some of these points. Althouqh 
the state patients compared with priv~te patients m~y be an in-
di~ation th8t the high work lo~d barn by doctors and oh8rm~cists 
:i. ii th f:.• p U b J. :i. ,:~ <,; e Y' '-.,' :i. 1.".'. t:: p Y' !'.:·:• 'v ' (:·:• n t ':,; th;::! Ill fr·· 0 I)) pr O 'v' :i. d :i. fi '] ;] d (·'.·' q l..l .:;.'; t F:: 
,:01.1n·s (·? 11 i 11,:J . It ,:.: .::in b,:-::, q u i:-:-:-<,; t :i. on rid 1,1hcth,, ..ir •"2 >;t 1~ .=:.1 coun ·=:;,:.-i 11 :i. n,:_:J J. ·=:; 
or'o •,; :i. ded .=:, t a 11 . 1.,/ht,iri :i. t :i. ·;;; not,,:-i d t h.=:.1t tho:,.' .:;.·,· .. ;r:.-,r';,1q1:.-:• k no1,1 l .-:,id,Ji:-:i 
·1 "'I'".' .,.-.. },: .. 
score for medicines cit,ta i ned from II e 1 sewhere" is at least, as 
high as the score for medicines supplied by health care profes-
sionals. In the light of the findings of the present study , fur-
ther research into the amount of counselling provided by health 
care professionals in both the state and crivate sectors needs 
to be undertaken. 
0 f equa 1 concern is the poss i b 1 i ty that the hea 1th care pro-
viders may have insufficient knowledge themselves to pass on to 
their patients, The frequent use of the term "Not indicated" to 
show that there are no specific instructions regarding a partic-
ular point in the Drug profile details supports this suggestion. 
Although the profiles are not intended as a complete reference 
work , they have been compiled from more than one reputable 
reference source and considerable time would have to be spent if 
these ''missing" pieces of information were to be searched for in 
other reference works . Such time is not available to the health 
c .3re professional in the field . The provision of more detailed 
inform.3tion should be made part of the responsiblity of re-
searchers and manufacturers. 
This study revealed that on average, just over half of the 
elderly made any attempt to "read up" about their medicines. 
This is a low proportion for a group of well educated individu-
als and may be evidence of the abdication by the patient of the 
responsiblity for his health to the doctor or pharmacist. Such a 
conclusion may be supported further by the fact that most of the 
participants appeared to be satisfied with the amount of in-
formation given to them by their health care providers. On the 
other hand, fail1.Jre of the participants to read up about their 
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medicines may be a sign of the shortage of easily understood 
medical literature such as patient package inserts available to 
the South African public. However , more detailed examination of 
the res1J 1 ts shows that participants who purchased their med i-
c i nes "elsewhere" and were thus entirely responsible for the 
choice ,::, f their medication were much more inc 1 i ned to read up 
about their medicines. Participants who received their medicines 
from the state services were least inclined to read further. By 
their very nature state services tend to de-personalise the in-
dividual which may encourage the abdication of reponsiblity to 
the system. Once the o•Jtpatient returns home, then his medica-
tion and the way in which it is used becomes his responsiblity. 
This point must be emphasised by more detailed co1Jnselling by 
the health care professionals and the use of patient package in-
serts. 
On the other hand , possible reasons for the low average knowl-
edge score may lie with the st1Jdy design and not the 
participants and their health care providers. The first criti-
cism may be that the participants' replies were too strictly 
"marked" during assessment. However, if the percent of correct 
answers given to the questions concerning drug name and purpose 
are compared against those obtained by Cartwright and Smith 
(1988) and by Kiernan et al. (1988) the figures compare favoura~-
ly. Cartwright found that 76% of their participants knew the 
purpose of their medication and Kiernan found that the purpose 
was known for 59% of presciption medicines and 78% of self-
prescribed medicines. The figure obtained for this study was 
86. 7% which may even indicate a tendency toward leniency. 
Similarly the participants in Kiernan' s study could correctly 
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give the name for 44% of prescribed medicines and 72% of self-
prescribed medicines . Name and strength were correctly quoted in 
52% of cases in this study. As the population sample in this 
study was , in terms of patient characteristics and drug use pat-
terns. very similar to the elderly of the USA .3nd UK, it would 
not be unreasonable to assume that there wo•.Jld also be 
similarities in their knowledge of their medicines. Evidence of 
such similarities may reasonably be taken to indicate a lack of 
bias in terms of study design. 
A further criticism may be that the cognitive function test used 
to e:-: ,.:lude the cognitively impaired elderly from the study 
sample was not sufficiently powerful or improperly applied. Con-
sequently marginally impaired ~lderly may have been included in 
the study which might have resulted in the lowering of the 
knowledge score. The significant decline in knowledge score with 
increasing age may be used as further evidence in this line of 
.3r,;iument , Whi 1st the researcher concedes that a smal 1 amount of 
bias may have been introduced at this point because of the in-
clusion of 25 participants who did not complete the cognitive 
function test, work done by Macdonald et al. (1977) showed that 
poorly orientated patients can also benefit from detailed 
co•.Jnselling. It is improbable that the inclusion of a few , 
marginally cognitively impaired elderly would reduce the average 
knowledge score by as much as 46% if the study population as a 
whole were adequately counselled. 
4 .. • 3. 1. IMPLICATIONS 0~ KNOWLEDGE ~CORE RES!,,!!.. TS 
One of the aims of this study was to ascertain if any rela-
tionship existed between knowledge scores and patient character-
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istics and drug use patterns. Apart from a significant decline 
in kn owledge with increasing age , no relationship between knowl-
edge score and other patient characteristics was found . The ab-
sence of a rel at i onsh i p between knowledge s core and si::)c i .3 l or 
education status is prob.ab l v e :q::, 1 i C-3 b le on the basis that the 
stud y group was relativel y homogenous. The lack. ,:Jf a rela-
tionship with factors such as gender , marital stat1Js _, co-
habitants and smoking and drinking habits is perhaps not une x -
pected although it may be partially due to a failure to identify 
any ralationships because of the small numbers of individuals in 
each sub-group. Althou ,;ih at first sight, the inverse rela-
tionship between age and knowledge score may appear to be par-
tially anticipated , it must be noted that no such significant 
relationship was found to exist when only self-prescribed medi-
cines were considered, Although the e:-:act reasons for these 
trends are not apparant from this study , two possible explana-
tions could be put forward : 
1. The very old patient has a different attitiJde from his 
younger counterparts towards his medicines. Fifty to sixty years 
ago , many of the medicines used today and their potential 
detrimental effects were not known and consequently the approach 
to the use of medicines was different . 
2 . The health care professionals have a different attitude 
toward the very old as compared with the young-old patients. Lt 
is a commonly held belief that old people tend to be forgetful 
and easily confused. Cartwright and Smith (1988) showed that the 
doctors in their study considered this to be the main reason why 
the elderly may be non-compliant. This belief may lead the doc-
tor to assume that counselling of the very old patient may not 
be worth the effort as the patient will have forgotten everyth-
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nific~nt decline in knowledge with age for self-prescribed
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the patient. Furthermore, this observation ma kes it less 
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could account for the decline in knowledge scores . Howeve
r , the 
decline in knowledge with increasing age may, in fact, be 
due ta 
a combination of both the points discussed above and consi
der8b-
Iv more researcn work needs to be undertaken before this p
roblem 
study design did not allow for the ident ification of a sta
tisti-
cally signif i cant relationshio between comoliance and kno
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score as the knowledge score was dependent on the oartici
oant's 
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The breakdown of the knowledge score into the different ques-
tions and the percent of correct answers given for each question 
highliqhts certain areas where the lack of knowledge b y the 
participants may compromise their ability to use their medicines 
safely . These areas have been identified as follows : 
1 . Participants were asked to state the ma x imum dose the y could 
t .3ke of a medicine only if they were using it on a "prn" basis 
or i f it were self-prescribed . A low average score rate was ob-
tained in response to this question and thus could be an indica-
tion of the potential for accidental overdosing using such prep-
.3rations , 
2 , The low overall score for the questions concerning interac-
tions could also be an indication of the potential for the inad-
vertant generation of adverse drug events and possible treatment 
f ~ ilure - both potentially serious and costly events . 
3 . The low score with respect to side effects may be evidence of 
the l .3ck of communication between the participants and their 
health care providers , In many of the interviews , the 
participants stated that the medicines they were taking were 
quite safe and that t~eir doctor would never prescribe a medi-
cine which would produce side effects . In view of the large num-
ber of medicines with narrow therapeutic margins that is used by 
the elderly , this is a dangerous attitude to have . Patients 
should be made aware of the dangers that may accompany the use 
of their medication in order that they may identi~y any poten-
tial adverse events and act on them promptly . 
4. Although in over half of the cases , the participants claimed 
to do further reading about their medicines , the number of cor-
rect answers scored for many of the questions was wel 1 below 
50% . This highlights the need for more detailed, patient-
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 compared 
.:;:,nd qui:"'!·=.; ti on·:;; 1,;h i ,:.:h fif!!f,id f u,~t h;:_~r . mor'(':.• .-:l•'=?t ~1 :i. 1,2 d :i. n·,,·0)·:;
;. t :i. ".;_1;::, ti on 
-':."1 r ,:,., 1~ ·".l :i. ·;; E• d : 
1. State- or clinic-suop lied participants had the low
est score 
for "N .'.'.lllli':i .:::,nd ·::;t·,~(-:~n ,Jth" o f m i'.·1 d i ,:.: :i. r1 ,::,, . 
far th:i.s =.ire firstly that the tendency of the state t
o use the 
mare complex generic name of the druq makes it difficu
lt far the 
p.=,.1t :i. r:_.,nt to -5;:.l'-r' ;:_ind r''!:)llli'.-!mb,::,)r' thi'.·! n;,:,m,2 of th,,,) [>1~ i::)c,;::, 1--· .=:.i
t :i. on , .=.ind 
·:::-•'?,:.:on d l \' th ;:.l t th 1::1 1,1 .=::, 'i i n 1,1 i--1 :i. ...-~ h pr' ,,.-i ·=,; .-.: r :i. p ·::: :1. o r1 ,,; .:;:, 1-· •?:! 1,1 r 
:i. t -!:: (-:,• n ;,., ri .-::i 
name of his medicine. 
2. Patients receiving care from the private sector are 
genera l ly 
b ,::,) t t 1:,) r· i n f o ,~ m ,::,) d o n t h o <:; ,,..) p o :i. n t s,. ·:;; u .-.: h -':.'I ·,:; i n t 0) r· .=.i ,::: t i ci n ·:::- .=.1 n
 d '::,. i d •,? 
e ff ,:0,:t·=:; 1,1h :i . .-.:h r,2q 1..1 :i. r·01 mor'(·:·) p,?::•r<;;on to r,01r·::;on coun ·=,=.i::111 
:i. n,J. f h :i. s.; 
111 .:_i \' , 0 n •.".'. E! .:;.1 (_:) ;:_1 :i. i"! , b (,::, •::! 'v' l d r:.-:• n ,.: ~::• CJ f t h i!:) h i •] h 1,,/ 0 r k l O ;_,) d .-.: -':
.l r' 1~ :i. €·) d \::, 'y' 
professionals working 1n the public sector preventing 
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up about their medicines m~y be th8t the st0te oractic
e of pre-
o~cking the med:i.c:i.nes prevents the oatients from obtain
ing p0ck-
age inserts. The entire svstem m8y discourage the p0t
i ent from 
becoming more involved in his health c~re. The findinq
 that the 
h i,;1hest score for "Reading up" was obtained in th,::,se cases where 
the medicines were purchased "E 1 sewhere" may be a sign of the 
participant' s greater i nvo 1 vement in his hea 1th care and his 
recognition of the need to be better informed. 
4,4 LABEL SCORE 
Once again , the paucity of information available on duration of 
use of medicines is apparant. It may be argued that in the case 
of prescribed medicines , duration of use may not be essential if 
the correct number of tablets for a course are supplied, How-
ever, it would then be necessary to state "Use until finished" , 
but inspection of the prescribed medicine containers showed that 
this was not the case. Of partic•Jlar concern is the fact that 
approximately one quarter of the names and an even higher per-
centage of the directions on the labels were not readily legible 
to the participants. This is especially true for medicines pur-
ch .3sed "E 1 sewhere" .3nd is an indication of the need for hea 1th 
care professionals and drug suppliers to pay more attention to 
the needs of the elderly patient. 
The low score for labels showing both the name and the descrip-
tive name or purpose of the medicine should serve as a warning 
to the health care professionals to be precise when discussing 
the patient's medication with him. When referring to a particu-
lar medicine, it would be adviseable to use both the true or 
proper name and the descriptive name to prevent confusion as to 
which preparation is being discussed. 
Although no significant relationship was found to exist between 
knowledge score and label score , as in the case of the knowledge 
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potential for confusion of the medicines and the perpetration of 
dangerous errors is heiqhtened. 
4.5 FINAL CONCLUSIONS AND RECOMMENDATIONS 
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to conclude that any such relationshios identified hold true far 
the entire South African elderly pooulation. As stated earlier, 
searched and a verv narrow picture has been presented. 
What can be concluded from this research has been largely cov-
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implications of the findings. As the drug use patterns iden t i-
fied are so s1m1lar to those of the American and British elder-
ly , it may be reasonable to assume that problems encountered in 
the drug manaqement of these elderly will also occur in the man-
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side effects and other important points of information such as 
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is that may be taken within 24 hours. Health care prDfess:i.onals 
and services appear to have a direct influence on drug use pat-
terns and on the patients' understanding of their medicines. In 
addition , these two factors may be influenced by the attitude of 
the professionals toward the elderly and also by the attitude of 
the elderly toward their own health management and the medicines 
used by them. Generally, container labels are not recognised as 
important conveyers of information and many contain little or no 
instruction with respect to the correct and safe use of the med-
icine. 
4. 5 ... 1 R_ECO_MM.ENDATIONS. 
Arising from the findings of this study and the insight gained 
the following recommendations are made : 
1. Communication skills of the health care professionals should 
be developed to ensure optimal patient medication knowledge. The 
low knowledge scores obtained in this study suggest that South 
African health care professionals are poor communicators of im-
po~tant information , not only verbally but also via the medicine 
container labels . Labels carry little information about the med-
icine and its use and many are illegible to the elderly patient. 
Doctors and pharmacists need to spend more time counselling 
their elderly patients about possible side effects and interac-
tions and where possible re-inforcing this with written instruc-
tion, preferably on the container label. Particular attention 
needs to be paid to the legiblity of these labels where the 
patient's eyesight may be poor, and counse 11 i ng techniques 
should be adjusted accordingly. 
2 . During the education of health care professionals , greater 
emphasis should be placed on the special considerations involved 
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in medicating the elderly. This research has confirmed that .3 
high percentage of the elderly use medicines and many use more 
than one concomittantly. Many of the prescribed medicines used 
are recognised as high-risk drugs for the elderly but even so 
man y are routinely used on a long-term basis. 
3 . Frequent review of the elderly patient's dru9 profile I by 
both the doctor and the pharmacist involved must be encouraged 
and the need for the continued use of each preparation should be 
questioned . Doctors must be urged to investigate each case care-
fu 11 y and to replace treatment using psychotropic agents and 
other high-risk drugs with careful counselling and alternative 
treatments . Most importantly , health care professionals need to 
be educated out of any II age- i st II attitudes and pre-conceptions 
that they may have. 
4 . Si mil ar research projects need to be undertaken in other 
parts of the country and amongst other population groups. The 
drug use patterns and drug education needs of all sectors of the 
South African elderly should be established before a definitive 
outline of their health care needs is compiled. 
5. So•Jth African health care professionals attending to the 
needs of caucasian elderly should keep abreast of relevant lit-
erature emanating from the USA and Britain. This study has shown 
that the drug use patterns are al 1 very similar , and for this 
reason, certain drug-orientated health care programmes found to 
be sucessf•Jl overseas may, with minimal ajustments, also prove 
to be sucessful here. 
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eir medi-
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1, Wh.:;it is your D~te of Birth?,,,.,,,,,, 
se:-: ;;ire yotJ? \ 1 J H.:;ile 
\ I ~ Neve1· ni.:;i1·r i ed 
I 3 '.widow/widm1er 
· GlFem.:;ile ·--· 
I 2 :oivor,:ed 
I 4,, IH.:;irr i ed 
4, Do you live .:;ilone? I I j yes L~J no 
5, Who is livin~ with ytiu? 
·--, . 
LLspo•Jse l~_;Frier,d 
I 3 ;Other _·f.:;imi 1,j l_o lNot .;ippl i,:.:;ible 
l , yo•J smoke tob.:;i,:,:o .;it .:;il 17 I I 1yes l9Jr,o 
If.you smoke, how m.:;iny pipes/cig.:;irs/cig.;irettes do you smoke in 
24 ho•Jrs? 
[I]between 1 ;;ind 19 
11 \20 ta 29 
11 !Ho1·e th.;in 30 
7.oo·you drink .;iny .:;il,:oholi,: bever.:;iges ;;it ;;ill? [IJyes 
On ~ver.:;ige, how often do you h.:;ive a drink? 
L' 16 to 7 d.;iys per week 
L.2:_ '4 to 5 d.:;iys per week 
,--, 
3 =? to 3 days per week -
. ----;-i 
1 __ _/~- .:on,:e a week 
[§J ·1ess th.;in on,:e· a month @l t,to"T P.P?t-«C f\ol l. 
8.To wh.;it le~el did yotJ complete yotJr edtJ~~tion? 
~No·· form.:;il ed•J•:ation 
l 2 ;S•Jb A, S•Jb e., .Std 1 
ITlstd 2, 3, 4 
8td 5,. 6, 7 
@td 8, 9, 10 
l1]rertiary Ed•.J~.:;ition 
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To f'.ige 2/ ••• 






D_ _ _I 
1+ 
LJ ,, 
Foi:t CFflC.~ LISI 
9. Are yo•J f•Jlly retired? 1
--,--\.es __ ., I Q __ lno 
NO L __ J __ l .1 
~ 
,1 
10.Befor~ retirement what was 
;;i) ·,•o•JI' o,: ,:u i:,a ti on? . , , ..... , .... , , , , , , , , , , , , , , • • • • •
 • • • • · • • • · • · • · • t ·.::i O I - ;20 
b)your husband's occupation? .. ,,,,,,,,,,,,,,,,·•••
•••••·•····•· ·=1======1==:1 ... 
11. What is si>yo•JI' o ,: ,:•Jpation
 now? ... ,,,,,,,,,,.,,.,,,,,,,,,,,,,,,,, I- { OI ·zcJ 
b) you1· h•Jsbar,d' s o,:,::•Jpation now?,,, : ,,,,,,,,,,,,,
,,,,,,, .I I I 
12.What is your Approximate income per MONTH? 
OZ]Hore than R3000 
I -:zt'R2500 R2999 
~R2000 - R249? 
(~R1200 - R1999 
~R1000 - R1199 
~R600 - RS'99 
[j]Rsoo R599 
I ¥.1Less than R499 
13, .Do you receive a State Old Age Pension? 
1 ~. Do ·.,,,~•J t-..:1 ·.,: e a regu 1 ::11· GP? · 1 · I l·,1es 
When did you last consult him/her? 
jllwithin the last month 




I~! ' -5" 
I I I ..... 
IO lna I_!& 
'2.6 
1 17'1 . -~Yoo_ i·1J LlJHore than 6 months ;igo. Lf'_J 1-JoT ni'?1-1c ~"!.~i:. • 
15.What is his /t,er name? .. , .. , . .{.QC/.Q .. 'P . . ~? '~,,,,,.,.,,,,.,,,,,, 
16.Do y~u ever go to ;iny of the day clinics or stat~ ho
s~itals for 
tre<>tment or ,:he,::k-ups7 ~ ·,1es I c> 'no 
When did you last visit one of these? 
Within the last n1or,th 
~Within the l<>st 2 to 6 n1onths 
I ·s jHore than 6 months <>go 
17.Which one do you go to more 
!Al 11 /Ji -+1 
~ ..ieT l\?p• 1Cl\c.'-e. ) / 0 I T °19 9 !:--~ .,.-----,---i 
often?.,,, J .. CQ.Q :: , , , •, • • • • • • • • · · • • L ! I 
To Paga 3,,, 
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a . Where do you usu::J1lly get your medicines: 
WAt .::JI ph':lrm;:i,:y (,:hemist> 
(lJ From yo•J1' do,:tor 
CTJ From the ,:1 i ni,: 
[AJElsewhere (Spe,:ify) ..•...•..•• ~( ••• ~ ,c:rc,: ................. . 
9.Do you belong to ;:i medic;:il ;:iid? LL]yes [£'.]no 






1 .I rJ 
4,2. 
APPENDIX~ 
COOING OF HRC SHEET: QUESTIONNAIRE 
ROW ONE - Participant particulars 















3 Participant Number 001 to 999 
6 Participant age (Q.Ql) 065 to 120 
Participant age group (Q,Ql) 1 to 8 
Participant sex M = 1 F = 0 (Q,Q2) 1 or 0 
Marital status (Q,Q3) 1 to 4 
Co-habitants (Q,Q4) y:n 1 or 0 
II (Q,Q5) 0 to 3 
Smoking habits (Q,Q6) y:n 1 or 0 
11 
- Type of smoker (Q,Q6) 0 to 3 
Drinking habits (Q,Q7) y:n 1 or 0 
11 
- Type of drinker (Q.Q7) 0 to 5 
level of education (Q.Q8) 1 to 6 
Fully retired (Q.Q9) y:n 1 or O 
Occupational Category before retirement (Q,Q10)1 to 5 
19 & 20 Occupational Group 11 11 (Q.Q10)1 to 20 
21 Occupational Category after retirement (Q.Qll) 1 to 5 






Monthly Income Group (Q,Q12) 1 to 8 
Occupational Group based on Income (Q , Q12) 1 to 5 
Recipient of State Old age pension (Q,Q13) y:n 1 or O 
Gener.:11 Practitioner (Q,Q14) y:n 1 or O 
Period since last consultation (Q,Q14) 0 to 3 
29 to 31 G. P. number (according to list) (Q.Q15) 001 to 999 
32 State Care (Q.Q16) y:n 1 or 0 
Period since last consultation (Q,Q16) 0 to 3 




Source of supply of medicines (Q.Q18) 1 to 4 
40 Source number (according to list) (Q , Q18) 001 to 999 
Medical aid (Q,Q19) y:n 1 or 0 
42 to 44 Medical aid No, (according to 1 ist) (Q, Q20) 001 to 999 
45 Has used prescribed drugs in past 2 weeks(IS,Ql)l or 0 
46 Not remembered prescribed drugs (IS.Q19) 1 or 0 
47 & 48 No. of not remembered prescribed drugs (IS.Q20)00 to 99 
49 Self prescribed medicines <IS . Q22) y:n 1 or 0 
50 & 51 Number of Self prescribed medicines 01 to 10 
52 & 53 Source of educational material (list) (IS.Q24) 01 to 99 
54 Satisfaction wrt knowledge of medicines <IS.Q25)1 or 0 
55 & 56 Cognitive Function Score <IS,Q26) 0 to 10 
57 Short Term Memory score <IS . Q26) 0 to 3 
58 to 59Visual Acuity Score (IS . Q27) 006 to 120 
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APPENDIX C INTERVIEW SCHEDULE Pagel 
Itl tEH'J I E\I SCIIED1Jl.E eot>Itlr.: 
t .\Htld1, 1:t.c JH1Bt 2 wcck!'I l,:;ive yn•.J
 •Jsed ,,..,. . .,. n1t),.Jf,::i 1,r-;; r:-1 · c!'l•.~1 · il:.~
; d 
- b·J iD do,::tm·7 ···-s ' 
rp-r.iirt 
, i,i I 
,, ~ - 2.C:;i1, yu•J 1H1n1e tl,em for 
n1e'7 




>4 f 19 
,~1 ,. 
'•,C'!lh yo•J l:ell n1e wl,'!lt. yo•.J m
· P. 1.J!'ll.1,•1 l>n1•1 1 <~!.:S eh:) r,:n
· ? 
!I.Ito" ofter, do ym1 t:;i~c 
I / o 
J~r r, / hf.It. JH' II 
@) 
,J:;iy 7 th,ea & IIIOJ' I? pt?r 
6 
(eV 
tintl?!I '!I ,J:;, ·y< 
6. em, yo•J l:e 11 n,~ wl 1ol I: f_ !I 1.1,e 111:;ir: i n1• .1n1 2,.,, ... 1 
ltf.l, '"' Ott 
(i) 0) 
tn 'v'tt•.1 




t.t' JJ ,1013. llow do yo1.1 
l Lrll l>o YD•J hkc 
tl!ll•. e i 1:7 
CD 
i I: wi 1:1, fnod 
cD 
IH ti, Wl!ll:P.1' 
ltll t ~~H ··~ ".I h H t 
@ 
01· 011 ;:iri r.!n1r:, t·1 sl:on1;1..:I, 
G) 
1n· ,., i 1:1, n, i I. k m · .:11 ,·~· 
ol:1,e,· 1:·j,~t! t1f •h·i,,k 
01"' 
w~le 
~, •. SQ., 1: • .111.,. , ood m· u-;;Jri,... 
tll' s ~?. i I: 
l>o you BW'!lllow ii: 
or d,JJJ1 I: OI' I: :;,f;e i I: •11"1JSlt!?~J G) 
m· ditnolved i11 ~1:;ite1· or J•.1l,~e
·1 
OJ•IO 
9.llow long hl!lve yo•.1 been I.JBi 11g ll, i!!I ht!?d
 i •:: i Im ·7 
.. -,~ 
@1 @t L_ to !I ,J:;,y9 to 6 nio1,t:f,9 
~ 
@ l 
@6 to l't d;,y11 @1 t:o 11 11,011t1,s (,)6 
@t', dl!l '{!I to 1 IIIOl1lh @J l l 
@ 16 
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t. !J 10 ·~·~ ;u · r:1 
l:n l !I ·,~~,·g 
hJ :·:~fl 'i' i-? ;n· ~ 
INTERVIEW SCHEDULE Page 2 
lYuhlJ.Do vn•..1 kno1,1 , \.lh;it is the re•.~omnH,!nded lf~n~_rt:h of tinw fen· \.lhi ..-.: h ·ro•..1 1 should carry on using this medicine? 
\ .Yv \:i. :I. , H ::.,v f! ·,;n•..1 bi?e n ·-~ .:;iu ti Cll'lf.!d ::.ibc11..1t o the 1· med i ,: i ne s th-:1 t yC11..1 s ho•..1 l d be 
11 ~aref1..1l about taking while ynu are using this m
edicine? y : n 
C::.m yo• .1 nanH? thE~m for nH?? 
' 'll'l1"' .,, .. .,, ~t· o11]rl \J(')I I t•r• '' "ll''''>f' 11 I ;!'_t\. ()1 .. lt thf.!Se nu:~di.::inf.!S? (I) ((J ,:;_ ' 1• I "' I . . . .. 7 . .. .• , :. , ... •:. ,.. .. .. ~• 
"" applicable/ not applicable 
rj~,13.H~ve you been ca1..1!ione~ to be careful -:1bout eating any p-:1rtic1..1l-:1r 
nz · foods or non - ~lcohol1c drinks or beverages \.lhile you are using this 
medi.•.~irn:!, ·1 :n 
Wt·,.:;it ;;ire they? 
U6'j;{l1.4. \,lh·,; shoi.Jl_d you t :, (·? .. ~;1rel1..1l -:1bo1..1t these foods? 
applicable/ nnt -:1ppli.cable 
IYol15.Have vo•.1 bet!n ca1..1ti.ortf.!d to be ,:;;.1reful for ;;.\r,y re::.iscm -:1bci•..1t ,:C1ns1 .1111inq 
45 alcohol \./hi.le you are taking this medicine? yin 
l~)~J1.1.i.\,1t·,·r s ho•.1ld yr11.1 be ·-~;1rHf•..1l ;.1bo1..1t .. ~ons1..1ming al,:ohol \.Ii.th this 
A(, medi ... ~ i.TH?? 
applicable/ not applicable 
· /o ji 7. Do yo1.1 k no1,1 of ::.n,·,; s i. de e f ff~,::t s or unw:;)nted elfects that m-:1y ".H':i.St! 
4&' c,ut c,f the use <Jl t:hi.s med:l.,:i.ne? vln 
C::)n VD'-' trill me \.lh;;:it ttu~se sidr.~ effe..-.:ts ma·,· be? 
.. J~,118.Wh;;it \.IO•.Jld yo •..1 do if yn1.J (·?:-:peri.E?n,::1?d ;:_\fl'y' of t:hE.'Sf~ sidt-:~ effE!•.,tir.? 
l'Yvli.9.nre thtH' !? =.rnv other medi,.,i.nes pres ,: ribed to vo• .1 in the p;.1st 2 Wf.!f.?l<s 
~ -- 'l'} th~t vou ,::;;ir,not remf1mb<-:H' th1~ n ;,_1n11~s of? y : r, 
L~r. bo. Ho\./ nwny ;::H'e tht~l'' f,!? 
' ,11 
n:•··9<) rner,e':lt (~ ' 1:; 3 t:o 1.B) 
\~\ .. L-·/2:::~.\,lit:h:i.n the r,a,.;t: 2 1,/(·!(·~k.s h ;.1·.1 r! 
\ 1 - prescribed to you by ':l doctor? 
(RepH a t Q's 2 to 2:1. 
you u ~; ed 
y:n 
anv medi c ines that \./ere NOf 
(''fc:;\::~3.Do you ever "Re;.1d 1..1p" ;;.1bn•rt: your medi.,:~ines to tr")' to find ()I .It men' (·! 
~ J~t i. r, f or·n1;.1t: i. on -~bout: them? y I n 
\ \ '24.~lh~~r·i:~ do vo•.1 norm .,1ll·r qet this i.nform .=iti.on? 'si · ·· 
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INTERVIEW SCHEDULE 
livJl2s.Do 'y'OIJ -feel that 'yOI.J are s• .. 1f-fi,:_: ientl·y informed c.lbO•Jt 
to enable you to use them safelv7 y:n 
Cognitive function and short - term memorv tests I 
Visual acuity test. 
u:m~I... SCORE 
sr-\_1,1;11, Can you read me the name cm the .I. c.lbE:~ 1 7 v : n 
~J2. Can you read me the directions an the label ? v : n 
Sl. 
2 . 0 3, N;,,im
e ,::if Drug "-1) Tr:::ide/Gener'i'-~ ;;)!'Id strength,, , , , , , 
{- 1 
51 · 
b) Descriptive n;;)me (eg Heart Tab s) . 
[ Yrj4,Dir·e,~tions (~uantity,,
 




5r- · .. 
Freq1..1en,.~'y', 
M;;)TH1er, . , . 
D1..1r ;.1t:i.on,., 
\Vols, F' ;.1t :i.ent Name,,,,,,,,,, 
,si 









I L _ I
Auxilli.=.iry l;;)bels y: n 
I ;2.., 3 







p h y .... 1 
Oo,~tor ::.s 2. 
Elsewhere 
.... 3 
.. .. 4 
Type of Health care service 
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APPENDIX D 
INTERVIEW SCHEDULE ANSWER SHEETS 
F''alge: of SHEET 1 
Residen,.::e: 
Fl'alt No, : 
Q 1 . . y : n "IRJ Q19. y : <[!] £1 ·--····..- -·· --·------··· - ·-- · Q20.0'~ [I] Q22. y : n [Y.~[]01 - 99 
Q 
Q23. y : n ~ ~- Q24 ,IT] OI - '7Cj 
5" ~ n_ 'St . 
Q25. y : n IYQI CogF ,Cl}· lo rn STMR. 0-3 LJVAa?6 -/.vU ... [.l 
KNOWLEDGE 
NAME: - - - -·-·-·-·-. ------ - ·-·- ·. 
~.~~~ 
~ 
.JI.' 1/o \ 
Q5. ,rn/not pPfrl 
u~Ll. . K> 




10 - L,2. 1-S- 2. ·v 
~l l I I J 
Q9. 
c•1 t l<J 




Q11, y : n 
~ 
)A~ 
. Q.1.3·, y : n 
"' L:.rJ Q14 . 
.. J[IRl 
Ql 5. y : n 
.sllil 
A 




















f'age: of pages. 
Res iden,.:e : 





341 I P!J f .!liO, 1Y.t 
Ql 1. y : Tl 
~ 
~~ 




Ql 5. y : n 
4llil 
JMk1 








CODE·l~~.j~jif~.,~:r,j~'; I J 1,1 
I ,t , II Ii f7 -
Name y : n J}K] 










f' ,oltt 1'-~I 
APPENDIX~ 
CODING OF HRC SHEET: INTERVIEW SCHEDULE 
ROWS TWO TO TWENTY - Drug particulars 
COLUMN DETAILS 
1 to 3 Participant Number 
DRUG CODE-NAME 
4 & 5 Drug Classification Category 
6 BLANK 
7 & 8 Drug Classification Subdivision 1 . 
9 BLANK 
NUMBERS 
001 to 999 
01 to 34 
01 to 1 . .., ;;.. 
10 & 11 Drug Classification Subdivision 2 01 to 10 
12to 16 Drug ID No. (As per compiled list) 00001 to 30000 
17 Prescribed/Self-prescribed/Not recently used 1 to 3 





Knowledge Score 1 <IS. Q2) 
K S 1 (IS.Q3) 
Applicable/Not applicable wrt <IS.Q3 & 2) 
K S 2 <IS. Q4) 





















K S 3 <IS.Q5) 
K S 4 <IS. Q6) 
Dose Incr./Decr./Unchanged/Not indicated 
K S 5 <IS.Q7) 
31 & 32 Hanner of use <IS.QB) 
33 
34 K 
II II II 
s 































6 <IS. QB> 
<IS.Q9) 
7 <IS. Q9) 
8 <IS.Q10) 
9 <IS . Q11> 
10 <IS . Q12) 
applicable wrt KS 9 & 10 
11 <IS.Q13) 
12 <IS.Q14) 
applicable wrt KS 11 & 12 
13 <IS . Q15) 
14 <IS. Q16) 
applicable wrt KS 13 & 14 
15 <IS.Q17) 
18 <IS.Q18) 




















































COOING OF HRC SHEET: INTERVIEW SCHEDULE Contd . 
LABEL SCORE 
51 L-3 be 1 Score 1 1 or 
5·, ,:.. L s ., ,:.. 1 or 
53 L C: 3 ., 1 or ...J .::. I 
54 L s 4 1~uanti ty 1 or 
55 Frequency 1 or 
56 Hanner 1 or 
57 Duration 1 or 
58 L s 5 1 or 
59 L s 6 1 or 
60 Au id 11 i .3ry L-3 be 1 y:n 1 or 
61 Handwritten/Typewriter Printer/ Printed 1 to 
62 He.31th care type 1 to 
NOTES : 
According to the Medicines and Related Substances Control 













Prescribed= 1 ; Self prescribed= 2; Not recently used(Within 
last 2 weeks) = 3. 
IS.Qy = Interview Schedule , Question y 
KS= Knowledge Score 
Applicable= 1 ; Not applicable= 0. 
In cases where a question <set of questions) is marked not 
applicable , the overall KS required for full marks shall be 
reduced by the same number of score points as allotted to the 
question(s) under consideration. 
Prn use= 1 ; Not Prn use= 0 
Frequency category numbered according to IS. 
Dose Change : Increased= 2; Decreased= 1; Unchanged= 0 
Manner of use numbered according to IS. 
Duration of use numbered according to IS. 




COGNITIVE FUNCTION TEST 





Name of Place 
Recognition of two persons 
Birthday <Date and month) 
Date of World War 2 
The State President's name 
Counting 20-1 backwards 
Address 














*From Hodkinson , 1972 and modified for the South African popu-
lation as by the Geriatric Unit , U . C . T . 
A score of below 7 on this test is considered to be indicative 















,.. .. ,s .... , ... 
*Based upon "Street Guide to Cape Town and Environs" 3rd 
Edition. MAP STUDIO 
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APPENDIX ti 
DRUG PROFILES .. 
These profiles are not intended to be a complete reference work . 
The greater part of these profiles has been compiled out of in-
formation available from the Package Inserts as required by the 
S01Jth African Medicines Control Council , the United States 
Pharmacopea (1988) , and the Extra Pharmacopea (Martindale , 28th 
Edn) . The information on vitamins and homeopathic medicines has 
been supplemented by information from "Vitamins in Medicine" 
(Barker and Bender , 1980) , "The Vitamin Bible" <Mindell , 1988) 
.3nd "Materia Hedica with Repertory" <Boericke , 9th Edn). 
The pharmacological classification is taken directly from that 
indicated on the Package Insert. Homeopathic and herbal prepara-
tions which have no classification indicated on their package 
inserts or labels .3re all classified under category 34 
"Other" , irrespective of their indications. 
In the case of medicines which are obtainable onl y on prescrip-
tion , the only drug interactions which are listed are those oc-
curing with medicines which may be purchased over the counter . 
For those medicines which may be purchased over the counter , all 
possible drug interactions are listed . 
The term "Not Indicated" is 1Jsed to show that the reference 
works used did not have any information on the subject. It is 
acknowledged that the information required may be available in 
other works not used in the compilation of these profiles. 
* In order to reduce the bulkiness of this volume , only the in-









I .N.D)C.A.T_ION.S .. : Angina pectoris , cardiac dysrythmias , mild to mod-
erate hypertension. 
RE.COH.M.ENDED DOSE RANGE .. :. 300 - 900mg daily in divided doses 
tH:l~I.t1.W.tt Q.QSE :_ 1200m,;i per d .3y 
H.AN.NER Of USE.:. At breakf .3st 
DIJRAT I ON OF US.E.:_ Not indicated 
INTERACTIONS ME.DICINES.:_ NSAID - decreased antihypertensive ef-
fects because of increased fluid retention. 
Sympathomimetics increased hypertension and possible heart-
block 
Xanthines - mutual inhibition 
Phenothiazines - icreased plasma levels of each medicine 
INTERACTIONS FOODS/NON-AL~OHOLIC BEVERAGES : Not indicated 
INTER.ACTIO_NS ALCOH.O.L .. :. Not indicated 
SID~ EFFECTS : Bronchoconstriction , bradycardia, congestive heart 
failure , sexual impotence , hypoglycaemia , skeletal muscle weak-
ness and GIT disturbances 
Vague fatigue and malaise , sleeplessness , vivid dreams and 










I _NDIC.AT.IONS : .. Relief of non-specific nasal congestion and nasal 
congestion and nasal allergic conditions. 
Decongestion of the respiratory tract including sinuses and 
antra and eusta c hian tubes. 
Treatment of aerotitis. 
RE.C_O_H_H_E_N_DED. D.05.E RANGE.: .. One to two tab 1 ets 3 ti mes .3 da y 
11.A.X.I .M.IJ.11. D.O S.E .. :. 8 t .3b 1 ets per 24 hours 
H_ANNE.R O_F US.E.: .. With or after food to reduce ,;iastric irritation 
DU_R_A_T_I O.N. OF. u.s .E .. : .. Not ind i C-3ted 
IN.T_ER.A_C_T_ION_S H.EDIC.INES : .. Trip r o 1 id i ne : 
creased antimuscarinic side effects 
HAOI increased cardiac stimulation 
c arinic activity of the antihistamine 
Ant i m uscar in i cs in-
and increased antimus-
Pseudoephedrine : Antihypertensive - increased blood pressure 
Beta-adrenerg i c b 1 ock i ng agents increased blood pressure and 
b r ad y cardia with possible heart block 
CNS stimulants - increased CNS stimulation 
Nitrates - decreased anti-anginal effects 
Levodopa - increased chance of arrythmia 
Rauwolfia alkaloids - decreased efficacy of pseudoephedrine 
INTERACTIONS. F_<)ODS/ NON.-ALCOHOL IC BE.VERAGES : Not indicated 
IN.T.ERA_CT.IONS ALCOHOL : .. Increased CNS depression 
SIDE EFFECTS : Drowsiness, sleep disturbances and hallucinations 
Increased blood pressure in hypertensives 
Acute Overdose leads to drowsiness, weakness and inco-
ord i nation, di ff i cu 1 ty urinating , respiratory dpression .• 
hypotension or hypertension , agitation , irritablity , convul-







IN_D_IC_A_T_I ONS_: Ant ihypertens i ve 
STRENGTH 
0 , 1mg 
10 , 0mg 
10 , 0mg 
R.EC.OMM.E.N.DED. D_OSE. RA_N_GE : .. One to 2 tablets daily 
C.0.D.E_ 
07 / 01/02 / 00080 
MAXIM.UM D_Q SE .. : Two tablets 3 times a day for short periods of 
time 
H_AN_N_ER OF U.5.E .. : .. \aJ i th milk or food to reduce gastric i rr it at ion 
DURATION OF US_E_: Not indicated 
I NTERA.CT IONS MED IC INES_: __ Sympathomi met i cs - increased blood pres-
s1.ire 
Antihistamines - increased CNS depression 
Sodium bicarbonate increased chance of developing 
hypochloraemic alkalosis 
High doses of calcium containing medicines or supplements - in-
creased chance of developing hypercalcaemia 
NSAID - increased fluid retention 
I _NTERACT_IONS FOD.S/NON-ALCOHOL.IC. BEVERAGES : Advised to eat low 
fat diets with lots of fruit 
INTERAC.TIONS ALCOHOL : Increased CNS depression 










2 , 5mg 
CODE. 
07/01/03/000.:,9 
INDICA_TI_0NS :_ Hypertension 
RE.C.OHHENDED. DOSE RANGE :_ One tab 1 et da i 1 y or twice da i 1 y 
MAXI.MUM D_0SE : .. Two tablets d -3ily 
HANNER 0~ USE _: With food or milk to reduce gastric irritation 
INTERACTIONS MEDICINE~ :- Sympathomimetics - increased blood pres-
sure 
CNS depressants - increased CNS depression 
NSAID - decreased efficacy of Aldoretic~ 
I _NTER.ACT.I ON.S F00DS/N.ON-A.L.C_0HO_L_IC BEVERAGES_ : Not ind i c .3ted 
IN.TERACT_IONS AL.COHOL : Increased CNS depression and increased 
orthostatic hypotension 
SIDE EFFECTS : Orthostatic hypotension 
Drowsiness, depression, an:dety , trouble sleeping and night-
m.3res , stuffy nose , bradycard i a , decreased se:-:ua 1 ab i 1 i ty and 
gynaecomastia , loss of appetite, nausea , vomiting and diarrhoea 
or constipation, rash , dry mouth , jaundice 
iv 













I ND I C_A_T I _ONS :_ H-3Y fever with nasal con,Jest ion, itchy, watery eyes, 
sneezing , cough and sinus congestion 
RE_COMM_E_N_D_ED_ D_OS_E RANGE_:_ One capsule every 12 hours 
H_AX_IMUM DO.SE_:_ Not more than 3 capsules every 24 hours 
MANNE_R OF USE __ :_ Not indicated 
D_UR_AT_ION O_F U_SE: Do not 1Jse frequently or over prolonged periods 
INTE_RACT_IONS_ MEDICINES_: Other anti cho 1 i nerg i cs 
antimuscarinic side effects 
Methyl dopa, reserpine and guanethidine 
antihypertensive control 
Digitalis - heart arhythmias 




INTERACT IONS FOODS/NON-A_L_COHOL IC BEVERAGES _: E:-tcess i ve intake of 
cola drinks , coffee and LucozadeR lead to increased nervousness 
INTER~~TIONS ALCOHOL : Increased CNS depression 
SIDE EFFECTS : CNS sedation with drowsiness, loss of concentra-
tion, lassitude, dizziness, hypotension, muscular weakness , 
inco-ordination and mental confusion 
GIT dist•Jrbances 
Headache, blurred vision, mood elevation or depression, ir-
ritablity, nightmares, anorexia, difficult urination, dry mouth , 
tight chest, tingling, heavy or weak hands. 
Insomnia, nervousness, tachycardia, tremors and muscle twitching 




ACTANR ( AC TAU 
t:!.B_li~ S_TRENGT_H C_O_D_E 
Alexitol sodium 400mg 11/04/0100127 
INDICATIONS :_ Hyperacidity, peptic ulceration , heartburn of preg-
nancy 
R,ECOMME_NDED DOSE_ R.A.NG_E_: __ 
Hyper .3c id i ty - 1 to 2 tabs .3s needed and ha 1 f to 1 hour after 
meals 
Peptic ulceration - 2 to 4 tablets every 3 to 4 hours 
Pregnancy - 1 to 2 tablets on an empt y stomach or half an hour 
after me .3 ls 
MAX I MUM DOSE _:_ Not indicated 
HANNER 0~ US~ : Sucked or swallowed with a little water or milk 
D.URATI.ON OF USE : Not advised t,::> take continuously for e:-:tended 
periods 
INTERACTIONS ME_DICINES : (As for aluminium 
hydro:-dde may affect the absorption 
anticholinergics, barbiturates, digo:dn _. 
warfarin , tetracyclines , fat soluble 
sucralfate , ketoconazole , and cimetadine . 
hydroxide) Aluminium 
of the following : 
quinine, quinidine, 
vitamins , phenytoin , 
INTERACTIONS FO.O_DS/N_ON-ALCOHOLIC BEVERAGES : Not indicated 
I NTERA.CT_I O_NS ALCOHOL _: Not ind ic .3ted 
S.I .DE EFFECTS : Constipation with impaction at high doses, 
phosphate depletion with long term use leading to osteomalacia 
and osteoporosis. Phosphate depletion leads to feelings of dis-
comfort .• loss of appetite, muscle weakness or unusual loss of 
weight 
Chalky taste, stomach ·cramps, nausea and vomiting, speckling or 
whitish discolouration of stools. 
vi 
ALFACALCIOOL <1~-hydroxyvitamin 0 3 ) 
NAME 
One-A 1 pha"'~ 
S.T RE N.G T.H 
0,25 \J9 
1 , 0 !JQ 
C_0DE 
22/01/0400063 
I .N.D.I.C.A.T.I.O.N.S. :_ Rena 1 bone disease , hypoparathyro id ism , secondar·t 
hyperparathyroidism , hypophosphataemic vitamin D resistant rick-
ets and osteomalacia, nutritional and malabsorptive rickets and 
DS te,:,m .3 lac i .3 
RE.C.OMH.END.ED. D.O.SE. RANGE .. : One microgram per da y 
t1.f.l.~.I.t1J:!.M. Q.Q.2.!;; ... : ... Depending on reasDns for use up tD 3µ ,;i per day 
H_AN.N.E.R OF. U.S.E .. :. Not ind i c:ated 
DU.R.A.T.I.O.N O.F USE : Depends ,:,n week 1 y and month 1 y monitoring of 
calcium blood levels 
INTERAC.TIONS MEDIC.INES .: Uns1Jpervised use of calcium and vitamin 
D s1Jpp 1 ements 
I .N.T.E.RACT IONS. FOO_D.S/NON-AL.C.OHOL IC BEVERAGES : .. Not indicated 
I .N.T.E.R.AC.T.I.O.N.S. A_LCOHO.L.: Not indicated 
SIDE EFFECTS : Vitamin D intoxication and hypercalcaemia initial-
ly indicated by weakness , fatigue , somnolence, headache , 
anore x ia, nausea, vomiting and diarrhoea and pruritis, 
A,;iit .:1tion , apprehension, pain in e:-:tremities, paralytic ileus, 




Zyloprim~ , Puricos~ 
I ND.I CAT I .O.NS .. : .. 







arthritis, hyperuricaemia , 






RECOHHE.NDED Q_Q_~-~ 8.8.t!G._~ ... :._ 100mg to 900mg per day in ti tr·ated doses 
H.A.X.I .H.UH DOSE.: .. 2 to 10 mg per kilogram body m.3ss per d .3y 
~ANNE~ OF US~: With food 
DURATION OF USE : Not indicated 
INTERACTIONS HEDICINES :_ High doses of sal icyl ates and other 
uriscourics - decreased allopurinol activity 
Urinary acidifiers (ammonium chloride, ascorbic acid , potassium 
or sodium phosphate) - increased xanthine stone formation 
Xanthines (aminophylline, theophylline) - doses of allopurinol 
greater than 600mg per day leads to an elevation of theophylline 
levels 
INTERACTIONS FOODS/NON-ALCOHOLIC ~~!ERAGES : Purine rich foods eg 
livers 
I.NTER.ACTIONS AL.COHOL_: .. Increases uric acid levels leading to 
decreased allopurinol efficacy 
SIDE EFFECTS : Skin rash , hives or itching 
Beeding sores on lips, blood in urine, chills and fever , dif-
ficult and painful urination, red , thickened burning or peelinf 
skin, sore throat and fever, swelling face, feet and lower legs , 
yellowing skin. 
Rarely : Loosening fingernails , numbness , tingling , pain , or weak-
ness of hands or feet, pain of 1 ower back, 1Jne:·{ P 1 a i ned nose 




IN.D.ICATIO.NS : Antacid 1Jsed to give S'y'mptomati'c relief in gastric 
and duodenal ulcer and reflux oesophagitis 
Treatment of h yperchlorhydria 
R.E.CO.MME.NDED DO.SE RANGE :_ 0, 5q to 1g as required 
MAXIMUM DOSE : Not indicated 
M.AN.NER OF US.E :_ Dispersed in water or milk , Tablets must be 
chewed 
DUR.AT I ON OF USE :. Chronic use may lead to osteoma lac i a , part i c1J-
l ar ly in patients low in phosphorous 
INTERA.CT IONS MED IC INES :_ Concom i ttant 1.Jse decreases the absorp-
tion of anticholinergics , barbiti.Jrates , digo:dn , quinine , 
quinidine , warfarin , tetracyclines , some vitamins, cimetadine 
and ranitidine , oral iron preparations , isoniazid , ketoconazole , 
chlorpromazine , phenytoin , sodium fluoride , oral phosphates , and 
sucralfate 
Lowered gastric pH may lead to the too rapid dissolution of the 
enteric coating of tablets such as bisacodyl tablets and result 
in gastric irritation 
INTERACT IONS FOODS/NON-ALCOHOLIC BE1,,iERAGES :. Not indicated 
I~JERACrION~ A~COHOL : Not indicated 
SIDE EFFECTS : Phosphate depletion with resultant increase in e x -
c retion of calcium and osteomalacia 
Large doses may lead to intestinal obstruction 
Nausea , vomiting and constipation 
AHBUPHVLLINE 
A theophylline derivative similar to aminophylline 
.HiQJg8J..lQ.t:!.~.:.. Bronc hosp as m 
R.ECOHHENDED DOSE RANGE_:_ 60mg to 120mg 
MAX I .M.U.M. D.05.E_:_ Not indicated 
H.ANNER OF. U_SE .: .. Not ind i c .3ted 
DUR.AT I .ON OF USE :_ Not ind i c .3ted 
INTERACT IONS MED.IC INES:_ As for theophy 11 i ne 
I .N.T.E.RA.CT_IONS. FO.OD.S/NON.-ALCOHOL.IC BEVERAGES:_ F o o d s h i g h i n 
:-(.3nth i nes such as coffee, choco 1 ate, tea, cola , may lead to e:-(-
acerbation of side effects if consumed in large amounts 
INTERACTIONS ALCOHOL : Not indicated 
SIDE EFFECTS.: Nausea and vomiting and gastric bleeding, visual 
disorders, insomnia, headache, anxiety , confusion, restlessness, 
hyperventilation, vertigo and palpitations 















AHBUPHYLLINE. ,,,,, , 
AMILORIDE HYDROCHLORIDE. 
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